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Abstract 
The Apicomplexan parasite Toxoplasma gondii is an obligate intracellular parasite. 
Infection by T .gondii causes the disease toxoplasmosis, which is one of the most 
prevalent parasitic diseases of animals and humans. It has been 100 years since the 
first discovery of the parasite in 1908; research on T. gondii has been carried out in 
many scientific disciplines consistently expanding the understanding of this parasite. 
In the last ten years, the developments of EST, microarray, genome sequencing and 
continuing efforts towards genome annotation has centralized the focus of T. gondii 
research on the understanding of gene expression and gene functions on the genome 
scale. Equipped with the technical advances in mass spectrometry and bioinformatics, 
proteomics has become established as an integral component in the post-genomics 
era by providing first-hand data on the functional products of gene expression. 
In this study, three complementary proteomic strategies, 1-DE, 2-DE and MudPIT, 
have been used to characterise the proteome of T. gondii tachyzoites. Protein 
identifications have been acquired for more than two thousand (2252) unique release 
4 genes, representing almost one third (29%) of the predicted proteome of all life 
cycle stages. Functional predictions for each protein were carried out, which 
provided valuable insights into the composition of the expressed proteome and their 
potential biological roles. The T. gondii proteomic data has been integrated into the 
publically accessible ToxoDB, where 2477 intron-spanning peptides provided 
supporting evidence for correct splice site annotation of the release 4 genome 
annotation. The incompleteness of the release 4 genome annotation has been 
highlighted using peptide evidence, confirming 421 splice sites that are only 
predicted by alternative gene models. Analysis has also been carried out on the 
proteomic data in the light of other genome wide expression data. The comparison of 
the proteome and transcriptome of Toxoplasma and other Apicomplexa parasites has 
revealed important discrepancies between protein and mRNA expression where 
interesting candidates have been highlighted for further investigation. A preliminary 
DIGE study has been developed to characterize protein expression changes in T. 
gondii grown in the presence or absence of glucose. 
In conclusion, this study has demonstrated the importance of proteomic applications 
in understanding gene expression profiles and regulation in T. gondii and highlighted 
the importance and potential of proteogenomic approaches in genome annotation 
process. The importance of temporal and quantitative proteomics as well as the 
future of systems biology has been discussed. 
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1.1  Toxoplasma gondii 
In 1908, Nicolle and Manceaux at the Pasteur Institute in Tunis discovered a parasite 
in North African rodents, the gundi, Ctenodactylus gundi [1]. In the same year, 
Splendore discovered the same parasite isolated from a rabbit in Brazil [2]. Both 
groups initially identified this parasite as Leishmania before the current name 
Toxoplasma gondii was proposed by Nicolle and Manceaux after extensive 
microscopic analysis of several tissues and experimental studies in 1909 [3]. 
In the last 100 years, research on T. gondii has been carried out in many scientific 
disciplines consistently expanding the understanding of this parasite. T. gondii is an 
obligate intracellular protozoan parasite which infects all warm-blooded animals [4]. 
Humans acquire T. gondii through ingestion of undercooked meat, contact with 
feline faeces, through drinking contaminated water and through transplantation of a 
contaminated organ [5]. In humans, T. gondii is frequently associated with 
congenital infection and abortion [6]. Infections of T. gondii are usually minor and 
self-limiting but it can cause encephalitis or systemic infections in the immune-
compromised, particularly individuals with HIV/AIDS [7].  
T. gondii is a member of the phylum Apicomplexa, class Sporozoa and subclass 
Coccidia.  All members of Apicomplexa share a common feature of the presence of 
an apical complex in one or more stages of the life cycle. The Apicomplexa include a 
number of medically and agriculturally significant pathogens such as Plasmodium, 
Cryptosporidium, Theileria, Neospora and Eimeria. In common with the other 
Apicomplexa, T. gondii has a complex life-cycle with multiple life-stages. 
 Chapter 1-Introduction 
 
3 
 
1.1.1  Life cycle of T. gondii 
T. gondii is a tissue cyst-forming coccidium with a heteroxenous life cycle. Felidae, 
for example domestic cats, are the only definitive hosts for T. gondii [8] and all other 
warm-blooded animals are intermediate hosts. There are three infectious stages of T. 
gondii: the tachyzoites, the bradyzoites and the sporozites. They are linked in a 
complex life cycle which is illustrated in Figure 1.1. 
 
Figure 1.1 Life cycle of T. gondii (Adapted from Dubey JP [9]) 
1.1.1.1  Life cycle in the intermediate hosts 
In intermediate hosts, T. gondii undergoes two phases of asexual development, the 
tachyzoite and bradyzoite.  
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1.1.1.1.1 Tachyzoite 
The term “tachyzoite” (Greek: tachos = speed) was proposed by Frenkel [10] to 
reflect the rapidly multiplied and invasive nature of this life stage. Tachyzoites 
invade host cells by actively penetrating through host cells (see section 1.1.3). 
Tachyzoites multiply asexually within the host cell by a repetitive specialized 
process called endodyogeny, in which two progeny form within the parent parasite 
[11, 12].  
The tachyzoite is crescent-shaped, approximately 2×7 µm with a pointed anterior 
end (defined by the direction of motility). It consists of a unique cytoskeleton 
(subpellicular microtubules, conoid, inner membrane complex), secretory organelles 
(rhoptries, micronemes, dense granules), endosymbiotic derived organelles 
(mitochondrion, apicoplast), eukaryotic universal organelles (nucleus, endoplasmic 
reticulum, Golgi apparatus, ribosomes), and specific structures (acidocalcisomes), all 
enclosed by a complex membranous structure termed the pellicle [13, 14]. 
In response to the stress of the host cell immune system, the tachyzoites convert to a 
slow growing form called bradyzoites. Stage differentiation from tachyzoite to 
bradyzoite is accompanied by a major shift in the antigenic expression profile and 
alterations to metabolism of the parasites [15-17]. 
1.1.1.1.2 Bradyzoite and tissue cysts 
The term “bradyzoite” (Greek: brady = slow) was also proposed by Frenkel [10] to 
describe the encysted stage of the parasite in tissues. Bradyzoites multiply slowly by 
endodyogeny in tissue cysts [15, 18]. Tissue cysts vary in size, young tissue cysts 
can be as small as 5 µm in diameter and contain only two bradyzoites [19] while 
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older ones can contain hundreds of bradyzoites and be elongated to 100 µm long 
[20].  
The crescent-shaped bradyzoites are 5-8.5×1-3 µm in size. Structurally, the 
bradyzoite only differs slightly from the tachyzoite. Bradyzoites are more slender 
than tachyzoites, and the nucleus is situated more towards the posterior end 
compared to the centrally located tachyzoite nucleus. Bradyzoites contain several 
amylopectin granules which stain red with PAS reagent where such material is either 
in discrete particles or absent in tachyzoites [20]. 
Tissue cysts are the final life-cycle stage in the intermediate host cells. The parasite 
may cause immediate toxoplasmosis or remain latent in the host for life. It has been 
found that a very small percentage (2 of 750, 0.27%) of tissue cysts rupture at any 
time during chronic infections and result in stage conversion back to the active 
tachyzoite form [21]. This interconversion mechanism is important to maintain a 
chronic infection and also causes disease reactivation in people with immune-
deficiencies, such as AIDS or malignancies [19, 22]. 
1.1.1.2  Life cycle in the definitive host 
Cats are the definitive host of T. gondii. They can be infected by ingesting oocysts, 
tachyzoites, bradyzoites or transplacentally. The bradyzoite-induced cycle is well-
characterized [23, 24]. After the ingestion of tissue cysts by cats, proteolytic 
enzymes in the stomach and small intestine dissolve the tissue cyst wall and 
bradyzoites are released. Bradyzoites then penetrate the epithelial cells of the small 
intestine and initiate the development of numerous generations of T. gondii, known 
as asexual enteroepithelial development [20, 24]. 
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1.1.1.2.1 Asexual development 
Five morphologically distinct types of T. gondii develop in intestinal epithelia cells 
in this stage and are designated types A to E [24]. Rather than generations 
conventionally known as schizonts in other coccidian parasites, “type” is used 
because there are several generations within each T. gondii type (see Figure 1.2). 
 
Figure 1.2 Coccidian cycle of T. gondii (Adapted from Dubey JP et al. [24]) 
These types were morphologically distinguishable from tachyzoites and bradyzoites 
that also occur in the cat intestine. Little is known about the structure or biology of 
type A [19]. Type B schizonts formed merozoites by endodyogeny [25], which has a 
similar relationship to that described for parasites invading the small intestine of the 
intermediate host [26, 27]. Type C, D, and E multiply by schizogony, which is also 
termed as endopolygeny [28]. In schizogony, the nucleus divides two or more times 
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without cytoplasmic division. Before or simultaneous with the last nuclear division, 
daughter organism (merozoite) formation is initiated near the centre of the schizont. 
The merozoites often remain attached to a small amount of residue cytoplasm at the 
posterior end; some merozoites are released from the host cell into the lumen, where 
they can reinvade enterocytes [24, 25]. 
1.1.1.2.2 Sexual development 
After the asexual development (types A-E), the sexual cycle starts. Merozoites 
released from the host cell reinvade new enterocytes and develop into either male 
(microgametocyte) or female (macrogametocyte) gametocytes [13]. In 
microgametogony, 15-30 male gametes (microgametes) are produced [29, 30]. Only 
one female gamete (macrogamete) is formed in macrogametogony [31, 32].  
Microgametes use their flagella to swim to and penetrate and fertilize mature 
macrogametes to form zygotes. That fertilization can occur has been proven from the 
identification of cross-fertilized parasites [33], however, the necessity and 
mechanism of fertilization remain uncertain [34]. After fertilization, an oocyst wall 
is formed around the parasite. Infected epithelial cells rupture and discharge oocysts 
into the intestinal lumen. 
1.1.1.2.3 Oocyst shedding and extracellular sporulation 
Cats can shed millions of oocysts in a few days [24, 35]. The oocyst is the only stage 
of T. gondii that can undergo extracellular development.  Oocysts are excreted in an 
unsporulated form and then form two sporocysts by asexual development 
(sporulation). Each sporocyst contains four sporozoites [13, 36-38]. Sporulated 
oocysts can survive for long periods under moderate environmental conditions 
before ingestion by an intermediate host [39, 40]. 
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1.1.2  Population structure of T. gondii 
Three different invasive forms make T. gondii a remarkably successful parasite. The 
rapid invasion of tachyzoites into virtually all types of animal cells followed by the 
ability of chronic infection maintained mainly in bradyzoites form and the spread of 
sporozoites shed in environmental resistant oocysts all contribute to its global 
distribution, and this suggests a large genetic diversity. 
The first genotyping studies on T. gondii in North America and Europe was 
published 15–20 years ago, led to the description of a clonal population structure of 
Toxoplasma with three main lineages, types I, II and III [41-43]. The clonal nature of 
three T. gondii lineages was confirmed by the high-fidelity sequencing of single-
copy genetic regions comprising both antigens and introns [44]. Within each lineage, 
the true rate of divergence were extremely low at less than 1 in 10,000 bp [45] and 
the genome wide polymorphism rate between three lineages has been estimated to be 
0.65% [46]. The absence of diversity within each of the three lineages and low 
divergence between lineages suggest the three lineages merged as the dominant 
strains relatively recently. Based on the assumption that mutations arise at a constant 
rate, it was estimated the three lineages were expanded from a common ancestor 
10,000 years ago [44]. The pattern of single-nucleotide polymorphisms (SNP) in the 
T. gondii genome also produced a model that types I and III strains are second and 
first generation offspring of a cross between a type II strain and one of two ancestral 
strains [46]. 
Strains which differ from the three well defined lineages have been described more 
frequently from more remote geographic areas [47, 48] and several studies on strains 
from South America revealed that they are genetically distinct from the Eurasian 
strains studied [49-52]. Combining T. gondii strains from Europe, North and South 
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America in a phylogenetic analysis of polymorphism in introns, a new picture of 
population structure is given. Eleven distinct haplogroups were recently defined with 
three major clonal lineages renamed as haplogroups 1, 2 and 3, and notably, all 
existing haplogroups are predicted to be derived from admixture of four ancestral 
lineages [53]. 
Although genetic diversities between the clonal lineages are small, they underlie 
large phenotypic differences that influence virulence. Studies in human cases 
(congenital, transplant and AIDS) from North Amedica and Europe indicate a major 
association with type II strains [42, 48, 54]. Type III strains are only seen in a few 
human cases with underlying immunodeficient state and type I strains have increased 
prevalence in some cases of congenital infection and AIDS patients [55, 56]. In 
mouse models, type I strains have been shown as highly virulent and type II and III 
strains are considered non-pathogenic [57]. Different degrees of mouse-virulence 
were shown in different clonal groups in South America [58]. Large molecular-
epidemiological studies will be needed to understand the distribution and virulence 
of different genotypes across the world, which will be important to develop 
intervention strategies and disease control. 
1.1.3  Host cell invasion, intracellular survival of tachyzoites and the 
role of related secretory organelles 
T. gondii is an obligate intracellular parasite; being able to invade a new host cell is 
crucial for survival and expansion of infection. During infection, most intracellular 
microbes and parasites take advantage of endocytosis or phagocytosis as a means of 
entry into cells [59, 60]. In contrast, T. gondii does not rely on existing routes, but 
uses its own active, parasite-driven penetration process [61]. 
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Figure 1.3 Host cell invasion process of tachyzoites  (a) Model of the 
glideosome system of T. gondii. As described in greater detail in section 1.1.3.1, the 
glideosome is the molecular machine that promotes gliding motility. (Adapted from 
Keeley A et al.[62])  (b) An integrated working model of Toxoplasma invasion. As 
decribed further in sections 1.1.3.2-5, the invasion process involves multiple steps 
including: initial attachment, formation of moving junction, injection of ROP 
proteins and the completion of invasion. (Adapted from Carruthers V et al.[63]) 
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1.1.3.1  Glideosome 
T. gondii, as well as other Apicomplexan parasites, utilizes a substrate-dependent 
locomotion called gliding motility for tissue migration and cell invasion [62, 64] (see 
Figure 1.3a). Gliding relies on a linear motor system (glideosome) in the pellicle of T. 
gondii between the outer plasma membrane and inner membrane complex (IMC). A 
class XIV myosin (MyoA), the myosin light chain and two gliding-associated 
proteins (GAPs) form the motor complex [65]. The motor complex is anchored in the 
outer membrane of the IMC and connected via filamentous actin (F-actin) and 
glycolytic enzyme aldolase. Aldolase links the complex to the cytosolic domain of 
transmembrane adhesive proteins (adhesins) that spans the outer plasma membrane 
[62]. Tachyzoites use this actin-based motility coupled with regulated protein 
secretion from apical organelles to actively invade host cells. 
1.1.3.2  Initial attachment 
An integrated multi-step working model has been shown in Figure 1.3b. The initial 
attachment of tachyzoites to the host cell surface is mediated by a family of GPI-
anchored surface antigens (SAGs) and SAG related sequence (SRS) proteins [66, 67]. 
A wide distribution of SAG and SRS proteins coated on the parasite surface [68], 
among which a few are known to dominate the surface of tachyzoites, SAG 1-3 and 
SRS 1-3 [69]. SAG and SRS proteins provide a low-affinity and lateral interactions 
between the parasite and host cell surface, which it has been postulated may allow 
the parasite to survey the host cell surface for an optimal invasion site [63]. 
The tachyzoite initiates penetration into the target cell exclusively using its apical 
end. Several lines of evidence suggest micronemes play an important role in the 
process. Firstly, many micronemal proteins (MICs) have been shown to migrate out 
to the apical surface of parasite during attachment under a calcium signal dependent 
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mechanism [70]. Secondly, many MICs possess domains that mediate protein-
protein or protein-carbohydrate interactions (for example thrombospondin-like, 
epidermal growth factor-like, lectin-like and so on) [71]. Finally, the genetic 
depletion of MIC genes such as MIC1 and MIC3 [72], MIC2 and MIC2-associated 
protein (M2AP) complex [73-75] substantially attenuates parasites invasion. The 
study of MIC1 and MIC3 also revealed that individual disruption of either MIC1 or 
MIC3 expression slightly reduced virulence in the mouse, whereas doubly depleted 
parasites are non-virulent and fail to produce a lethal infection [72]. Together, this 
evidence suggests that the parasite expresses a variety of adhesive MIC proteins to 
target a wide range of host cells and create a robust binding-interface by using 
multiple receptors. 
1.1.3.3  Moving junction 
Almost simultaneously as microneme secretion, a calcium-dependent conoid 
extrusion is observed [63, 76]. The precise role of conoid extrusion is unclear, it 
could serve to bring the apical tip closer to the host plasma membrane [63] or be an 
important requisite for microneme secretion [76]. At around the same time of these 
events, another attachment step is executed which depends on the expression of a 
micronemal protein apical membrane antigen 1 (AMA1) [77]. During or after 
secretion, AMA1 forms a stable complex with three rhoptry neck (RON) proteins 
(RON2, RON4, RON5), which together occupy a structure known as the moving 
junction (MJ) [78, 79]. 
The MJ is a ring-like band at the intimate contact of host and parasite plasma 
membranes. The first role of the MJ is likely to be an anchor, which allows the actin-
myosin motor to “pull” the parasites into the nascent vacuole in the host cell. AMA1 
is secreted from micronemes onto the plasma membrane and anchored by a 
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transmembrane domain. While RON4 and RON5 do not have transmembrane 
domains, RON2 has three predicted transmembrane domains that may act as a bridge 
by inserting into the host plasma membrane [80]. As invasion proceeds, the MJ 
migrates from anterior to the posterior end and forms the border or rim of the nascent 
parasitophorous vacuole (PV). This brings into play the other role of the MJ which is 
likely to act as a molecular sieve that selectively removes parasite proteins and 
restricts access of host proteins to the forming vacuole [81, 82]. All of the known 
MIC proteins other than AMA1 and other transmembrane proteins anchored in the 
cytoskeleton are selectively excluded suggesting the filtering takes place on the 
cytoplasmic face of the plasma membrane. Many proteins gain access to the vacuole 
by partitioning into lipid rafts which raises the possibility that the MJ actively orders 
lipids within the bilayer and thus influence the protein composition of the vacuolar 
membrane [80]. 
1.1.3.4  ROP proteins are injected into host cells 
Simultaneously or immediately thereafter the MJ is formed, the proteins located in 
rhoptry bulb (ROPs) are injected to the host cytoplasm [83]. A detailed proteomic 
analysis of the contents of the purified rhoptries provided a comprehensive list of 
RON and ROP proteins [84]. Thirty eight novel proteins were identified and the 
location of 11 out of 12 novel proteins was verified as rhoptry by the production of 
antibodies [84]. Furthermore, rhoptry proteins were distinguished according to their 
sub-organellar location as either bulb (ROP) or neck (RON). This study found that 
all of the RON proteins identified have homologues in Plasmodium which suggests 
their involvement in processes that are common to the Apicomplexa phylum [80, 84]. 
On the contrary, nearly all of the ROPs are unique to either Toxoplasma or 
Plasmodium indicating that ROPs are highly adapted to the intracellular niches that 
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they occupy [80, 84]. In Toxoplasma, ROPs migrate to one of three general locations 
after injection: the lumen of the nascent PV, the parasitophorous vacuole membrane 
(PVM) or the host cell nucleus. 
ROP1 is released during invasion and accumulates within the lumen of the nascent 
PV [85]. Interestingly, ROP1 synthesized in one parasite can migrate to the PV of 
another parasite [86]. The ROP2 family of proteins generally migrates to the host 
cytosolic side of the PVM [87-89]. The ROP2 family contains a conserved 
serine/threonine (S/T) kinase domain, although most other members lack key 
residues predicted to be necessary to phosphorylate proteins [80, 90]. Recently, a 
highly polymorphic member protein ROP18 was confirmed as having kinase activity 
and could have potential roles in parasite growth and virulence [91, 92].  ROP2 has 
also been suggested to be involved in the recruitment of host cell mitochondria by 
resembling a mitochondrial-import signal [88, 93]. Recent studies pointed out a third 
destination of ROPs; two rhoptry proteins, PP2C-hn [94] and ROP16 [95] have been 
observed in the host cell nucleus. PP2C-hn is a protein phosphatase of the 2C class 
(hn is the abbreviation for host nucleus) and ROP16 is a putative protein kinase; both 
proteins are directed to the nucleus by a conventional nuclear localization signal 
(NLS) [89]. ROP16 is likely to modulate host signalling by indirectly inducing the 
activation of the signal transducer and activator of transcription (STAT 3/6) 
signalling pathways with consequent effects on host IL-12. Furthermore, ROP16 has 
shown strain-specific polymorphism where the allele shared by types I and III is 
effective in mediating sustained phosphorylation of STAT3, while the allele found in 
type II does not [95]. This interaction may in part explain the much lower levels of 
IL-12 that are induced by type I or III versus type II strains following infection of 
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macrophages and subsequently the differences of Toxoplasma strain virulence [95, 
96]. 
RONs and ROPs are essential to the host cell invasions and PV establishment, 
however, the characterization of molecular interactions and biological functions are 
still at an early stage where great efforts are being carried out using genetic and 
cellular tools [80, 89]. 
1.1.3.5  Completion of invasion 
It takes only 15-20 seconds before the MJ completes its migration [97]. The invasion 
arrives to its final stage: pinching off and separation of a complete PVM. The 
process involves fission of the PVM and host plasma membrane that can take as long 
as two minutes. The exact mechanism is unclear, for example how are the residual 
MJ complex or other parasite and host fission proteins involved [63]. 
1.1.3.6  Intracellular survival 
Once inside the host cell, the PV is used as a platform for tachyzoites to modulate 
several host cell functions that support parasite replication and lead to a long-term 
chronic infection. Mitochondria and endoplasmic reticulum (ER) from the host cell 
rapidly surround the PVM and are recruited in the supply of a dedicated nutrient 
source for the support of parasite division [98]. The host intermediate filaments (IFs) 
and microtubules (MTs) are also reorganized around the PV providing intracellular 
localization and structural integrity support [99, 100]. Functionally, host cell 
modifications induced by the parasites includes the inhibition of inflammatory host 
responses, interference with regulatory and effector functions of immune cells, and 
manipulation of host cell apoptosis [101]. 
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Three functionally distinct membranous subcompartments are organized in the PV 
[102]. The PVM is a thin membranous extension prolonged within the host cell 
cytosol. The second subcompartment consists of host organelle-sequestering tubulo 
structures (HOSTs), which are microtubule-based PVM invaginations that channel 
cholesterol-enriched host endolysosomes into the PV [99]. The third 
subcompartment is the membranous nanotubular network (MNN), which extends 
into the vacuolar lumen that link the parasites together and to the PVM [103, 104]. 
MNN is thought to maintain parasites in an ordered arrangement within PV that 
allows their synchronous division [102].  
Up to now, the Toxoplasma proteins identified in the PV originate from either the 
rhoptries or the dense granules[102]. In addition to ROPs that are injected into the 
host cell during invasion (section 1.1.3.4), a burst of dense granule proteins (GRAs) 
are secreted into the PV within the first few minutes of PVM formation [83, 105]. 
GRA1 is a calcium-binding protein and the only completely soluble GRA protein 
within the vacuolar space [106]. All other GRAs associate with distinct PV 
membranous sub-compartments: GRA2, 4, 6, 9 and 12 associate with MNN, while 
GRA3, 5, 7 and 8 associate predominantly with the PVM and GRA7 with the 
HOSTs [102, 107]. GRAs share no obvious homology with proteins of known 
function but are likely to be involved in intracellular parasite development and 
multiplication and their secretion is likely to continue on a basal level as long as 
parasite multiplication takes place [102]. 
1.1.4  T. gondii genome 
The first output of T. gondii genome sequencing project was finished in 2003 [108]. 
The 10 × shotgun genome sequencing and annotation of the type II strain ME49 was 
performed by the Toxoplasma Genome Consortium, under collaboration between Ian 
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Paulsen from the Institute for Genomic Research (TIGR) and David Roos from the 
University of Pennsylvania, and led to a draft version of the 80 Mb genome sequence 
[108, 109]. In addition to this effort, the Wellcome Trust Sanger Institute determined 
the 5 × shotgun sequencing of type I strain RH chromosome 1a and 1b as well as a 
whole genome bacterial artificial chromosome (BAC) library [110]. The type II 
ME49 strain was the first strain to be sequenced followed by two other strains, GT1 
and VEG; all data are available on ToxoDB [108].  
A genetic linkage map was used to assemble the gene coordinates from scaffolds to 
14 chromosomes of ME49 strain [111]. The chromosome map for ME49 strain was 
used as a template to create GT1 and VEG strain chromosomes [108]. Gene 
prediction programs including GLEAN, GlimmerHMM, TigrScan and TwinScan 
were used for ME49 strain genome annotation in 2003, followed by the release of a 
major integrated and updated version on ToxoDB (version 4) in 2006 [108]. In the 
latest release of ToxoDB (version 5), genome sequences of the three strains are 
between 61-64 Mb in size. A newer version of genome annotation for ME49 strain is 
also updated together with a brand new genome annotation for GT1 and VEG strains 
[108]. The numbers of genes for T. gondii are currently predicted to be 8102 for the 
ME49 strain, 8145 for the GT1 strain and 7945 for the VEG strain [108]. 
All the raw genomic sequences and genome annotations of the latest version of 
genome sequencing project can be downloaded at ToxoDB [112]. This valuable 
information provided the foundation of many genome-wide researches of T. gondii 
including the whole proteomic analysis of tachyzoites carried out in this study. 
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1.2  Proteomics 
Proteins are the end products of most genes, the identification of expressed proteins 
and their functions are central to the understanding of biological meaning of the 
genome. The term proteome was introduced by Marc Wilkins in 1994 at a 
conference [113] to describe the entire complement of proteins expressed by a 
genome, cell, tissue or organism. More specifically, it is the set of expressed proteins 
at a given time under defined conditions. Papers that began to use the term were 
published thereafter [114, 115].  
The biological importance and interest of studying global protein expression and 
understanding functional genomics have driven the field of „proteomics‟ which has 
rapidly progressed in recent years. Around 200 research articles and reviews were 
published each month in the first half of 2009. The rapid growth of proteomics has 
been supported by technical advances in key areas of proteomics research.  
To start with, protein separation techniques were employed such as 2-D 
electrophoresis and 2-D liquid chromatography (LC) to deal with the complicated 
protein samples. The next step has benefited from advances in mass spectrometry in 
which the sensitivity and capability of measuring mass-to-charge ratio (m/z) of 
ionized peptides and proteins are consistently improving. The final step took 
advantage of the development of dedicated bioinformatics packages that analyse, 
visualise and interpret proteomic data to achieve a better understanding of the 
biological system under study. Simultaneously, the flood of draft and complete 
genome sequencing projects and new high-throughput sequencing platforms 
provided essential sequence databases for proteomics data searching.  
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Proteomics add such a value to biological research that it shifts the paradigm from a 
„one-protein-at-a-time‟ view to a new „global‟ view. Hundreds of expressed proteins 
can be identified and characterized in a high throughput manner that was not 
possible before. The following sections will discuss the current developments and 
applications of proteomics in detail. 
1.2.1  Proteomic strategies for high-throughput protein identification 
Several proteomic strategies have been developed to achieve high-throughput protein 
identifications. Typically, they can be divided into two groups, „top-down‟ and 
„bottom-up‟. „Top-down‟ proteomics is a straight forward approach in which intact 
proteins are analysed by MS. Due to the instrument limitations, analysing intact 
protein samples is more difficult to achieve by MS. „Bottom-up‟ proteomics is a 
more commonly used strategy which analyses enzymatically or chemically produced 
peptides of the protein samples (See Figure 1.4). 
Figure 1.4 Proteomic strategies for protein identification (Adapted from Han 
et al. [116]) 
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1.2.1.1  Bottom-up proteomics 
Bottom-up proteomics uses information acquired from peptide detection to infer the 
protein identification. According to the method by which the peptide mixture is 
produced, this approach can be further divided into two strategies.  
The first strategy is to separate the complex sample in protein space, by using protein 
fractionation and separation techniques such as gel electrophoresis. The resulting 
single protein or appreciably less complex protein mixture is then digested into 
peptides. The peptides can be analyzed by peptide mass fingerprinting (PMF) or 
following further peptide separation by LC coupled to a tandem mass spectrometer 
[116, 117]. 
The other strategy is to separate the complex sample in peptide space, which is also 
known as „shotgun proteomics‟. Protein digestion is carried out without or with 
minimum sample pre-fractionation. The peptides produced are separated by 
multidimensional chromatography and analyzed by tandem mass spectrometry [117, 
118]. 
1.2.1.2  Top-down proteomics 
Top-down proteomics is a relatively new strategy which is mainly restricted to the 
use of more powerful Fourier-transform ion cyclotron resonance (FTICR) mass 
spectrometers. In this approach, intact proteins are ionized and fragmented inside the 
mass spectrometer and high-resolution mass measurement is made [119]. 
FTICR utilises a new type of fragmentation technique called electron-capture 
dissociation (ECD). In ECD, the recombination of an electron with the multiply 
protonated peptide/protein ion makes differences in bond dissociation energies less 
important and induces protein backbone cleavages [120]. This technique provides 
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great fragmentation efficiency for small to medium sized proteins [121-123]. For 
protein ion molecules larger than ~ 50 kDa, protein tertiary structures become more 
complex with many non-covalent interactions which reduce the fragmentation 
efficiency and make top-down proteomics inefficient [124]. Recent developments to 
tackle this problem include prefolding dissociation (PFD) that dissociate ~240 
residues from each terminus of protein [125] or using limited digestion to produce 
larger peptides (>5 kDa) [126].   
Top-down proteomic approaches examine the entire protein sequence directly which 
enables a more complete characterization of protein isoforms and post-translational 
modifications (PTMs) [127, 128] and lead to exciting de novo sequencing [129]. 
However, the requirement for direct infusion of a single protein or simple protein 
mixture remains a major challenge for large-scale high throughput proteome 
characterization. Kelleher‟s group presented the first large-scale top-down 
proteomics on a LTQ-FTICR system that uses high-resolution MS/MS data obtained 
on a chromatographic time scale [130]. The study identified 22 proteins from a 
single LC-MS/MS run and 38 proteins were unambiguously identified in 
metabolically labelled proteome experiments. 
Despite the rich protein characterization information provided by the top-down 
proteomic strategy, the sophisticated instrumentation setup, technique restrictions 
and relatively small protein identification yields under the current development stage 
mean that bottom-up proteomics is still the most suitable strategy for large-scale 
protein identification projects. The following sections will discuss the bottom-up 
proteomic approach in more details. 
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1.2.2  Sample preparation and separation 
Sample preparation and fractionation are crucial in a successful proteomic analysis. 
The separation and fractionation of a sample benefits downstream applications 
enormously by improving the resolution of analysis. Proteins in the sample need to 
be extracted from cells, denatured, disaggregated and solubilised before being 
analysed by proteomic approaches. 
Cell lysis can be achieved by osmotic lysis, detergent lysis, enzymatic lysis of the 
cell wall, mechanical blending, sonication, freeze/thaw and manual grinding [131]. 
During or after cell lysis, interfering compounds such as salts, proteolytic enzymes, 
nucleic acids, polysaccharides, lipids and particulate material must be diluted, 
inactivated or removed. 
As discussed in section 1.2.1, before complex protein samples can be analysed by 
MS, sample separation needs to be achieved in either protein space or peptide space. 
Sample separation in protein space is typically achieved by gel electrophoresis 
followed by enzymatic digestion. Sample separation in peptide space is achieved by 
direct digestion of complex sample followed by liquid chromatography separations. 
1.2.2.1  Sample separation in protein space 
One-dimensional and two-dimensional gel electrophoresis (1-DE and 2-DE) are 
commonly used in proteomic studies. They separate solubilised proteins samples 
according to their physical properties and provide visualization representations of the 
proteome studied. 
1-DE is a well established widely used technique which separates proteins based on 
their molecular mass using SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
[132]. Proteins are reacted with the anionic detergent SDS to form negatively 
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charged complexes. Denatured proteins bind to SDS in a relationship proportion to 
mass and independent of amino acid composition and sequence. Proteins are 
separated by the polyacrylamide matrix on the basis of molecular mass. 
2-DE couples isoelectric focusing (IEF) in the first dimension with SDS-PAGE in 
the second dimension, and enables protein separation on the basis of isoelectric point 
(pI) followed by molecular mass [131]. 2-DE can resolve thousands of proteins 
simultaneously and detect < 1 ng of protein per spot [131].  
Separated proteins on the gel need to be visualized by staining methods. One big 
challenge is the huge differences of protein abundance in the sample, which can 
range between 7-8 orders of magnitude in a cell [133]. High sensitivity, high linear 
dynamic range and compatible with downstream protein identification procedures 
are required for a good staining method. Commonly used methods include organic 
dyes such as colloidal Coomassie Blue (detection limit ~30 ng) [134], negative stain 
with metal cations such as zinc chloride (20-50 ng) [135], silver stain such as silver 
nitrate stains (5-10 ng) [136] and fluorescence stain such as SYPRO Ruby (1-2 ng) 
[137]. This enables a frozen-in-time view of the proteome which reflects changes in 
protein isoforms, PTMs and expression levels. 
Bands and spots separated by 1-DE and 2-DE are excised followed by in-gel protein 
digestion. Trypsin is the most widely used enzyme for protein identification based 
proteomics. It cleaves specifically after arginine or lysine residues, producing 
peptides with an average size of 800-2000 Da [138]. 
1.2.2.2  Sample separation in peptide space 
Shotgun proteomics separates samples in peptide space. Complex samples are 
directly digested using one or a combination of proteases such as Lysine-C (Lys-C), 
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V8 and trypsin. One combination is using Lys-C followed by trypsin. Lys-C fully 
preserves its activity in the presence of 8 M chaotropic agent urea, the accessibility 
of this enzyme to peptide bonds is higher than the accessibility of trypsin, which 
remains active up to 2 M urea. 
Sample digestion results in a highly complex of peptide mixture. The peptides are 
then separated by multidimensional liquid chromatography before analysis by 
MS/MS. A typical setup using this strategy is called multidimensional protein 
identification technology (MudPIT) [139, 140]. MudPIT couples a strong cation 
exchange (SCX) column with a reversed phase (RP) column to separate peptides 
using 2D liquid chromatography. Peptides are displaced from SCX to the RP column 
using 12 salt step gradients. The RP column then progressively elutes peptides over a 
gradient of acetonitrile (ACN) with increasing hydrophobicity. Peptides are then 
analysed by MS/MS which is reviewed in section 1.2.3. 
Although a MudPIT experiment requires less labour with simple automated setup, it 
results in greatly increased complexity of the generated peptide mixture. Achieving a 
good result requires highly sensitive and efficient separation. Information is also lost 
upon the conversion of intact proteins into a mixture of peptides, and it also involves 
significantly more computer power for data analysis. 
1.2.3 Mass spectrometry used in protein identification based proteomics 
MS is a technology that measures the mass-to-charge ratio (m/z) of molecules. Mass 
spectrometers consist of three key components. An ion source that converts 
molecules into gas-phase ions, a mass analyzer that separates charged molecules 
according to their m/z and a detector that records the number of ions at each m/z 
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value. Various ionization sources and analyzers can be combined to facilitate 
proteomic research. 
1.2.3.1  Ionization 
Two soft ionization methods are used in proteomics due to their ability to produce 
intact ions from peptides and proteins, matrix-assisted laser desorption/ionization 
(MALDI) [141] and electrospray ionization (ESI) [142]. 
In MALDI, matrix (aromatic acids) is used to protect the analytes from being 
destroyed by laser light and to assist vaporization and ionization. The analytes are 
embedded into a crystalline matrix on a metal „target‟ plate. The target is then placed 
in the vacuum of a MALDI source and pulses of laser light (typically a nitrogen laser) 
are directed at the matrix. The matrix absorbs the laser energy and transfers its 
charge to the analyte molecules, as the matrix evaporates, analytes are liberated and 
ionized. The observed ion that contains a neutral molecule [M] is protonated to form 
a singly charged quasimolecule [M+H] 
+ 
[117, 141]. 
In ESI, the sample is presented in a liquid form and thus can be easily associated 
with online liquid chromatography. The typical solvents are prepared with water, 
volatile organic compounds (e.g. methanol, ACN) and acetic acid which increases 
the conductivity. The solution containing the analytes flows into a capillary that is 
subject to a high voltage (2-3 kV) which forms the solution into a fine spray of 
highly charged droplets. The flow of droplets is then directed through a counter-
current flow of heated gas, causing the solvent to evaporate and the charge 
concentration of the surface of the droplets to increase. It then reaches a critical 
unstable state, known as the Rayleigh limit; the droplets deform into smaller and 
lower charged particles in a process known as Rayleigh fission [143]. The Rayleigh 
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fission is repeated until individually charged analyte molecules remain. ESI 
generally produces a mixture of singly and multiply charged ions [M+nH] 
n+
 [117, 
142]. 
1.2.3.2  Mass analysis 
Four types of mass analysers are commonly used in proteomic research: quadrupole 
(Q), ion trap, time-of-flight (TOF), Fourier-transform ion cyclotron resonance 
(FTICR).  
Quadrupole mass analysers separate ions based on the stability of their trajectories in 
the oscillating electric fields. The quadrupole consist of four parallel metal rods, each 
opposing rod pair is connected together electrically with a radio frequency (RF) 
potential applied. A direct current voltage is superimposed on the RF potential to 
make ions travel along the central axis of the rod. Only ions of a certain m/z will 
reach the detector for a given ratio of potentials while other ions with unstable 
trajectories will collide with the rods. A range of m/z values can be scanned by 
continuously varying the voltages [117]. 
Ion trap mass analysers trap charged molecules using electric or magnetic fields. The 
Quadrupole ion trap (QIT) is most often used and includes the 3D ion trap (Paul ion 
trap) and the linear ion trap. In the 3D ion trap, ions are trapped by electric fields 
produced by a ring-shaped electrode (RF potential) and two end-cap electrodes (dc 
potential). Ions enter the trap from one of the end-cap electrodes and oscillate at the 
frequencies that related to their m/z values. By changing the voltages applied to 
electrodes, ions of certain m/z become excited and are ejected from the opposite end 
cap [144, 145]. The linear ion trap is similar to the 3D ion trap except that the 
electromagnetic signals are designed to trap ions in a rectangular-shaped space. Ions 
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are confined radially by a set of quadrupole rods with RF potentials and axially by a 
static electrical potential on end electrodes. Linear ion trap MS provides increased 
ion storage capacity (10 times compared to the 3D ion trap) and faster scanning 
speeds [117, 145, 146]. 
Orbitrap is a new type of ion trap mass analyser invented by Makarov [147]. It 
provides high mass accuracy and high-resolution capabilities which has the potential 
to be useful for proteomic research [148, 149]. It consists of an outer barrel-like 
electrode and a coaxial inner spindle-like electrode. Ions are trapped and orbit 
around an inner spindle-like electrode, and oscillate harmonically along its axis. The 
frequency of these harmonic oscillations is independent of the energy and spatial 
spread of ions and is inversely proportional to the square root of the m/z. These 
oscillations are detected using image current detection and are transformed into mass 
spectra using Fourier transform similar to FITCR [116, 147, 149]. 
In a TOF mass analyser, ions that are accelerated in an electrical field, then travel 
through a field-free vacuum tube towards an ion detector. All ions with the same 
charge receive the same amount of kinetic energy in the source, while the velocity of 
the ion depends on their m/z. A reflectron with a constant electrostatic field can be 
used to reverse the path of ions towards the detector. Given the tube length and the 
measured times of flight, the mass-to-charge ratio of the ion can be calculated. A 
delayed extraction device can be used to equilibrate the ions which allows the initial 
velocity of ions to be standardised prior to the entrance of the TOF analyser [117]. 
FTICR mass analysers provide the greatest capability for mass resolution and mass 
measurement accuracy. It determines the m/z of ions based on the cyclotron 
frequency of the ions in a fixed magnetic field. FT mass spectrometers consist of a 
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cubic cell inside a strong magnetic field. Injected ions rotate around the magnetic 
field with a frequency according to their m/z. By varying the electric fields, changes 
in the ion frequency of rotation can be measured and converted to m/z by performing 
a Fourier transform [117, 150]. 
1.2.4  Protein identification using MS data 
In bottom-up proteomic research, protein identification is made by matching the 
experimental peptide MS data to a virtual peptide mass database. A virtual database 
contains known protein sequences acquired from predicted gene models, open 
reading frames (ORFs) translated from genomic sequences or EST data. Theses 
sequences are then in silico digested using the same cleavage specificity of the 
protease employed in the experiment to produce theoretically determined peptide 
mass data.  
According to the instrument setup, two types of MS data can be used to determine 
protein identifications: Peptide mass fingerprinting (PMF) data generated by 
MALDI-MS and peptide fragment fingerprinting (PFF) data generated by tandem 
MS, typically ESI-MS/MS. 
1.2.4.1  Peptide mass fingerprinting based identification 
Using peptide mass fingerprinting to determine protein identification was 
independently developed in 1993 by several groups [151-155]. This method is based 
on the use of a list of the molecular masses of digested peptides, served as a 
fingerprint that uniquely defines a particular protein. Experimental spectra of a 
candidate protein which contain m/z ratios of digested peptides are compared with 
theoretical spectra produced by a virtual database and a similarity score is given.  
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Protein (or proteins, in the situation of homologues or multiple proteins in the sample) 
in the virtual database with the top-ranking similarity score is considered the protein 
identification for the spectra. Scoring algorithms for PMF take into account many 
factors such as dissimilarities in the peptide masses caused by calibration errors, 
contaminant or missing peaks, chemical modifications and post-translational 
modifications (PTMs), etc. 
Protein identification based on PMF data is fast and efficient; however, several 
limitations may lead to a poor or false identification. From the database point of 
view, if a protein sequence or an unknown sequence modification is not present in 
the virtual sequence database, the similarity score cannot be made or the result 
represents a false-positive. From the sample point of view, in the case of multiple 
proteins present in the sample, the increase in complexity of the spectra may result in 
poor or false-positive identifications; meanwhile, if the size of protein in the sample 
is too small or the concentration is too low, insufficient peptides MS data can be 
produced for confident protein identifications.   
1.2.4.2  Tandem mass spectrometry based identification 
Tandem mass spectrometry (MS/MS) uses two mass analysers in series. The first 
analyser separates the peptides according to their m/z values; selected peptides 
(precursors) are fragmented and the m/z ratios of the resulting fragments are 
measured by the second analyser. The most widely used fragment method is 
collision-induced dissociation (CID). It internally heats precursors by multiple 
collisions with neutral gas atoms. The C-N bond of the peptide backbone is 
fragmented into a series of b-fragment (charge remains at the N-terminus) and y-
fragment (charge remains at the C-terminus) ions [156]. 
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The principle of peptide fragment fingerprinting (PFF) based identification is very 
similar to the PMF approach. It correlates the experimental MS/MS spectrum with 
virtual MS/MS spectra generated from in silico digestion of proteins to peptides and 
fragmentation of these peptides. Protein identification can be made on several 
independent peptide identifications. The better the overall sequence coverage of the 
protein, the more confident the protein identification is. Scoring algorithms take into 
account the mass of the precursor peptide, chemical and post-translational 
modifications, etc. 
PFF based identification has several advantages over PMF. It does not require all the 
peptides of a given protein to be confirmed to achieve a confident identification. It 
can work with complex peptide mixtures or to search homologous databases. It can 
also provide detailed information about peptide sequences and about possible post-
translational modifications. However, the PFF approach also has limitations: firstly, 
same as PMF, a confident identification relies on the presence of protein sequence in 
the virtual sequence database, although small sequence variations like PTM can be 
partly compensated for by the identification of other peptides in the protein. 
Secondly, non-peptide contamination and poor fragmentation can influence the 
confidence of identification. 
1.2.5  Proteomic data interpretation and integration 
The output of protein identification based proteomic studies is usually a list of 
expressed proteins in the sample inferred by MS data. Whilst of considerable value 
in itself, subsequent characterization of the proteins identified is the next stage, from 
which important biological information about the sample can be gleaned. A further 
area in which proteome data is of great value is the integration of proteomic 
expression data with other genomic resources. The integration centralizes the current 
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knowledge about a particular organism on a genome expression level and proteomic 
data can also help confirm and refine existing genome annotations (see section 
1.2.6.1). 
1.2.5.1  Proteomic data interpretation 
Interpretation of proteomic data uses combined evidence from two approaches:  first, 
manual interpretation of information extracted from experimental data in the 
literature; secondly, information derived by automatically transferring existing 
knowledge about a homologous sequence to the targeting sequence. This latter 
approach is the basis of protein prediction programmes designed to predict protein 
sequence features or motifs based on a set of trained rules. 
1.2.5.1.1 Manual interpretation 
Manual interpretation process allows input from highly trained and knowledgeable 
curators. Curators are able to access and extract information from free text in 
literatures and assess all the information available. Several organism-specific and 
universal projects have been carried out for this purpose and publicly available 
online databases are designed to host the information gathered [157-161]. Among 
these efforts, UniProt is a universal database that commonly used for proteomic data 
interpretation. 
UniProt [157] provides a universal curated protein database that stores and 
interconnects information from various sources including a non-redundant collection 
of protein sequences, metagenomic data and functional annotation. The component 
site UniProtKB/Swiss-Prot contains manual records with the information extracted 
from literature and curator evaluated computational analysis [162]. Annotated 
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information includes protein function, catalytic activity, subcellular location, disease, 
structure and post-translational modifications. 
Although manual curation provides the most reliable information for proteomic data 
interpretation, it is very time consuming. To assist this, text mining methods have 
been recently developed to automatically extract information from literature [163-
165]. However, the current techniques are still under development due to 
complicated syntactic patterns in natural language and restrictions in the processing 
non-textual material i.e. figures [165].  
1.2.5.1.2 Automatic prediction 
The main aim of automatic prediction is to transfer previously characterized protein 
information to uncharacterized homologous proteins. Homologous proteins are 
descended from a common ancestral protein that similar sequences or structures are 
often found and similar functions are often observed. Homologues can be further 
divided into orthologues and paralogues where orthologues are separated by a 
speciation event and paralogues are the product of gene duplication [166]. In 
automatic prediction, both sequence similarity and structure similarity based 
approaches are commonly used. 
While there is no perfect protocol for automatic prediction, the most commonly used 
tool is Basic Local Alignment Search Tool (BLAST) [167]. A BLAST search 
compares the query sequence with protein sequences from various databases and 
reports a similarity score to exactly or partially matched sequences in the databases. 
However, it does not provide sufficient guidelines on whether the annotations can be 
safely transferred to the new sequence. Utilizing orthologues group mapping 
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databases like COG [168] and OrthoMCL[169] can improve confidence of the 
matching. 
A global sequence or structural similarity cannot always be found for a novel protein. 
In a study of 120 complete genomes, an average of 22.4% of proteins in a genome 
are reported as singleton (gene families containing only a single member) [170]. In 
these cases, signature-based resources can be used to infer protein functions when 
one or more protein signatures can be identified.  
Protein signatures are defined by either a regular expression method that shows 
patterns of conserved amino acid residues [171] or the Hidden Markov Model 
(HMM) method which provides a statistical profile based on probabilities of finding 
an amino acid at a given position in the sequence [172]. There are many publicly 
available signature databases of protein families and domains, including sequence-
based PROSITE [171], Pfam [173], PRINTS [174] PANTHER [175] and structure-
based SUPERFAMILY [176] and Gene3D [177]. 
Protein signatures can be used in combination to predict protein functions. For 
example, proteins with no significant sequence similarity but have similar functions 
might be expected to share some common features like post-translational 
modifications, protein-sorting signals and similar subcellular localizations. Universal 
or organism-specific software packages can be developed to predict certain protein 
features based on a set of trained rules [178-181]. 
1.2.5.1.3 Integration of annotations 
Manual curation provides the most accurate information about a certain protein, but 
handling large-scale proteomic data is very labour and time consuming while 
automatic approaches trade accuracy for a larger coverage and higher speed. As 
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many annotation methods and databases exist for genomic and proteomic data, using 
any single method will result in biased or even no predictions. However, trying to 
use all of them at the same time will not only increase the workload but also lead to 
confusion in rationalizing the different results obtained. Integration of different 
sources of data into a single comprehensive source would greatly support proteomic 
data interpretation.   
InterPro [182] is one such database that integrates all the protein signatures from 
multiple databases. Signatures from member database Gene3D, PANTHER, Pfam, 
PIRSF, PRINTS, ProDom, PROSITE, SMART, SUPERFAMILY and TIGRFAMs 
that match the same set of proteins in the same region on the sequence, and that 
describe the same domain, family, repeat, active site, binding site or post-
translational modification, are grouped into single InterPro entries by a curator.  
Each InterPro entry contains high-quality manual annotation providing useful 
information on descriptive abstracts, taxonomy, structural links and cross-reference 
to external databases such as IntAct [183], MEROPS [184] and Enzyme Commission 
numbers [185], and Gene Ontology (GO) terms [186] where possible. Recent 
development has allowed links in InterPro to be made to distributed annotation 
system (DAS)-related tools such as the SPICE 3D structure viewer [187] and the 
Dasty Client [188]. DAS comprises a reference server that contains information for 
other client-servers to communicate and exchange biological annotations with [189].  
Integrated information provided by InterPro is used to aid the manual annotation 
process by curators in UniProtKB/Swiss-Prot as well as being the basis of the 
automatic annotation system in UniProtKB/TrEMBL [157]. For individual 
proteomic studies, information provided by InterPro provides valuable addition to 
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organism-specific manual and automatic data interpretations. Collectively, they 
provide a preliminary view of biological features contained within the proteomic 
data. 
1.2.5.2  Proteomic data repository and integration 
While data interpretation can be carried out at the level of the individual research 
group, proteomic data integrated with other proteomic resources can benefit the 
global research community. Using a public repository of proteomic data not only 
preserves the effort and information made by an individual group, but also provides 
significant advantages that small scale studies cannot achieve. 
Fundamentally, each proteomic study only samples a “snapshot” of the expressed 
proteins at a given time under a defined condition. By combining efforts from many 
research groups, a large volume of data with different time points and conditions can 
be acquired, which can highlight important trends by providing a dynamic view of 
the biological process. On the other hand, with access to large volumes of data 
generated from various proteomics platforms, limitations of different platforms can 
be assessed which will stimulate the development of improved methodology. 
1.2.5.2.1 Data format for MS output 
With the increasing complexity of evolving and diversifying methods and 
technologies used in proteomic research, the efficiency of data repository would 
benefit from a standardized data format. The minimum information about a 
proteomics experiment (MIAPE) is a project carried out by the Human Proteome 
Organization-Proteomics Standards Initiative (HUPO-PSI) [190]. This guideline 
aims to provide sufficient experimental details for publication and allow data 
exchange and comparison between different datasets.  
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A data format mzML was developed in 2008 under the auspices of the HUPO-PSI 
[191]. mzML replaced two competing data formats using vendor-neutral XML 
(Extensible Markup Language): mzData, developed by HUPO-PSI [192] and 
mzXML, developed at the Institute for Systems Biology [193]. The format is 
expected to become the single, unifying format for unprocessed proteomic MS data 
which is supported by nearly all the instrument and software vendors [191]. The 
other PSI standard format for peptide and protein identification, analysisXML, is still 
under development [194]. 
1.2.5.2.2 Public proteomic data repositories 
While the new standardized data formats are being developed and adopted, currently 
there are four main public repositories actively storing proteomic data for the 
research communities: the Proteomics identifications database (PRIDE), the Global 
Proteome Machine databases (GPMDB), PeptideAtlas and Tranche [195]. 
PRIDE is a database of protein and peptide identifications with their corresponding 
literature publication [192]. Closely related to HUPO-PSI, PRIDE supports the PSI 
standard reporting guideline (MIAPE) and data formats (mzML and analysisXML). 
PRIDE provides public access to the details of experiment by experiment accession 
number, protein accession number, literature reference and sample parameters 
including species, tissue, sub-cellular location and disease state [192]. It allows 
comparison of data generated from different research groups and allows referees to 
examine and validate the data before publication [196]. 
GPMDB hosts proteomic data of a number of eukaryotic species and is likely to be 
the first to categorise the whole human proteome [195]. It is part of the GPM (The 
Global Proteome Machine Organization), which is an open-source system for 
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analyzing, storing and validating proteomic data generated from MS/MS spectra 
[197]. GPM developed peptide identification search engine pipelines including 
X!Tandem (matching spectra to sequence) [198], X!P3 (proteotypic peptide profiling) 
[199] and X!Hunter (matching spectra to annotated spectrum libraries) [200]. The 
GPMDB uses its own data format XIAPE (Xml Information About a Proteomics 
Experiment) which is a simplification and extension of MIAPE and a new 
compressed format Common 1.0 to compress and depress MS/MS data files. 
PeptideAtlas is a project of Seattle Proteome Center (SPC) aims to achieve a full 
annotation of eukaryotic genomes through validation of expressed proteins [201]. 
PeptideAtlas integrates the Trans-Proteomic Pipeline (TPP) developed by SPC 
which is a collection of tools that uniformly analyse MS/MS data generated from 
different instruments, and assigned peptides using a variety of different database 
search programs [202]. All the sequences and spectra in the database are processed 
through the TPP to achieve a high quality database, along with false discovery rates 
at the whole atlas level [203]. 
Tranche software is an open source file sharing tool that enables collections of 
computers to easily share large amount of data sets [204]. Using the software, 
Tranche network can be created by anybody or any institution. The 
ProteomeCommons.org Tranche network is the first instance of a Tranche network 
in existence. It supports data sharing in proteomics as well as address the problem of 
data loss through computer hardware failure or changes in staff [195]. Any file type 
is allowed by the network, including glycomics, metabalomics and 2-D gel data, but 
MS/MS data is its main focus. Data uploaded to the network are replicated several 
times to protect against accidental loss, sharing and dissemination of data is secure 
and all datasets are citable in scientific journals [204]. 
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1.2.6  Data integration and applications 
Integration of proteomic data provides biological and technique advantages for 
proteomic research. Firstly, proteomic data can be used to verify and improve the 
prediction of genome annotations. Secondly, by comparing proteomic data with 
transcriptomic data, the importance of post-transcriptional and post-translational 
control of protein abundance in biological process can be examined. 
1.2.6.1  Proteogenomics 
Genome annotation normally comprises two components, identification of protein 
coding sequences (CDS) and the functional annotation of protein products (discussed 
in the previous sections). Identifying protein-coding genes is the primary process 
which provides the foundation to all the downstream analyses. While the 
conventional work flow for bottom-up protein identification based proteomics relies 
upon the accurate prediction of protein-coding genes within the genome, expression 
data acquired from proteomic research can also be used to feedback into the gene 
finding process to improve the quality of the flow from its source.  
Despite the significant effort that has been made in genome annotation, the estimate 
of correct gene structure prediction is only 50% for the human genome [205]. The 
correction rate is estimated to be higher at two-thirds in eukaryotes with compact 
genomes such as Arabidopsis thaliana [206]. Expressed sequence tags (ESTs) and 
cDNA alignments studies carried out in Apicomplexan genome annotations revealed 
slightly better results. However, even in the most studied Apicomplexan genome of 
P. falciparum, approximately 24% of the genes in the current databases are still 
predicted incorrectly [207]. The correction rate falls in the case of T. gondii, where 
41% of ToxoDB v4.3 gene models contained at least one inconsistency with full-
length cDNAs [208]. 
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By mapping peptides identified against predicted gene models and six-frame 
translation of the genomic DNA sequences (ORFs), proteomic data can be used to 
independently validate the prediction of protein-coding genes, confirm the 
translational expression of these genes and predict new genes. Initial studies tested 
this idea by querying MS/MS data against translated genomic sequence of bacteria 
Haemophilus influenza, Mycobacterium tuberculosis, plant Arabidopsis thaliana and 
human genomes on a small scale [209-212]. The approach was further tested on a 
small bacterium Mycoplasma pneumonia which validated the majority of the 
predicted genes (ORFs), as well as suggesting 16 new genes [213]. The success of 
the previous studies lead to the first use of proteomic data as a primary resource for 
Mycoplasma mobile genome annotation [214]. 
Proteogenomics approaches are increasingly used in various aspects of genome 
annotation including validating predicted gene models and detecting novel genes 
[213-216]; confirming the expression of hypothetical genes [217-220] and validating 
alternative splicing variants [220, 221]. The information gathered in proteogenomic 
researches can also provide a valuable training set to improve gene identification, 
predict peptide signals and improve the development of new genome annotation 
pipelines. 
1.2.6.2  The interaction of proteome and transcriptome 
Upon the completion of genome annotation, another important post genomic 
application is transcriptomics. The transcriptome is the complete set of transcripts in 
a cell at a specific developmental stage or physiological condition.  
Two types of technologies are widely used to measure the expression profile of the 
transcriptome, hybridization based and sequence based. Hybridization based 
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approaches typically involve incubating fluorescently labelled cDNA with custom-
made or commercial oligonucleotide microarrays and measuring the intensity of the 
fluorescent dye used [222, 223]. Sequence based approaches directly determine the 
cDNA sequence. Early techniques include the use of relatively low throughput 
cDNA or EST libraries [224, 225]. Tag-based methods such as serial analysis of 
gene expression (SAGE) [226], cap analysis of gene expression (CAGE) [227] and 
massively parallel signature sequencing (MPSS) [228] were developed to provide 
quantitative expression data in a high throughput manner.  
Recent technical development has seen a novel RNA-Seq (RNA sequencing) 
approach that is based on high-throughput sequencing. In summary, the technique 
starts with the conversion of a population of RNA (total for small RNAs, such as 
microRNA or short interfering RNAs, and fractionated for larger RNA, such as 
poly(A) tail) to a library of cDNA fragments with adaptors attached to one or both 
ends. Each molecule in the library is then sequenced with a high-throughput 
sequencing platform to obtain short sequences from one end or both ends [229]. 
RNA-Seq can be done on a variety of high-throughput sequencing platforms 
including Illumina IG [230], Applied Biosystems SOLiD [231] and Roche 454 Life 
Science systems [232]. The resulting sequences can be aligned to a reference 
genome or reference transcripts (intron eliminated), or assembled de novo without 
the genomic sequence to produce a genome-scale transcription map [229]. 
One of the main purposes of transcriptomic studies is to test how particular 
conditions (such as, differentiation, transformation and environment) influence 
global gene expression. These changes at transcriptional level are then used to 
assume the same changes happen at the protein expression level under the particular 
condition and therefore enable the putative functions of proteins to be assigned. This 
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concept is under the commonly accepted „guilt-by-association‟ hypothesis that the 
function of hypothetical genes may be similar to those of annotated genes that share 
the same expression profile [233]. However, with the availability of proteomic data, 
the real changes at the protein expression level can be directly and accurately 
measured first hand. 
In fact, using transcriptomic data to infer protein functions is not only indirect, but 
potentially very unreliable. The „guilty-by-association‟ hypothesis has been 
challenged by in silico approaches in which expression clusters found in microarray 
data do not in general agree with functional annotation classes [234]. This finding 
has been further verified and supported by several large scale studies comparing 
proteomic and transcriptomic expression profiles. Data from combined proteomic 
and transcriptomic analysis revealed discrepancies in the correlation between mRNA 
expression levels and protein abundance in plant seeds [235], mouse embryonic stem 
cells [236], yeast [237] and Plasmodium [238, 239]. 
Although the discrepancies between transcriptome and proteome weaken the 
application of protein function assignments using transcriptomic data, they enlighten 
new applications that allow a better understanding of basic biological processes. 
Despite the possibility that the discrepancies are caused by technical limitations 
whereby the same level of analytic resolution is not reached between transcriptome 
and proteome, the other possible explanations have more biological meaning and are 
worth further investigation. One possible explanation is the selective degradation of 
proteins. A study found that more than 80% of the cellular proteins are degraded 
through a proteasome-dependent pathway [240], while another study found the half-
lives of 576 human A549 adenocarcinoma cells range from many tens of hours to 
just 6 min [241], all adding to the complexity of the protein expression profile. On 
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the other hand, the role of post-transcriptional regulations such as mRNA decay and 
translational repression may also contribute to the discrepancies between mRNA 
expression level and protein abundance [242-244]. The integration of transcriptomic 
and proteomic expression data will provide a dynamic view of gene expression at 
mRNA and protein level, which will in turn increase the understanding of various 
biological processes.  
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1.3   Aims 
The knowledge of T. gondii biology has been steadily increasing in the last century. 
The last thirty years have seen a rapid progression in the understanding of gene 
expression of the parasite along with some major technical developments. 
In the 1980s, using immunocytochemical techniques, the identification of specific 
antibodies led to the cloning of individual genes [106, 245], which allowed the 
identification of the expression and localization of two surface antigens. In 1998, the 
development of expression sequence tags (ESTs) [246] rapidly accelerated the rate 
of gene discovery by generating >7000 ESTs that identified more than 500 new T. 
gondii genes. Moving onto 2002, microarray experiments were developed to provide 
large scale gene expression profiling of tachyzoite to bradyzoite differentiation [247-
249]. In the same year, a pioneering study on the T. gondii proteome has been carried 
out using reproducible 2-DE maps, which led to the identification of around 30 
proteins [250]. In 2003, the first output of the T. gondii genome sequencing project 
was completed followed by the continuing efforts towards genome annotation [108, 
112]. The focus of T. gondii research has gradually moved to the understanding of 
gene expression and gene functions on the genome scale. 
Inspired by the fascinating features of T. gondii and technical advantage developed 
in recent years, this PhD study aims to investigate some important biological and 
technical issues of the proteomic research of T. gondii. This study is achieved 
through the following steps: 
 Multiple proteomic platforms are used to identify T. gondii tachyzoite proteome. 
 A collection of bioinformatics tools are used to characterize and categorize the 
expressed tachyzoite proteome. 
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 The method of integrating the proteomic data with other genomic sources is 
examined, and the possibilities and applications of proteomic data in the field of 
proteogenomics are discussed. 
 A comparison of proteomes and transcriptomes of several Apicomplexan 
parasites has been carried out with data acquired from this study and other 
publicly available expression data, where the meanings of comparison results are 
discussed. 
 Finally, a preliminary case study has been carried out to test the applications of a 
quantitative proteomic method DIGE in understanding protein expression 
changes of T. gondii tachyzoites grown in the presence or absence of glucose. 
Together, this study aims to achieve a comprehensive coverage of the expressed T. 
gondii tachyzoite proteome and at the same time, examine and discuss the 
applications and potentials of this proteomic data in a broader integrative systems 
biology view. 
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2.1  Introduction 
The sequencing and annotation of the T. gondii genome has promoted the rapid 
development and application of proteomic analysis on the parasite. Studies have 
been carried out to investigate the mechanisms of host cell invasion, the structure 
and composition of the apical organelles, the organization of the cytoskeleton and 
the “entire” proteome of tachyzoites [84, 251-253]. 
Being the active, infectious stage of Toxoplasma, the tachyzoite has been the focus 
of proteomic studies and so far, no significant data has been published on the other 
life cycle stages. Type I strain RH tachyzoites have been used for most proteomic 
studies since they have almost no bradyzoite differentiation in vitro under standard 
culture conditions [254, 255].  
The success of a proteomic project is based on the combination of several 
components, such as good sample isolation and preparation techniques, access to 
expensive specialist equipment for protein separation and mass spectrometry and 
finally, comprehensive data analysis capability. Among the pioneering studies on the 
T. gondii proteome, reproducible 2-DE maps were developed in 2002, in which over 
1000 individual polypeptide spots could be resolved [250]. Of these, 71 protein spots 
were analysed by both MALDI-TOF and post-source decay mass spectrometry and 
due to the limited availability of genomic sequences at that time, this study resulted 
in around 30 protein identifications [250]. Another early attempt at the T. gondii 
tachyzoite proteome revealed up to 224 protein spots on a 2-DE gel and localized 13 
parasite excretory antigens on the gel by Western or T-cell blot [256]. Since then, 
equipped with a better understanding of parasite biology and number of technical 
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advances, the research interest has focused on biologically interesting T. gondii 
subproteomes. 
2.1.1  T. gondii subproteomes 
Studies on T. gondii subproteomes have been benefited from a greater understanding 
of Toxoplasma biology, which has enabled improved sample preparation methods 
such as organelle purification based on density [84] and the collection of apical 
molecules via secretion stimulated by the elevation of Ca
2+ 
[257]; the growing 
availability of sub-cellular markers and the increasingly accurate gene models 
provided by bioinformatics resources [112].  
For example, one study has characterised the proteome of rhoptry organelles [84]. A 
French press was used to disrupt tachyzoites, followed by the fractionation of a 
mixture of rhoptries, dense granules, mitochondria and apicoplasts from cell lysates 
by a Percoll gradient. Sucrose flotation gradient was used to improve the enrichment 
of rhoptry proteins and the sample was analysed by 1-DE LC-MS/MS [84]. This 
study identified 38 novel rhoptry protein candidates and distinguished rhoptry 
proteins according to their sub-organellar location as either bulb (ROP) or neck 
(RON) [84].  
Another subproteomic study prepared excretory/secretory antigens (mainly 
microneme and dense granule proteins) freely released from T. gondii tachyzoite by 
incubating filter-purified parasites in 1% (v/v) ethanol. The protein contents were 
characterized by 2-DE followed by N-terminal sequencing or MALDI-MS, and 
MudPIT [253]. A similar proteomic study used Ca
2+
 ionophore A23187 to stimulate 
calcium-mediated excretion of proteins from T. gondii tachyzoites. The protein 
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contents were characterized by 2-DE followed by N-terminal sequencing or MALDI-
MS [257].  
A proteomic analysis of enriched cytoskeletal components partially purified the 
conoid/apical complex. Parasites were extracted in lysis buffer which left a parasite 
ghost consisting of the apical complex, attached subpellicular MT and the cortical 
filament network. The conoid and remnants of the apical complex cytoskeleton were 
further purified by sonication and differential centrifugation [251]. This study has 
identified ~200 proteins which represents 70% of the cytoskeletal protein 
components, and characterized seven novel proteins among which the targeting 
sequence for recruitment into the cytoskeleton during invasion was determined for 
five proteins [251]. 
Together with these studies, many proteomic efforts have been made to understand 
the key proteins and post-translational modification events involved in host-cell 
invasion, and intracellular survival processes [258-260]. However, the global 
characterization of the T. gondii tachyzoite proteome has not seen many additions 
since the early effort in 2002. 
2.1.2  Whole proteome profiling of Apicomplexan parasites 
While no major global proteomic study has been published on T. gondii since 2002, 
several large-scale studies have investigated the global protein expression profile of 
other Apicomplexan parasites. 
Two whole cell proteome studies have characterized the proteomes of four different 
life cycle stages of Plasmodium falciparum using MudPIT and 1-DE LC-MS/MS in 
2002 [261, 262]. Comprehensive proteomic approaches have also been used to 
analyse the proteome of Plasmodium berghei, Plasmodium yoelii and Plasmodium 
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gallinaceum [238, 239, 263]. Together, these studies provided detailed proteomic 
coverage of several life cycle stages of the Plasmodium species making it one of the 
most studied microbial proteomes.  
Whole proteome studies have also been carried out on Cryptosporidium parvum 
sporozoites. One study investigated the non-excysted and excysted forms of 
sporozoites using LC-MS/MS coupled with iTRAQ isobaric labelling and MudPIT. 
Together, 303 C. parvum proteins were identified among which expression of 26 
proteins have been shown to increase significantly during excystation [264]. In 
addition to this, a comprehensive study to characterise the proteome of excysted 
sporozoites of C. parvum was performed using 2-DE MALDI-TOF or LC-MS/MS, 
1-DE LC-MS/MS and MudPIT. In total, 1237 non-redundant proteins were 
identified in this life cycle stage, which represents approximately 30% of the entire 
predicted proteome ([265] and Appendix X) and significantly expands upon current 
knowledge.  
2.1.3  Aims 
In this chapter, a multi-platform global proteome analysis of T. gondii tachyzoites 
was performed. The strategy was to harness technological advances developed in the 
field of proteomic research and the recent availability of extensive genomic 
sequences and genome annotation to enable the rapid identification of proteins at the 
whole-cell scale. The result had the potential to improve significantly the knowledge 
of protein expression in this important parasite, complement current transcriptional 
data and provide a useful dataset from which improvements in gene annotation can 
be made. 
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2.2  Materials and methods 
2.2.1  T. gondii tachyzoite culture 
Tachyzoites of T. gondii strain RH were maintained twice a week in vero cells 
(African Green Monkey kidney fibroblast-like cell) (purchased from ECACC, cat. 
84113001).  
Uninfected vero cells were grown routinely at 37°C in a 5% CO2 humidified 
incubator (BINDER
®
) in 25 cm
2
 bottom (T25) vented cell culture flasks (BD 
Falcon
TM
) using filter sterilised IMDM medium (Cambrex) supplemented with 5% 
FCS and 1% Pen/Strep (SIGMA-ALDRICH, 10,000 U/ml). Sub-confluent cultures 
(70-80%) were detached from the cell culture flask surface by washing the cells 
twice with 5 ml HEPES buffer and incubating the cells in 5 ml Trypsin-EDTA 
(Sigma) for 5 min at 37°C. Cells were flushed down and transferred to a centrifuge 
tube (BD) and centrifuged at 1500 g for 5 min. The cell pellet was resuspended with 
5 ml IMDM medium and cells were reseeded at 1×10
5
 in 5 ml of IMDM in a T25 
flask.  
Vero cells were infected with T. gondii tachyzoites after 24 hours incubation at a 
parasite-to-cell ratio of 4:1. Both vero cells and tachyzoites were counted using a 
neubauer haemacytometer (Assistent). Tachyzoites were incubated for 3 or 4 days 
prior to sample collection. 
T. gondii tachyzoites were scraped off from the cell culture flask using a sterile cell 
scraper (BD Falcon
TM
) and were separated from the cells by filtration through 3 µm 
pore-size Nuclepore
® 
polycarbonate filters (Whatman, UK). Tachyzoites were then 
washed twice with PBS (pH 7.4) with centrifugation at 1500×g for 20 min at 4°C. 
The pellet was resuspended with 1 ml PBS and transferred to a 1.5ml eppendorf tube; 
 Chapter 2-Identifying the T. gondii tachyzoite proteome 
 
51 
 
a final centrifuge was then performed at 16,000×g for 5 min at 4°C. The supernatant 
was discarded and the pellet was stored at -20°C. 
2.2.2  Sample quantification 
To estimate protein content in the sample, protein quantifications of tachyzoites were 
performed as follows. The frozen pellet was first solubilised using 100mM Tris/HCl 
pH 8.5 and the soluble fraction was quantified with the BCA assay (Bio-Rad Protein 
Assay). The insoluble fraction was then further solubilised using 2% SDS 
supplemented with 100mM Dithiothreitol (DTT) and quantified with the 2-D Quant 
Kit (GE Healthcare). 
2.2.2.1  Solubilisation 
The T. gondii pellet containing approximately 1×10
8
 tachyzoites was kept on ice 
during the whole process. An aliquot of 500 µl of 100mM Tris/HCl pH8.5 was 
added to the pellet which was incubated on ice for one hour, with vigorous vortexing 
every 10 min during the incubation. Three cycles of freeze-thaw were performed 
after incubation. Each cycle consisted of 2 min vigorous vortexing, followed by fast 
freeze with liquid nitrogen and quick thaw to room temperature. The sample was 
centrifuged at 16,000×g for 30 min at 4°C. The supernatant was transferred into a 
new tube and quantified with BCA assay. A further 200 µl of 2% SDS and 100mM 
DTT buffer was added into the pellet. Three cycles of 5 min heating at 90°C and 2 
min vigorous vortexing were carried out to assist solubilisation. Solubilised protein 
was then quantified with 2-D Quant Kit. 
2.2.2.2  BCA assay 
Tachyzoite protein quantifications were performed using the Bio-Rad Protein Assay. 
Coomassie Plus reagent was diluted 1:4 with water. BSA standards were made by 
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serial dilutions from 1mg/ml stock. Samples were diluted into 1:10, 1:20, 1:40 and 
1:80. Each blank, sample and standard was prepared in triplicate and pipetted into 
the appropriate well in a 96-well plate. An aliquot of 200 µl of prepared Coomassie 
reagent was added into every well. The plate was incubated at room temperature 
between 5 min to 1 hour, and the absorbance was read at 560nm in a microplate 
photometer (Multiskan Ascent, Thermo). A standard curve of blank-corrected 
standard absorbance versus protein concentration was plotted and sample protein 
quantifications were calculated according to their absorbance. 
2.2.2.3  2-D Quant Kit 
Proteins solubilised with 2% SDS and 100mM DTT were quantified using the 2-D 
Quant Kit. Working reagent was prepared by mixing 100 parts of colour reagent A 
with 1 part colour reagent B. BSA standards were set up by adding different volumes 
of 2 mg/ml BSA standard solution. Sample was added undiluted and diluted 1:10 
and prepared in duplicate. Precipitant (500 µl) was added into each tube, vortexed 
briefly and incubated for 2-3 min at room temperature, then 500 µl of co-precipitant 
was added into each tube and mixed briefly. Tubes were centrifuged at 16,000×g for 
5 min. The supernatant was discarded and 100 µl of copper solution and 400 µl of 
distilled water were added to each pellet which was then vortexed briefly. Working 
colour reagent (1 ml) was added into each tube and incubated at room temperature 
for 15-20 min. Absorbance was read at 480nm with Ultrospec 2100 pro 
spectrophotometer. A standard curve of blank-corrected standard absorbance versus 
protein concentration was plotted and protein quantifications were calculated 
according to their absorbance. 
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2.2.3  1-D gel electrophoresis (1-DE) 
Sample was separated on a 16 cm long and 1.0 mm thick 1-D SDS-PAGE gel using 
PROTEAN
TM
 II Slab Cell kit (Bio-Rad). Gels were cast following the recipes listed 
in Table 2.1 for stacking gel and Table 2.2 for separating gel. 
Table 2.1 5% Stacking Gel 
Reagent Volume Comment 
dH2O 13.6 ml  
30% (w/v) Acrylamide 3.4 ml  
0.5 M Tris/HCl (pH 6.8) 5 ml  
10% (w/v) SDS 200 µl  
10% (w/v) APS 200 µl Add fresh 
TEMED 20 µl Add fresh 
Table 2.2 12% Separating Gel 
Reagent Volume Comment 
dH2O 33.5 ml  
30% (w/v) Acrylamide 40 ml  
1.5 M Tris/HCl (pH 8.8) 25 ml  
10% (w/v) SDS 1 ml  
10% (w/v) APS 500 µl Add fresh 
TEMED 100 µl Add fresh 
Electrode (Running) buffer was prepared as a 10 × stock solution according to Table 
2.3 and diluted to 1 × working solution prior to use. 
Table 2.3 10 × SDS-PAGE Electrode (Running) Buffer 
Reagent Volume Comment 
Tris base 30.3 g  
Glycine 144 g  
SDS 10 g  
dH2O to 1 litre  
40 µl 2× SDS-PAGE loading buffer (see Table 2.4) was added to the pellet which 
contains 1×10
8
 T. gondii tachyzoites. Three cycles of 5 min heating at 90°C and 2 
min vigorous vortexing were carried out to assist solubilisation followed by a final 
centrifugation at 16,000×g for 3 min.  
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Table 2.4 2×SDS-PAGE Loading Buffer 
Reagent Concentration Comment 
0.5 M Tris-HCl (pH 6.8) 100 mM  
SDS 4 % (w/v)  
Bromophenol Blue 0.2% (w/v)  
Glycerol 10 % (v/v)  
DTT 200 mM Add fresh 
dH2O   
 
The supernatant was loaded into a single sample well and separation was performed 
by electrophoresis at constant current of 16 mA for stacking and 24mA for 
separating gels. Run time was between 6-7 hours; after running, the gel was removed 
from the plate and fixed for 2 hours in 40 % (v/v) ethanol, 10 % (v/v) acetic acid. 
The gel was then washed twice with dH2O and stained in colloidal Coomassie blue 
(1 part methanol, 4 parts colloidal stock (50g Ammonium sulphate, 500 ml dH2O, 6 
ml phosphoric acid and 10 ml 5% (v/v) Coomassie stock)) for 1-7 days.  
2.2.4  2-D gel electrophoresis (2-DE) 
2.2.4.1  Sample preparation  
Two strategies have been used for sample preparation which resulted in similar 
preparation results determined by the sample quantification assay and the 
visualization of the stained gels. 
a) 120 µl of lysis buffer A (see Table 2.5) was added to the frozen pellet which 
contains 1×10
8
 T. gondii tachyzoites. Three cycles of freeze and thaw were 
performed; each cycle comprised 2 min of vigorous vortexing, followed by fast 
freeze with liquid nitrogen and quick thaw to room temperature. The sample was 
centrifuged at 16,000×g for 30 min at 4°C. 
 
 Chapter 2-Identifying the T. gondii tachyzoite proteome 
 
55 
 
Table 2.5 Lysis buffer A 
Reagent Volume Comment 
Urea 8M  
CHAPS 4% (w/v)  
Tris-base 40mM  
DTT 60mM Add fresh 
IPG buffer 0.5% (v/v) Add fresh 
dH2O   
b) 120 µl of lysis buffer B (see Table 2.6) was added to a 1×10
8
 T. gondii tachyzoite 
pellet. The sample was incubated at room temperature for 2-4 hours with a vigorous 
vortex every half an hour. The sample was then centrifuged at 16,000×g for 5 min. 
Table 2.6 Lysis buffer B 
Reagent Volume Comment 
Urea 7M  
ThioUrea 2M  
ASB-14 2% (w/v)  
CHAPS 4% (w/v)  
Tris-base 20mM  
Protease Inhibitor 
Cocktail Tablets (Roche) 
1×  
DTT 60mM Add fresh 
IPG buffer 0.5% (v/v) Add fresh 
dH2O   
2.2.4.2  IPG strip rehydration 
From either 1a or 1b, the supernatant was transferred to a new tube and rehydration 
buffer (supplemented with 40mM DTT and 0.5% IPG buffer) was added to a final 
volume of 450 µl. The solution was then loaded to one reservoir slot of the 
immobiline DryStrip reswelling tray (GE healthcare). A 24 cm IPG strip (pH 4-7 or 
pH 3-11 NL) was placed in the reservoir slot with the gel side down. DryStrip cover 
fluid (3 ml) was then overlaid onto the strip and the tray covered with the lid. The 
tray was left at room temperature for a minimum of 10 hours for a complete 
rehydration.  
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2.2.4.3  First-dimension Isoelectric Focusing (IEF) 
The rehydrated strip was placed on an Ettan
TM
 IPGphor II
TM
 (GE healthcare) 
following the manufacturer‟s handbook. IEF was run at 20°C, with 75 µA per strip 
with the following steps (see Table 2.7). 
Table 2.7 IEF Protocol 
Step Voltage Mode Voltage Duration (Hour) 
1 Step 500 V 2 
2 Gradient 1000 V 8 
3 Gradient 10,000 V 3 
4 Step 10,000 V 4.25 
2.2.4.4  Second-dimension SDS-PAGE 
Second-dimension SDS-PAGE was performed on a precast DALT Gel 12.5(26 × 20 
cm) (GE Healthcare) using the Ettan DALTsix electrophoresis System (GE 
Healthcare).  
The IPG strip was removed from the Ettan
TM
 IPGphor II
TM
 and two steps of 
equilibration were carried out. Firstly, 100 µg of DTT was added into 10 ml of 
equilibration buffer (2% (w/v) SDS, 50 mM Tris-HCl pH 8.8, 6M urea, 30% (v/v) 
glycerol, and 0.002% (w/v) bromophenol blue). The IPG strip was washed in 
equilibration buffer I on a shaker for 15 min. Equilibration buffer II was made up by 
adding 250 µg of iodoacetamide (IAA) into 10 ml of equilibration buffer. The IPG 
strip was washed in equilibration buffer II on a shaker for 10-15 min. 
The equilibrated IPG strip was then assembled onto a DALT precast gel following 
manufacturer‟s instruction. The Ettan DALTsix System was setup according to the 
product handbook using the electrophoresis buffer kit supplied. The gel was run at 
20°C with an initial wattage of 3 W for 0.5 hour and 17 W per gel thereafter. 
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After electrophoresis, the gel was removed from the plate and fixed for 2 hours in 
40 % (v/v) ethanol, 10 % (v/v) acetic acid. The gel was washed twice in dH2O and 
stained in colloidal Coomassie blue (1 part methanol, 4 parts colloidal stock (50g 
Ammonium sulphate, 500 ml dH2O, 6 ml phosphoric acid and 10 ml 5% Coomassie 
stock)) for 1-7 days.  
2.2.5  Manual tryptic digestion 
Slices from 1-DE gels or plugs from 2-DE gels were cut out and placed in separate 
eppendorf tubes. An aliquot of 15 µl of 50 mM ammonium bicarbonate (Ambic)/ 50% 
(v/v) acetonitrile was added into each tube and incubated for 10 min at 37°C to 
destain the plugs/slices. The destain step was repeated 2-3 times until the gel plugs 
were fully destained and the destain buffer was discarded at each step.  
For 1-DE gel slices, two additional reduction steps were carried out before moving 
onto the next step. DTT (50 µl of 10 mM in 100 mM Ambic) was added to each tube 
and incubated for 30 min at 37°C. The DTT solution was discarded and 50 µl of IAA 
(55 mM in 100 mM Ambic) was added to each tube, followed by 1 hour incubation 
at 37
 
°C in the dark. IAA was discarded after incubation. 
For both 1-DE slices and 2-DE gel plugs, 15 µl of 100% acetonitrile was added into 
each tube, followed by 15 min incubation at 37°C. This step was repeated until the 
gel plugs turned completely white indicative of dehydration. The solvent was 
removed and tubes were incubated at 37°C for 10 min to evaporate the remaining 
solvent. 
25 µg of sequencing grade trypsin (Roche) was first diluted with 250 µl of 50 mM 
acetic acid to make a stock solution. Stock solution was further diluted into working 
reagent at a 1:10 ratio with 25 mM Ambic. An aliquot of 10-15 µl of trypsin 
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(according to the size of the gel plugs) was added to the evaporated plugs and the 
tubes were incubated at 37°C for 1 hour. An additional 10 µl of 25 mM Ambic was 
added into each tube, followed by overnight incubation at 37°C. The digested 
solution was run on the LTQ immediately afterwards or stored at -20°C. 
2.2.6  LTQ (LC-MS/MS) 
The LTQ work for the 1-D SDS PAGE gel slices and part of the 2-D SDS PAGE gel 
analysis was performed by Dr. S.J. Sanderson. Briefly, the LC-MS/MS platform was 
setup using a LTQ ion-trap mass spectrometer (Thermo-Electron) coupled on-line to 
a Dionex Ultimate 3000 (Dionex) HPLC system equipped with a nano pepMap100 
C18 reversed phase column (75 µm; 3 µm, 100 Angstroms). The column was 
equilibrated in 98.9% (v/v) water/ 2% (v/v) acetonitrile/ 0.1% (v/v) formic acid (FA) 
at a flow rate of 300 nl/min. Sample injections of 15 µl of tryptic peptides were 
loaded onto a C18 TRAP, desalted and washed for 3min at a flow rate of 25 µl/ min 
prior to being loaded onto a nano pepMap100 C18 column at 300 nl/ min. The 
peptides were eluted at a flow rate of 300 nl/ min with a linear gradient of 0-50% 
(v/v) acetonitrile/ 0.1% (v/v) FA over 30 min, followed by 80% (v/v) acetonitrile/ 
0.1% (v/v) FA for 5 min. The column was then equilibrated in 98.9% water/ 2% 
acetonitrile/ 0.1% (v/v) formic acid for 5 min (total run time per sample was 50 min). 
Ionised peptides were analysed in the mass spectrometer (0-106 m/z, global and Msx) 
using the “triple play” mode, consisting initially of a survey (MS) spectrum from 
which the three most abundant ions were determined (threshold = 200-500 TIC). 
Collision energy was set at 35% for 30 min. The charge state of each ion was then 
assigned from the C13 isotope envelope “zoom scan” and finally subjected to a third 
MS/MS scan. The LTQ was tuned using a 500 fmol/µl solution of glufibrinopeptide 
(m/z 785.8, [M+2H]
2+) and calibrated according to the manufacturer‟s instructions. 
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The resulting MS/MS spectra (dta files) were merged into an mgf file which was 
submitted to Mascot searching.  
2.2.7  Mascot searching of MS data acquired 
Mascot searching was carried out on a local Mascot server. A local Toxoplasma 
database was selected which comprised of the following components retrieved from 
ToxoDB: ORF>50 aa from clustered EST; ORF>50 aa from whole genome shotgun 
(10×); Twinscan predictions; TigrScan predictions; GlimmerHMM predictions; 
Organellar Sequences and Annotated Proteins, release 4 (release 4 gene models). 
MS/MS Ion Search was used to search the data output from the LTQ. Database 
search parameters included: fixed carbamidomethyl modification of cysteine 
residues; variable oxidation of methionine; a peptide tolerance of ± 1.5 Da; MS/MS 
tolerance ± 0.8 Da; +1, +2, +3 peptide charge state; and a single missed trypsin 
cleavage. Instrument was set as ESI-TRAP.  
2.2.7.1  Manual Validation of Mascot Results 
For 1-DE and 2-DE results, additional manual validation was carried out on the 
proteins identified by Mascot that were based on a single peptide and/ or proteins 
which returned a Mascot score < 60. The protein identification was accepted if a) a 
matching peptide possessed an individual ion score above the significant threshold 
for identity or extensive homology (typically >44), or b) upon manual inspection of 
individual peptide MS/MS spectra at least 60% percent of the candidate y-ions were 
at a minimum signal to noise ratio of 10%. Spectra which failed to pass either rule 
were regarded as false positive identifications, which can result from an 
accumulation of several peptides with low ion scores. 
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2.2.8  Multidimensional protein identification technology (MudPIT) 
Sample preparation, mass spectrometric analysis and MS data searching were 
performed by Dr. Judith H. Prieto from John R.Yates‟s lab, Scripps Research 
Institute, La Jolla. The procedures are as follows: 
2.2.8.1  Sample preparation for MudPIT 
A pellet of 1 × 10
9
 tachyzoites resuspended to approximately 800 µg/ml in 500 l 
100 mM Tris/HCl buffer pH 8.5 was lysed by three cycles of freeze/ thaw and the 
Tris-soluble and insoluble protein fractions separated at 16,000×g for 30 min. 
Digestion of soluble fractions: MS compatible detergent Invitrosol was added to 1% 
(v/v), the solution heated to 60C for 5 min, vortexed for 2 min, denatured with 2 M 
urea, reduced with 5 mM TCEP, carboxyamidomethylated with 10 mM 
iodoacetamide, followed by addition of 1 mM CaCl2 and trypsin at a ratio of 1:100 
(enzyme: protein) and incubated at 37C overnight. Digestion of insoluble fractions: 
10% (v/v) Invitrosol was added to the pellet which was heated to 60C for 5 min, 
vortexed for 2 min and sonicated for 1 h. The sample was diluted to 1% (v/v) 
Invitrosol with 8 M urea/ 100 mM Tris/ HCl pH 8.5, reduced and 
carboxyamidomethylated as before, and digested with endoproteinase Lys-C for 6 h. 
The solution was diluted to 4 M urea with 100 mM Tris/ HCl pH 8.5 and digested 
with trypsin as described above. 
2.2.8.2  Mass spectrometric analysis by MudPIT 
Five soluble replicates and four insoluble samples were each subjected to MudPIT 
analysis with modifications to the method of Link et al.[266], using a quaternary 
Agilent 1100 series HPLC coupled to a Finnigan LTQ-ion trap mass spectrometer 
(Thermo, San Jose, CA) with a nano-LC electrospray ionization source. Peptide 
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mixtures were resolved by strong cation exchange LC upstream of RP-LC. Each 
sample (100 µg of protein) was loaded onto separate microcolumns and resolved by 
fully automated 12 step chromatography.  
2.2.8.3  SEQUEST searching of MS data acquired 
A local Toxoplasma database was used (as in section 2.2.7). To identify contaminant 
host proteins the parasite database was supplemented with a contaminant database 
(the complete prokaryote and mammalian databases from NCBI). To estimate the 
amount of false positives a reverse database was added. Poor quality spectra were 
removed from the data set using an automated spectral quality assessment algorithm. 
Tandem mass spectra remaining after filtering were searched with the SEQUEST 
algorithm version 27. All searches were in parallel and were performed on a Beowulf 
computer cluster consisting of 100 of 1.2 GHz Athlon CPUs. No enzyme specificity 
was considered for any search. SEQUEST results were assembled and filtered using 
the DTASelect (version 2.0) program which uses a quadratic discriminate analysis to 
dynamically set XCorr and DeltaCN thresholds for the entire data set to achieve a 
user-specified false positive rate (<5% peptides false positive in this analysis). The 
false positive rates are estimated by the program from the number and quality of 
spectral matches to the decoy database. 
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2.3  Results 
2.3.1  T. gondii tachyzoite proteomic analysis by 1-DE 
A large format 1-DE gel was performed to resolve solubilised proteins from 1.1 × 
10
8 
tachyzoites (220 µg of protein) (see Figure 2.1). In total, 129 gel slices were 
manually excised from the entire length of the resolving gel; each slice was 
tryptically digested, submitted to LC-MS/MS and searched against the local 
Toxoplasma database using Mascot (as in section 2.2.7).  
 
Figure 2.1 Tachyzoite proteins resolved by 1-DE. Proteins from 1.1×10
8
 T. 
gondii tachyzoites were resolved on a 16 cm 12% (w/v) SDS-PAGE gel and stained 
with colloidal Coomassie blue. The gel was cut into 129 contiguous gel slices. Each 
slice was tryptically digested and analysed by LC-MS/MS. The masses of protein 
standards and the positions of gel slices are shown. 
An average of approximately 20 proteins were identified from each gel slice (ranging 
from 2 proteins per slice from a region at the top of the gel to 51 proteins per slice in 
the middle of the gel) and the overall number of individual identification is 2778 (see 
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Figure 2.2 for a sample of the protein identification table and Appendix I for the list 
of individual protein identifications).  
 
Figure 2.2 A sample of protein identification table of Mascot results. Listed 
in the columns (from left to right) are: the gel slice number, ranking of each protein 
hit returned from the Mascot search for that gel slice, corresponding gene 
annotations and descriptions, Mascot scores, number of matching peptides to each 
protein and sequence coverage.  
In many instances the same protein was identified in multiple gel slices which could 
be due to proteolytic processing events, post-translational modifications, isoenzymes 
or simply that a given protein band spanned more than one gel slice. When 
redundancy between proteins with the same identification is removed, assuming the 
variants are the products of a single gene, the expression of 923 individual genes was 
identified (comprising 857 release 4 genes and 66 alternative gene models and ORFs; 
discussed in section 2.4.3). 
In addition to the first 1-DE gel, another 1-DE experiment was performed with prior 
sample fractionation of 9.85×10
7
 tachyzoites using 100mM Tris/HCl pH 8.5 with the 
aim of increasing sample resolution and thereby protein identification. Both Tris-
soluble (120 µg of protein) and Tris-insoluble (130 µg of protein) fractions were 
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resolved by 1-DE (see Figure 2.3). The most divergent region (~50-100 kDa) 
between soluble and insoluble fractions was determined by eye and 25 gel slices 
were excised correspondingly, followed by tryptic digestion, LC-MS/MS analysis 
and Mascot searching. When the redundancy was removed, expression of 351 
individual genes (335 release 4 genes and 16 alternative gene models and ORFs) was 
identified from the 50 gel slices on the second gel (see Appendix II for tables listing 
individual protein identifications). 
 
Figure 2.3 Tris-fractionated tachyzoite proteins resolved by 1-DE. Proteins 
from 9.85×10
7
 T. gondii tachyzoites previously fractionated into Tris-soluble (120 
µg of protein) and Tris-insoluble (130 µg of protein) fractions were resolved on a 16 
cm 12% (w/v) SDS-PAGE gel and stained with colloidal Coomassie blue. 
Contiguous gel slices (25) spanning ~50-100 kDa were excised from both lanes. 
Each slice was tryptically digested and analysed by LC-MS/MS. The masses of 
protein standards and the positions of gel slices are shown. 
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When redundancy between proteins with the same identification from both 1-DE 
gels was removed, 1012 individual gene products (939 release 4 genes and 73 
alternative gene models and ORFs) were identified (see Appendix III for non-
redundant list of protein identifications). 
2.3.2  T. gondii tachyzoite proteomic analysis by 2-DE 
Both broad, non-linear (pH 3-10NL) and narrow, linear (pH 4-7) range 2-DE gels 
were used to resolve tachyzoite proteins (see Figure 2.4). In total, 1217 protein spots 
were excised from 2-DE gels (783 spots from the pH 3-10NL separation and 434 
spots from the pH 4-7 separation). Each protein spot was tryptically digested, 
analysed by LC-MS/MS and searched for protein identity using Mascot. 
Similar to the 1-DE results, many proteins from separate spots shared the same 
identity and some gel spots contained more than one protein (discussed in 
section 2.4.2). When redundancy between proteins with the same identification 
from both 2-DE gels was removed, 616 individual gene products (547 release 4 
genes and 69 alternative gene models and ORFs) were identified (see Appendix 
IV for list of MS evidence obtained from 2-DE proteome maps of T. gondii 
tachyzoite proteins). 
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Figure 2.4 Tachyzoite proteins resolved by 2-DE. (a) Soluble proteins from 
2.53×10
8
 tachyzoites (516 μg of protein) resolved by IEF over a broad, non-linear 
pH 3-10 range. (b) Soluble proteins from 1×10
8
 tachyzoites (200 μg of protein) 
resolved by IEF over a narrow, linear pH 4-7 range. Both pH3-10NL and pH 4-7 IEF 
strips were further separated by molecular mass on a 12.5% (w/v) acrylamide gel 
under denaturing conditions. Protein spots are visualized using colloidal Coomassie. 
Spots with the same protein identification are boxed. Gel annotation was assisted by 
Dr. S.J. Sanderson.  
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2.3.3  MudPIT analysis of T. gondii tachyzoites 
Whole tachyzoite protein was fractionized into Tris-soluble and Tris-insoluble 
fractions, and each fraction processed for MudPIT analysis by Dr Judith Prieto in 
John R. Yates‟s lab, Scripps Research Institute, La Jolla as detailed in sections 
2.2.8.1-3. This resulted in 1300 and 2328 protein identifications, respectively. A total 
number of 2409 non-redundant proteins were identified, which comprises 2121 
release 4 genes and 288 alternative gene models and ORFs. Of the release 4 genes 
identified, 15.3% were uniquely identified in the Tris-soluble fraction and 48.0% 
were uniquely identified in the Tris-insoluble fraction (see Appendix V for protein 
identifications made by MudPIT). The higher number of proteins identified in the 
Tris-insoluble fractions is likely to reflect incomplete solubilisation in the Tris buffer. 
This is indicated by the transmembrane domain (TM domain) prediction results 
where 20.0% of proteins identified in the Tris-insoluble fractions possess at least one 
TM domain, compared to 8.4% in the Tris-soluble fractions.  
2.3.4  Comparison of protein identifications from the three proteomic 
platforms 
Prior to the commencement of this study in 2005, total protein expression evidence 
was limited to T. gondii sub-proteomes and the previous preliminary tachyzoite 
proteome study from the Wastling group [84, 250, 253]. In total just around 300 
release 4 genes were known to be expressed, representing less than 4% of the 
predicted genome. In this study, when the results from the three proteomic platforms 
were combined, a total number of 2252 non-redundant release 4 gene identifications 
were obtained from the tachyzoite stage of the parasite. This represents the 
expression of approximately 29% of the total number of release 4 predicted genes in 
 Chapter 2-Identifying the T. gondii tachyzoite proteome 
 
68 
 
the genome. Notably, 813 of the 2252 (36%) proteins identified are annotated as 
hypothetical or conserved hypothetical proteins on ToxoDB. With the expression 
evidence acquired in this study, the status of these proteins can now be changed to 
“confirmed” proteins. Figure 2.5 illustrates the degree of overlap between the protein 
identification results derived from each of the three proteomic platforms. 
 
Figure 2.5 T. gondii tachyzoite expressed proteome: comparison of 
proteomic platforms. Venn diagram showing the number of unique and 
shared non-redundant release 4 gene identifications obtained from each of the three 
proteomic platforms. 
The comparison shows that MudPIT produced the largest number of identifications; 
however, a number of proteins were uniquely identified from gel-based approaches 
(59 for 1-DE; 40 for 2-DE). A more detailed comparison of the different proteomic 
platforms used is discussed in section 2.4.2. In addition to the identified release 4 
genes, 394 non-redundant alternative gene models and ORFs were identified from 
the entire dataset. The implication for genome annotation of these additional 
identifications out with the release 4 genes is further examined and discussed in 
chapter 4. 
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Searching against the contaminant database mostly returns trypsin and keratins with 
a wide range of identification scores for all three proteomic platforms used. This has 
been observed by other studies and [267] keratin contamination should be regularly 
monitored to keep the level to the minimum. 
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2.4  Discussion 
In this study, a significant proportion of the T. gondii predicted proteome has been 
identified. This result benefited from the careful consideration of several important 
technical challenges such as proteomic platform selection; database design and the 
searching strategy for MS data acquisition, which are discussed in detail in the 
following sections. 
2.4.1  Coverage of the predicted proteome 
Using multiple platforms has proven to be an efficient and powerful approach in 
protein identification based proteomic research [262, 265, 268, 269]. In this study, 
three independent proteomic platforms were used to maximise the coverage of the 
expressed proteome. More than two thousand (2252) unique release 4 genes have 
been identified, which represents almost one third (29%) of the predicted proteome 
of all life cycle stages. This work significantly improved the knowledge of the T. 
gondii proteome, increasing the percentage of known expressed genes from ~4% to 
29% of the total genome. The coverage was further expanded by the identification of 
394 non-redundant alternative gene models and ORFs.  
The coverage of the predicted proteome from one life cycle stage in this study is 
similar to or marginally better than other large scale Apicomplexan proteomic 
studies. For example, 32% for C. parvum excysted sporozoites [265], 20% for 
sporozoites and 16% for merozoites of P. falciparum [261], and 20% in a later T. 
gondii tachyzoite study [270]. Since the exact number of proteins in the predicted 
proteome of T. gondii tachyzoite is unknown, whether the 1/3 coverage of the whole 
predicted proteome represents a significant proportion of all the expressed proteins 
from the tachyzoite stage or rather a reflection of the detection limitation of the 
 Chapter 2-Identifying the T. gondii tachyzoite proteome 
 
71 
 
proteomic techniques requires further investigation. For example, the detection of 
low abundance proteins is hampered in the presence of more abundant proteins 
during MS analysis and considering the continuous synthesis and degradation of 
proteins with varying turnover rates [271], it is difficult to include all the proteins in 
a single “snapshot” during sampling. The slightly higher coverage of the predicted 
proteome achieved by this study and the C. parvum study [265] is likely to have 
benefited from the three complementary proteomic platforms used which enhanced 
the detection of proteins with different properties. The difference and benefits of the 
three proteomic platforms are further discussed in section 2.4.2.     
In fact, higher proteomic coverage can be expected when more life stages are studied.  
A proteomic study in P. falciparum has revealed that 49% of expressed sporozoite 
proteins are unique to this stage and an average of 25% of proteins is shared with any 
other stage. Taking all four stages studied into consideration, only 6% of proteins are 
common to all stages [261]. A transcriptome study of T. gondii found that 50% of 
expressed tachyzoite genes (day 7) are shared with the genes expressed in mature 
bradyzoites (day 17) [272]. If a similar overlapping percentage can be applied to the 
T. gondii proteome, a much higher coverage of the predicted proteome can be 
expected when multiple life cycle stages are studied. 
2.4.2  Comparison of the three proteomic platforms used 
Complementary proteomic platforms, the gel based techniques of 1-DE and 2-DE 
followed by LC-MS/MS and the gel free technique, MudPIT were used in this study. 
While each platform contributed to the overall coverage of the proteome by 
identifying unique proteins shown in Figure 2.5, they also have their own advantages 
and limitations in proteomic studies. 
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The gel based techniques used in this study generally detect more peptides per 
protein identification and hence deliver higher confidence scores than protein 
identification obtained from MudPIT. This can be explained by the sample 
separation in protein space prior to MS analysis, which results in a less complex 
peptide mixture to be analysed by MS and database searching. 
Among the gel based techniques, 1-DE has a wider application in protein separation 
compared to 2-DE, it has a higher loading capacity and the presence of SDS enables 
a better solubilisation of hydrophobic proteins (for example, membrane proteins, 
which are important for parasite invasion and survival in host cells). In fact, 14.2% 
of proteins identified by 1-DE possess at least one transmembrane domain (TM 
domain), which is higher than 9.7% for 2-DE. 1-DE has identified more proteins 
than 2-DE in this study, which has also been observed in previous studies [265, 269]. 
In addition to that, 1-DE benefits high throughput proteomic analysis with a simpler 
experiment setup and less labour intensity. 
In this study, a similar Tris solubilisation strategy as used for a Plasmodium 
proteome [261] was tested on a second 1-DE experiment. The analysis of 50 slices 
from the most divergent region led to the identification of 335 release 4 genes, of 
which 82 genes were not previously identified in the first 1-DE experiment. The 24.4% 
increase in protein identification may look encouraging initially. However, among 
359 release 4 genes identified from the equivalent region on the first 1-DE 
experiment, 108 genes have not been identified in the second 1-DE experiment. 
Taking into account that a 23-38% increase of protein identification can be expected 
simply by analysing the same sample twice by LC-MS/MS [273], and considering 
the extra labour required to complete the analysis, only the initial 50 slices have been 
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analysed in the second 1-DE experiment. The same Tris solubilisation strategy was 
applied for the more automated MudPIT platform. 
In comparison with 1-DE and MudPIT, 2-DE has difficulty in resolving very large or 
small proteins, low abundance proteins, hydrophobic proteins and proteins with 
extreme pIs. 2-DE experiments are also very labour intensive. However, despite 
these limitations, the 2-DE approach has uniquely identified 40 release 4 genes in 
this study. More importantly, 2-DE is able to provide additional information about 
the expressed proteome that other platforms fail to provide. It delivers a reference 
map of intact proteins, which reflects changes in protein expression levels, isoforms 
or post translational modification (PTM).  
In this study, clusters of proteins from different gel spots are often found to share the 
same identification as shown in Figure 2.4. These clusters of proteins are likely to 
represent isoenzymes or proteins with PTMs. This phenomenon highlights an 
important application of 2-DE, PTM analysis. For example, protein phosphorylation 
is a key PTM that is crucial in controlling enzyme activities, protein degradation and 
particularly, T. gondii invasion and host cell interaction [274, 275]. Several 
phosphoprotein groups identified in this study showed as horizontal strings of spots 
on the gel since proteins containing negatively charged phosphate groups are 
separated according to their pI differences. 2-DE provides a rapid and 
straightforward visualization method of the potential PTM events; peptides from 
proteins of interest can be enriched by affinity chromatography or chemical 
approaches [276-278] and analysed further by tandem MS. 
MudPIT identified the largest number of proteins in this study. Using a gel free 
platform, MudPIT can identify proteins with extremes of isoelectric point and 
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molecular weight [139]. Simplified sample separation in peptide space together with 
the use of two dimensional chromatography increases the resolution of separation 
and also provides higher loading capacity. This allows low abundance proteins and 
hydrophobic proteins to be identified [279]. In this study, 18.0% of proteins 
identified by MudPIT possess at least one TM domain, which is higher than the 
results from both 1-DE and 2-DE. In addition to this, MudPIT analysis is readily 
automated which benefits the high throughput requirement of proteomic research. 
However, MudPIT generates a highly complex peptide mixture, which requires 
considerable computing power for MS data searching. The dedicated and costly 
instrument setup and operational expertise required also prevent easy access for 
individual labs. 
With various protein identification techniques available in this rapidly developing 
proteomics field, choosing a good combination of techniques is central to providing 
the largest number of protein identifications whilst utilising limited amounts of 
sample and labour. In this study, 2-DE gels with two pH gradient ranges were used 
to enable a broad sampling from pH 3-10, and at the same time achieve increased 
resolution for the detection of low abundance proteins in pH 4-7 range. By running 
the second 1-DE experiment, it has been demonstrated that additional protein 
identifications can be achieved with repeated analysis, but it is unclear whether the 
extra proteins identified are the results of difference in 1-DE gel separation or the 
repeated LC-MS/MS analysis. It is hard to justify the extra material and labour 
required to complete the analysis of the second 1-DE experiment especially when a 
Tris pre-fractionation method has been applied to a more automated MudPIT 
platform where five soluble replicates and four insoluble replicates have been 
analysed. 
 Chapter 2-Identifying the T. gondii tachyzoite proteome 
 
75 
 
2.4.3  Database design to maximize protein identification 
A successful translation of the raw MS data to protein identification relies on a good 
sequence database design that can maximize the coverage of potential protein coding 
sequences (CDS). This will make greatest use of the peptide information acquired in 
the previous steps. As reviewed in section 1.1.4, various gene prediction algorithms 
have been used for T. gondii genome annotation. These include ab initio gene 
prediction methods TigrScan and GlimmerHMM, and integrative methods such as 
GLEAN and TwinScan that combine experimental data, comparative genomic 
alignments and ab initio methods [280-282]. A major updated version was made 
available on ToxoDB version 4 in 2006 (release 4 gene model), which integrated 
experimental data such as expressed sequence tags (ESTs) [112].  
However, despite all the effort that has been made, the release 4 gene model is far 
from a perfect dataset that can be used as the only sequence database for MS data 
searching. It was shown that 41% of release 4 gene models are likely to be imperfect  
containing at least one inconsistency with full-length cDNAs [208]. Comparison of 
release 4 gene models and genes predicted by other methods revealed a more 
complicated mixture of gene models. It has been found that any two prediction 
methods used generally share less than 12% identical predicted genes (head to head 
comparison) and 68% to 87% of sequences predicted by each prediction methods are 
unique to other prediction methods [270]. 
The above finding confirmed that using any single gene model is not sufficient to 
cover all the possible coding sequences. In this study, a lot of effort has been made to 
overcome this issue. MS data generated from the 1-DE experiment was initially 
searched against a sequence database that comprised all applicable coding sequences 
on ToxoDB version 3. Upon the publication of release 4 gene models in 2006, a new 
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sequence database was designed to achieve the best coverage of potential T. gondii 
coding sequences. Both release 4 gene models and gene models provided by other 
prediction methods and experimental evidence such as clustered expressed sequence 
tags (collectively termed as alternative gene models) were used. These were 
complemented by the inclusion of open reading frames (ORFs) translated from 
genomic sequences. MS data generated from the 1-DE experiment was re-searched 
against the new sequence database and subsequent data analysis was repeated. 
Searching against the new sequence database enabled us to realize the imperfection 
of release 4 gene models and led to the development of strategies to improve genome 
annotation and shorten the time consuming data re-submission process, which is 
further discussed in Chapter 4. 
2.4.4  Search engines and result verification 
The successful identification of low-abundance proteins in the sample has been an 
important issue in proteomic research. For example, the expression of 9 surface 
antigen related genes in T. gondii, which serve important roles in host cell 
attachment and interfacing with the host immune response during invasion [69], 
were found to be below the 10 percentile in a microarray experiment [112]. If the 
expression of these genes remains low at a translational level, the successful 
identification of these genes in a proteomic study is expected to encounter some 
technical limitations. 
 Firstly, the stochastic nature of peptide sampling by the mass spectrometer leads to a 
bias towards more protein identifications from peptides of higher concentrations. 
Secondly, different search engines used in MS data analysis also vary the results 
because of the difference in the search engines themselves as well as different false 
discovery rates applied [273, 283]. A recent test sample study distributed 20 highly 
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purified recombinant human proteins to 27 independent laboratories and compared 
the protein identification results acquired. Although most of the laboratories 
generated high quality MS data which was sufficient to identify all 20 proteins tested, 
only seven laboratories correctly reported all the proteins due to the differences in 
database setup and the search engine used [267].  
In this study, manual inspection has been used to preserve the valuable expression 
evidence of low-abundance proteins acquired by MS data and protein identifications 
were also verified by searching against decoy and contaminant databases. Protein 
identification based on a single peptide and proteins that return a Mascot score < 60 
are normally regarded as low confidence identifications, but these can also represent 
real expression of low-abundance proteins. For 1-DE and 2-DE results, manual 
inspection of individual peptide MS/MS spectra has been carried out on the proteins 
identified by Mascot (as described in section 2.2.7.1).  
For MS data searching of MudPIT results, although manual inspection is not feasible, 
a decoy database that contains reversed sequences from the target database was used 
to estimate the false discovery rates (FDRs). The FDRs were calculated at 3.84% for 
Tris-insoluble fractions and 3.11% for Tris-soluble fractions, which are very 
respectable figures as < 5% is considered a low FDR for MudPIT [284, 285].  
Approaches have been developed to improve the performance of MS data searching 
by adapting the results from multiple searching engines. This approach can 
significantly reduce the FDR of the result [284] and improve the confidence of 
protein identification based on a single peptide [284, 286]. Using multiple search 
engines for MS data allows on average 35% more peptide identifications to be made 
at a fixed FDR of 1% compared with using a single search engine [286]. The 
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development of this multiple search engine platform is nearly completed in the 
Wastling group in collaboration with Dr Andy Jones, University of Liverpool. It is 
expected to bring significant benefits to the current study and on-going proteomic 
studies by re-querying raw MS data using this platform. 
2.4.5  Conclusion 
Through the years, the rapid improvement of genomic and proteomic techniques has 
provided us with an ever improving MS detection sensitivity and capability, more 
accurate genome annotations and more efficient MS data search engines. It is 
essential to harness the latest technical development in this dynamic proteomic 
research. In this study, the three complementary high-performance proteomic 
platforms as well as a carefully designed up-to-date database and searching strategy 
for MS data acquisition allowed us to achieve a comprehensive coverage of the 
expressed T. gondii tachyzoite proteome. Comparing the results of this study with 
what had been achieved in 2002, a great improvement has already been seen. It is 
safe to speculate that a better coverage can be achieved in the near future within this 
on-going field of proteomic research. 
While the identification of several thousand expressed proteins provides a milestone 
for proteomic research, in combination with the power of bioinformatics 
interpretation, the protein expression data will further benefit the understanding of T. 
gondii biology, which is investigated and discussed in Chapter 3. To harness the 
proteomic data in a broader, system biology level, the value of the proteomic data in 
the process of genome annotation and the comparison between proteomic and 
transcriptomic data are discussed in Chapters 4 and 5, respectively. 
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3.1  Introduction 
Once the expressed proteome has been identified, bioinformatics interpretation plays 
an important role in understanding the biological functions of the proteins. As 
reviewed in section 1.2.5, functional assignment of an unknown protein using a 
bioinformatics approach relies on the assumption that proteins which have similar 
amino acid sequences or similar structures share similar functions. Data 
interpretation typically combines evidence from two approaches: databases that 
provide manually curated data from literature and predictions made by computer 
programs that automatically transfer existing knowledge about a homologous 
sequence to the targeting sequence. 
For Toxoplasma gondii, ToxoDB (http://toxodb.org/toxo/) serves as a functional 
genomics resource that hosts the largest collection of T. gondii genome sequences 
and annotations [112] and is widely accredited as such by the T. gondii research 
community. On ToxoDB, product description and GO annotation of release 4 genes 
are provided where applicable [108]. This information provides valuable insights 
into the function of T. gondii genes and was used as the primary resource for data 
interpretation in this study. 
In addition to the information provided on ToxoDB, there are a range of specific and 
universal prediction programs that can be used to infer the biological functions of the 
proteins identified. SignalP [178] and TMHMM [179] predict the existence of signal 
peptides and transmembrane domains in a protein sequence, respectively. The entry 
of virtually all proteins into the secretory pathway is controlled by signal peptides 
[287, 288]. In T. gondii, signal peptides direct proteins to important localizations 
central to invasion, such as the extracellular surface during gliding motility [65], the 
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secretory traffic to apical organelles [83], the dense granule [289] and the apicoplast 
[290]. Proteins with transmembrane domains also play an important role in the 
tachyzoite stage such as in gliding motility [62], the moving junction [80] and, the 
majority of the dense granule proteins (GRAs) are predicted to be transmembrane 
proteins [291]. The results of these two prediction programs can be used to infer the 
biological properties of the expressed proteome as well as to examine the quality of 
proteomic sampling when compared with whole genome predictions. 
With the exception of Cryptosporidium, most of the clinically important 
Apicomplexan parasites studied possess two endosymbiotic organelles which carry 
DNA in addition to the nucleus: the mitochondrion and the apicoplast [292-296]. 
The growth of T. gondii is inhibited by drugs that impair apicoplast autonomy at the 
level of DNA replication, transcription, RNA processing and translation [297, 298]. 
Its algal origin also means many proteins and pathways are not shared by the human 
host. Together, these properties make the apicoplast a very promising drug target. 
Comparatively little is known about the Toxoplasma mitochondrion. This may partly 
reflect the diversion of research interest to the apicoplast, and the difficulty in 
defining the mitochondrial genome [299]. However, studies have linked 
mitochondrial function with T. gondii stage conversion whereby the exposure of 
mitochondrial inhibitors stimulates the transition of tachyzoites to bradyzoites in 
vitro [300, 301]. Additionally, the exact role of the mitochondrion in energy 
metabolisms still requires more investigation [299, 302]. The importance of these 
two organelles in Apicomplexan parasites led to the development of two specific 
prediction programs PATS [180] and PlasMit [303] respectively, which were used in 
this study. 
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In addition to the resources provided on ToxoDB and programs that are designed to 
predict specific properties of a gene, the integrative protein information database 
InterPro [182] was used in this study to determine protein functions as well as GO 
annotations. Global sequence analysis tools were also used in the study, BlastP [167] 
and AmiGO [304] were used to infer functional information of proteins based on 
sequence similarity, and WoLF PSORT [181] was used to predict subcellular 
localizations of proteins identified. Together, the results of bioinformatics 
interpretation will not only represent the predicted distribution of the expressed 
proteome but also expand the knowledge of the functions of these proteins in the 
important biological processes of T. gondii.  
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3.2  Materials and Methods 
Several bioinformatics prediction programmes were used to assist protein function 
determination. Briefly, protein sequences were searched using BlastP to characterize 
protein functions and infer possible subcellular localizations. SignalP was used to 
predict proteins that contain signal peptides; TMHMM was used to predict 
transmembrane domains contained within a protein; results returned from PATS, 
PlasMit and WoLF PSORT together with release 4 gene descriptions and GO 
cellular component predictions provided by ToxoDB were combined to obtain 
subcellular localization predictions of proteins.  
Functional categorization was constructed using the GO classifications listed on 
ToxoDB for each release4 gene, which were then assigned to specific MIPS 
categories within the FunCatDB functional catalogue. Genes without a GO 
classification were assigned a putative MIPS category using additional information 
provided by Blast, Pfam domain alignments, InterPro and from independent 
literature searches. 
3.2.1  Protein-protein Blast (BlastP) 
BlastP (http://www.ncbi.nlm.nih.gov/BLAST/) is a powerful sequence alignment 
tool provided by National Centre for Biotechnology Information (NCBI). It 
compares protein sequences to other previously characterized protein sequences in 
the database. The alignment and conserved domain results based on sequence 
similarity are used to conjecture functional and evolutionary information of query 
sequences. Default settings were applied in this study. 
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3.2.2  SignalP  
SignalP 3.0 (http://www.cbs.dtu.dk/services/SignalP/) is an online bioinformatics 
prediction server which predicts the presence and location of signal peptide cleavage 
sites in given amino acid sequences provided by The Centre for Biological Sequence 
Analysis at the Technical University of Denmark [178]. In this study, sequences 
were uploaded in fasta format, default settings were applied for searching. 
3.2.3  TMHMM 2.0  
TMHMM 2.0 (http://www.cbs.dtu.dk/services/TMHMM-2.0/) is a bioinformatics 
prediction server provided by The Centre for Biological Sequence Analysis at the 
Technical University of Denmark [179]. The server is programmed to predict 
transmembrane helices in proteins using a hidden Markov model. In this study, 
sequences were uploaded in fasta format and default settings were applied for 
searching. 
3.2.4  PATS 
PATS (prediction of apicoplast targeted sequences) (http://gecco.org.chemie.uni-
frankfurt.de/pats/pats-index.php) is an online bioinformatics program provided by 
the Molecular Design Laboratory, Goethe University, Frankfurt which provides 
predictions of apicoplast targeted sequences in Apicomplexan parasites. PATS uses a 
neural network analysis and has been trained with Plasmodium falciparum proteins 
[180].  In this study, default settings were applied. 
3.2.5  PlasMit 
PlasMit (http://gecco.org.chemie.uni-frankfurt.de/plasmit/index.html) is an online 
neural network software also provided by the Molecular Design Laboratory, Goethe 
University, Frankfurt, which predicts mitochondrial transit peptides in P.  falciparum 
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[303]. In this study, PlasMit was used to predict possible mitochondrial proteins in 
conjunction with other prediction software.  
3.2.6  WoLF PSORT Prediction 
WoLF PSORT (http://wolfpsort.org/) is an online server for protein subcellular 
localization predictions provided by the Computational Biology Research Centre, 
National Institute of Advanced Industrial Science and Technology (AIST), Japan 
[181]. The server has been trained with yeast sequences from SWISS-PROT with the 
annotation of Yeast Protein Database (YPD). In this study, the organism type was set 
as animal and default settings were applied. To be considered a valid prediction the 
possibility percentage of the first localization result must be at least twice that of the 
second localization percentage.  
3.2.7  AmiGO 
AmiGO (http://amigo.geneontology.org/cgi-bin/amigo/go.cgi) is the official online 
database for searching and browsing the Gene Ontology database and is provided by 
an international consortium [304]. In this study, AmiGO was used to match the 
protein function information retrieved from literature or other data sources to the 
controlled vocabulary of terms and identifiers defined by the Gene Ontology project. 
A Blast tool provided by AmiGO was also used to search GO descriptions of a 
protein when no GO annotation is available elsewhere. 
3.2.8  Munich Information Centre for Protein Sequences Functional 
Catalogue (MIPS FunCat) 
MIPS FunCat (http://mips.gsf.de/projects/funcat) is an annotation scheme for the 
functional description of proteins from prokaryotes, unicellular eukaryotes, plants 
and animals [305]. The FunCat consists of 28 main functional categories that cover 
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general fields like cellular transport, metabolism and cell rescue, defence and 
virulence. In this study, proteins identified were assigned to the most relevant 
category according to the functional information provided by GO annotation on 
ToxoDB, Blast, Pfam domain alignments, InterPro and independent literature 
searches. 
3.2.9  Metabolic Pathway Coverage 
The KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway 
(www.genome.jp/kegg/) [306] was used to examine the coverage of identified 
proteins on key metabolic pathways. Conversion of T. gondii genes to key metabolic 
pathway components was determined using the Metabolic Pathway Reconstruction 
tool for T. gondii available on ToxoDB (http://roos-
compbio2.bio.upenn.edu/~fengchen/pathway/). Glycolysis and gluconeogenesis are 
important energy production pathways in Toxoplasma and were chosen as model 
pathways in this study. Proteins identified from tachyzoites were mapped onto the 
reconstructed glycolysis and gluconeogenesis pathways for T. gondii. 
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3.3  Results 
3.3.1  SignalP and TMHMM predictions 
Proteins identified from T. gondii tachyzoites were subjected to SignalP and 
TMHMM predictions. In this study, 10% of the identified official ToxoDB release 4 
genes were predicted to contain a signal peptide and 17.6% of the identified official 
ToxoDB release 4 genes contain transmembrane domains. Predictions of identified 
alternative gene models and ORFs returned results of 9% and 21% respectively.  
The results are closely similar to T. gondii genome predictions for signal peptide and 
transmembrane containing proteins provided on ToxoDB (11% and 18% 
respectively) and indicate unbiased sampling of the study. Similar proportions of 
signal peptide have been reported in the expressed proteome of Plasmodium 
falciparum [261] and similar proportions of transmembrane domain containing 
proteins are found in the expressed proteome of Cryptosporidium parvum and P. 
falciparum [261, 265]. Together they suggest a good sampling standard has been 
achieved in proteomic studies where signal peptide containing proteins and 
transmembrane domain containing proteins are not under represented. 
3.3.2  Subcellular Localization Prediction 
The subcellular localizations of proteins identified were collectively inferred by the 
predictions made from PATS, PlasMit, WoLF PSORT and release 4 gene 
descriptions and GO cellular component classification provided by ToxoDB. Figure 
3.1 shows the distribution of predicted subcellular localizations of expressed proteins 
in the tachyzoite stage. 
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Figure 3.1 Subcellular localization of the expressed tachyzoite proteome. (a) 
Subcellular localization of identified official ToxoDB release 4 genes. The 
prediction was first assigned according to gene descriptions and GO annotation 
provided by ToxoDB. The sequences of proteins with no information provided on 
ToxoDB were submitted to PATS, PlasMit and WoLF PSORT. The results were 
combined to obtain predicted subcellular localizations. (b) Subcellular localization of 
identified alternative gene models and ORFs. The prediction was made by the 
combined results of PATS, PlasMit and WoLF PSORT. 
A wide distribution of subcellular localizations in the expressed proteome was 
observed. The subcellular localization predictions of identified alternative gene 
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models and ORFs have shown a different distribution pattern, which was influenced 
by the resources available. The impact of prediction programs used was discussed in 
section 3.4.1.3. For release 4 genes identified, nuclear, cytoplasmic, plasma 
membrane and mitochondrial proteins are among the most represented categories 
which reflect the rapid gene expression, protein synthesis, extracellular interaction 
and energy generation events required in the tachyzoite stage which is the rapidly 
multiplicative, invasive form of the parasite. More than 100 proteins were predicted 
to be apicoplast proteins. A significant number of apical complex proteins (44) were 
detected which potentially have important roles in invasion and maintenance in host 
cells. There are also many proteins that are putatively involved in secretory pathways 
that are predicted to be located to the endoplasmic reticulum-golgi, plasma 
membrane and extracellular locations. 
3.3.3   Functional Categorization 
Functional information for the proteins identified was acquired from gene 
descriptions and GO annotations listed on ToxoDB, and these were then assigned to 
specific MIPS categories. Proteins that have no GO classification were assigned a 
putative MIPS category using additional information provided by BlastP, AmiGO, 
Pfam domain alignments, InterPro and from independent literature searches. Figure 
3.2 shows the functional categorization of proteins identified in this study. 
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Figure 3.2 Functional categorization of the expressed tachyzoite proteome. 
Functional assignments of identified official ToxoDB release 4 genes. The prediction 
was first determined by gene description and GO annotation provided on ToxoDB 
and then assigned to appropriate MIPS FunCat categories. Putative functional 
assignment was made to the remainder of identified proteins with information 
acquired from BlastP, Pfam domain alignments, InterPro and literature searches. (b) 
Functional assignment of identified alternative gene models and ORFs. The 
prediction was made by information acquired from BlastP, Pfam domain alignments, 
AmiGO blast and then assigned to appropriate MIPS FunCat categories. 
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Similar to subcellular localization predictions, functional categorization of identified 
alternative gene models and ORFs has shown a different pattern than that of release 
4 genes, which is further discussed in section 3.4.1.3. For release 4 genes identified, 
categories that are highly represented in the results are metabolism, cellular transport, 
protein synthesis and protein fate (folding, modification, destination) which reflect 
the highly active metabolism, protein synthesis and cell division functions required 
in the tachyzoite stage. Importantly, 77 proteins are assigned to the “cell rescue, 
defence and virulence” category, many proteins of which are required in the invasion 
of and maintenance in the host cell by the tachyzoite stage.  
3.3.4  Metabolic Pathway Coverage 
ToxoDB provided a reconstructed version of the KEGG pathway for T. gondii. 
Proteins identified in this study were cross-referenced with the glycolysis and 
gluconeogenesis pathways. Table 3.1 lists the Toxoplasma gene ascribed to each 
constituent of the glycolysis and gluconeogenesis pathways. The EC numbers are 
included for reference to Figure 3.3.  
Table 3.1 Component enzymes of the glycolysis and gluconeogenesis 
pathways, EC numbers and corresponding Toxoplasma gene identifiers. 
EC Numbers Description ToxoDB ID 
1.1.1.1 Alcohol dehydrogenase 583.m05453 
1.1.1.27 L-lactate dehydrogenase 44.m00006 
1.1.1.27 L-lactate dehydrogenase 80.m00010 
1.2.1.12 
Glyceraldehyde 3-phosphate dehydrogenase 
(phosphorylating) 
80.m00003 
1.2.1.3 Aldehyde dehydrogenase (NAD(+)) 41.m00032 
1.2.4.1 Pyruvate dehydrogenase (acetyl-transferring) 50.m03083 
1.2.4.1 Pyruvate dehydrogenase (acetyl-transferring) 50.m03618 
1.2.4.1 Pyruvate dehydrogenase (acetyl-transferring) 59.m03618 
1.8.1.4 Dihydrolipoyl dehydrogenase 20.m03954 
2.3.1.12 Dihydrolipoyllysine-residue acetyltransferase 20.m00373 
2.3.1.168 
Dihydrolipoyllysine-residue (2-
methylpropanoyl)transferase 
641.m00177 
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2.7.1.1 Hexokinase 57.m00001 
2.7.1.11 6-phosphofructokinase 42.m00123 
2.7.1.11 6-phosphofructokinase 49.m03242 
2.7.1.40 Pyruvate kinase 129.m00253 
2.7.1.40 Pyruvate kinase 55.m00007 
2.7.2.- 
Phosphotransferases with a carboxy group as 
acceptor 
37.m00745 
2.7.2.3 Phosphoglycerate kinase 41.m01331 
2.7.2.3 Phosphoglycerate kinase 641.m00193 
3.1.3.11 Fructose-bisphosphatase 20.m03907 
3.1.3.11 Fructose-bisphosphatase 46.m01668 
3.1.3.11 Fructose-bisphosphatase 50.m00005 
3.6.1.7 Acylphosphatase 55.m04800 
4.1.2.13 Fructose-bisphosphate aldolase 46.m00002 
4.1.2.13 Fructose-bisphosphate aldolase 46.m02920 
4.2.1.11 Phosphopyruvate hydratase 59.m03410 
4.2.1.11 Phosphopyruvate hydratase 59.m03411 
4.6.1.- Phosphorus-oxygen lyases 44.m02781 
4.6.1.- Phosphorus-oxygen lyases 52.m01648 
5.3.1.1 Triosephosphate isomerase 42.m00050 
5.3.1.1 Triosephosphate isomerase 44.m02801 
5.3.1.9 Glucose-6-phosphate isomerase 76.m00001 
5.4.2.1 Phosphoglycerate mutase 113.m00016 
5.4.2.1 Phosphoglycerate mutase 59.m03656 
6.2.1.1 Acetate--CoA ligase 57.m03124 
Note: Data acquired from the Metabolic Pathway Reconstruction for T. gondii 
available on the KEGG Pathway site accessed via ToxoDB (http://roos-
compbio2.bio.upenn.edu/~fengchen/pathway/). 
In the predicted T. gondii glycolysis and gluconeogenesis pathways, all but two 
enzyme components were detected in the expressed proteome, the exceptions being 
(EC 3.6.1.7-acylphosphatase and EC 1.1.1.1-alcohol dehydrogenase). Figure 3.3 
shows the coverage of the expressed tachyzoite proteome on the reconstructed 
KEGG pathway of glycolysis and gluconeogenesis for T. gondii.  
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Figure 3.3 Metabolic pathway coverage: Glycolysis and gluconeogenesis.  
Conversion of T. gondii genes to key pathway components was determined using the 
Metabolic Pathway Reconstruction for T. gondii available on the KEGG Pathway 
site accessed via ToxoDB (http://roos-compbio2.bio.upenn.edu/~fengchen/pathway/). 
EC number to ToxoDB gene mapping is listed in Table 3.1. Enzymes coloured in 
green and blue indicate expression evidence which has been confirmed by mass 
spectrometric data; blue also signifies genes identified by the 2-DE. Enzymes 
coloured in red are pathway components that have not been identified in this study. 
All other enzymes (shown in white) are those for which no corresponding T. gondii 
gene has been assigned.  
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3.4  Discussion 
3.4.1  Coverage of the expressed tachyzoite proteome 
The results of the bioinformatics interpretation show the expressed proteome of 
tachyzoites identified in this study covers a wide spectrum of proteins. SignalP and 
TMHMM results are very similar to the whole genome prediction which probably 
indicates that the sampling method used in the study was unbiased towards 
membrane and secreted proteins. It is not known what proportion of the expressed 
proteome comprises signal peptide or transmembrane domain containing proteins in 
the individual life cycle stages; however, it is likely that the rapidly dividing, 
invasive tachyzoite would employ a significant number of secreted proteins. The 
prediction that nearly one fifth of proteins identified possess at least one 
transmembrane domain reflected the importance of transmembrane proteins in 
protein secretion during the host cell invasion and intracellular survival. 
A broad distribution of subcellular localizations and functional categories and a near 
complete coverage of the glycolysis and gluconeogenesis pathways are also evidence 
that a sensitive and non-biased sampling has been achieved. The profile of 
subcellular localization and functional categorization reflect well the biological 
requirements of rapidly dividing, invasive tachyzoites. The expressions of proteins 
from several important subcellular compartments that serve unique biological 
functions have been confirmed by proteomic techniques.  
Categories with particular biological interest include proteins secreted by the three 
distinct organelles micronemes, rhoptries and dense granules. The sequential 
secretion from these organelles plays an important role in host cell invasion and 
intracellular survival (as discussed in section 1.1.3). Additionally, structural proteins 
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that support cellular movement during invasion have been identified as well as 
proteins from the unusual apicoplast organelle.  
3.4.1.1 Invasion and survival-apical complex, secretory organelles and others 
Despite the lack of organelle specific prediction programs, the expression of several 
known secretory organelle proteins have been detected in this study according to the 
ToxoDB gene description. These include 12 microneme proteins, 7 rhoptry proteins 
and 7 dense granule proteins. The apical complex, which contains micronemes, 
rhoptries, dense granules, the conoid and cytoskeletal components, is essential in 
both host cell invasion and survival of Apicomplexan parasites [83, 307, 308]. Forty 
four proteins identified in this study are annotated to locate to the apical complex. To 
achieve an accurate result, the assignment was entirely based on ToxoDB either by 
gene description or annotated GO cellular component. However, there are two other 
published studies that focused on the sub-proteome of the apical complex which 
indicate a potentially broader collection of apical complex proteins that exist.  
3.4.1.1.1  Comparison with experimental data 
In a proteomic study that specifically enriched conoid/apical complex material [251], 
179 proteins (release 4 genes) were identified as apical complex proteins after 
excluding contaminants from other subcellular organelles. Of those, 59 proteins were 
detected in multiple replicates by multiple peptides which were regarded as good 
evidence of apical complex proteins. However, as the list of 59 proteins is not 
released, a direct comparison cannot be made with this study. Among the 179 
proteins identified at the first stage, 104 have been identified in this study but only 
one protein (583.m05259, conserved hypothetical protein) has been assigned as an 
apical complex protein.  
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In the other study that characterized the proteome of purified rhoptry organelles [84], 
56 proteins (release 4 genes) were identified, of which 50 proteins have been 
identified in this study. Out of the 50 proteins, seven have been assigned as apical 
complex proteins on ToxoDB. The comparison with the other organelle specific 
proteomic studies indicates the sensitivity of this study is high. However, it also 
highlighted the fact that with limited information confirmed by genome annotation 
and the lack of apical organelle specific prediction programmes, the results of this 
study are likely to under-represent apical complex proteins. It also indicates that 
potential apical complex proteins have been mistakenly assigned to other general 
categories. For example, among 104 proteins which overlapped with conoid/apical 
enrichment study, two proteins have been assigned to cytoskeleton and 22 proteins 
have been assigned to the cytoplasm.  
3.4.1.1.2  Comparison with in silico predictions 
A recent study that employs bioinformatic approaches to predict candidate proteins 
associated with the apical organelles [309], focused on signature Pfam domains like 
PAN, TSP-1 and EGF motifs found in microneme proteins, and then searched the 
domain patterns in all available completed Apicomplexan genome sequences. The 
results suggested 60 candidate microneme proteins in T. gondii [309]. The whole 
tachyzoite proteome confirmed the expression of 15 of those candidate microneme 
proteins, 8 of which have not been assigned as “apical” in this chapter as no further 
localization confirmation can be found elsewhere. 
Together, the comparison of the data acquired in the current study with other 
experimental and computational studies showed that this study has achieved a good 
coverage of potential apical complex proteins and provided important protein 
expression evidence for more focused apical complex studies in the future. In 
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addition to that, based on different results from several studies, no well-defined 
apical complex proteome has been agreed. The prediction method used here, which 
is largely based on ToxoDB annotation, is suited to a global proteome survey rather 
than an in-depth study and the result serves as a good starting point in understanding 
apical complex proteomes. 
3.4.1.1.3 Examples of other important proteins during invasion process 
During invasion, the motor complex is formed by a class XIV myosin (MyoA), the 
myosin light chain and two gliding-associated proteins (GAPs) [65]. There are five 
known class XIV myosins in T. gondii: myosin A, B, C, D and E [310-313]. In this 
study, 14 proteins identified are annotated as myosin related proteins on ToxoDB. 
These include the expression of four putative myosins: A, C, D and E. In fact, there 
is no myosin B annotated on ToxoDB possibly due to the fact that myosin B and 
myosin C are the products of differential RNA splicing and share the majority of 
their sequences [310]. Additionally, four myosin light chain proteins have also been 
identified as well as five actin proteins. Although gliding-associated proteins (GAPs) 
have not been annotated on ToxoDB from which no protein identification can be 
made, good proteomic coverage of the glideosome has been achieved in this study. 
Another interesting group of proteins are SRS (SAG-related sequences) proteins 
which are thought to mediate attachment to host cells and activate host immunity 
thereby regulating the parasite's virulence [69, 314]. There are 46 SRS proteins 
predicted on ToxoDB version 4, of which 17 proteins were identified in this study. 
Confirmation of protein expression of these genes in this study will provide higher 
confidence in further characterization of SRS proteins.  
Chapter 3-Bioinformatics interpretation of the proteomic data 
 
98 
 
3.4.1.2  Endomembrane system, apicoplast and metabolic pathways 
The cell nucleus, cytoplasm and mitochondrion are among the subcellular locations 
that are well represented by protein constituents. Proteins involved in metabolism, 
transcription, protein synthesis, protein modification and degradation are required by 
the parasite for cell division and re-modelling and are highly represented in this 
study. 
The endomembrane system plays an important role in secretory pathways [315]. In 
this study, 23 proteins identified are predicted to locate to the endoplasmic reticulum 
(ER). The expression of three COPII-coated vesicle proteins are also detected which 
mediate the protein transportation between the ER and Golgi [316] as well as 9 
proteins that are predicted to locate to the Golgi. There are also a large proportion of 
proteins that are predicted to be involved in cellular transport and proteins with 
binding functions, which have potential roles in transporting host nutrients to the 
parasite and supporting cytoskeleton during invasion. In addition to the ER to Golgi 
route, proteins encoded by nucleus are also transported through the ER to an 
important endosymbiotic organelle, the apicoplast [290, 317]. 
3.4.1.2.1 Protein trafficking to the apicoplast 
With a genome size of just 35 kb, the apicoplast only encodes genes required for 
gene expression (such as ribosomal RNAs and tRNAs) and a few protein coding 
genes [318]. The majority of genes coding apicoplast proteins have been transferred 
to the nuclear genome, and their expression products are targeted back to the 
apicoplast post-translationally [319]. The apicoplast is the location of several 
anabolic pathways such as the biosynthesis of fatty acids, isoprenoids (i.e. sterols 
and ubiquinones), and iron-sulfur clusters [290, 320, 321]. Inhibition of the 
apicoplast metabolic function or interference with its DNA replication is lethal for 
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the parasite which make it an attractive drug target [298]. Thus, valuable information 
is provided by a good understanding of the proteins targeted to the apicoplast. 
In this study, with the information from both ToxoDB annotation and bioinformatics 
program PATS, 110 proteins identified are predicted to target to the apicoplast. 
Comparing this to the 222 apicoplast genes annotated on ToxoDB, expression of 86 
(39%) of them have been confirmed in this study. Prediction of the remaining 24 
putative apicoplast proteins was made by PATS, a program that can predict 
apicoplast targeted sequences in Apicomplexan parasites.  
These include seven aminoacyl-tRNA synthetases (145.m00322, 145.m00604, 
27.m00832, 39.m00356, 50.m00020, 55.m04665 and 80.m00063) and genes 
involved in anabolic pathways. For example, five genes are annotated to be involved 
in fatty acid biosynthetic processes (44.m00012, 49.m05646, 42.m03469, 
55.m00019 and 76.m01567) and two genes are annotated to be involved in a 
mevalonate-independent pathway of the isopentenyl diphosphate biosynthetic 
process (42.m03570 and 55.m04989). 
The biosynthetic pathways of the apicoplast require effective mechanisms to provide 
the organelle with carbon sources, ATP, and reducing power. Carbohydrate 
metabolism plays a central role in energy production and the synthesis of metabolites. 
In this study, five proteins identified in the apicoplast are involved in the glycolysis 
and gluconeogenesis pathways (129.m00253, 20.m00373, 50.m03083, 55.m00007 
and 59.m03618) and two proteins are involved in the tricarboxylic acid (TCA) cycle 
pathway (42.m03524 and 76.m01567). A putative pyruvate dehydrogenase 
(50.m03083), a central enzyme for the carbohydrate metabolism that provides the 
link between the glycolytic pathway and the TCA cycle, is also identified in 
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apicoplast. The localization of pyruvate dehydrogenase (50.m03083) in the 
apicoplast, rather than its common localization of mitochondrion, has been 
confirmed by several reports [322-324]. However, a recent study has localized one of 
the TCA cycle enzymes (42.m03524, aconitate hydratase, putative) to the 
mitochondrion using a construct with a C-terminal myc epitope fusion [324], which 
contradicts the PATS prediction used in this study and likely indicates a prediction 
error. The reliability of PATS prediction is further discussed in section 3.4.2. 
When the metabolic pathways were examined with the entire list of the expressed 
proteins identified in this study, a very promising coverage of glycolysis and 
gluconeogenesis pathways, as well as other pathways has been shown. 
3.4.1.2.2 Metabolic pathway coverage 
Glycolysis, gluconeogenesis and the TCA cycle are central pathways of 
carbohydrate metabolism. They are essential for matching the cellular demand for 
energy, reducing power and precursors for biosynthesis pathways. 
With only two enzymes in the glycolysis and gluconeogenesis pathways not having 
been identified in this study (EC 3.6.1.7-acylphosphatase and EC 1.1.1.1-alcohol 
dehydrogenase), it has shown a good coverage of the proteome data on these 
important energy pathways in the tachyzoite stage. In fact, the protein expression of 
these two genes have not been detected by other proteomic studies listed on ToxoDB 
[112], which may reflect a technical limitation of the detection of these genes by 
proteomic approaches.  
A good coverage has also been achieved on other key energy production pathways 
with 15 out of 18 enzymes identified in the T. gondii TCA cycle pathway and 26 out 
of 34 enzymes identified in oxidative phosphorylation pathway. 
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3.4.1.3  Coverage of bioinformatics prediction 
In functional categorization assignments, despite employing the strategy of using 
multiple prediction programs, the function of 817 proteins (36% of the proteome 
identified in this study) cannot be clearly determined based on a sequence similarity 
approach alone. The same difficulty was seen in a proteomic study of related 
Apicomplexan parasite C.parvum [265] where the function of 39% of the expressed 
proteome was unclassified. Similarly, in a P.falciparum study [261], more than 40% 
of expressed proteins from various life stages were listed as hypothetical, conserved 
hypothetical or functional unclassified proteins. 
The proportion of sequences with undetermined function is significantly higher for 
the 394 alternative gene models and ORFs at 70%. This reflects the larger proportion 
of atypical or truncated sequences that exists in the 394 sequences. At the same time, 
while subcellular localization prediction programs can make predictions on atypical 
or truncated sequences, sequence signatures and domain pattern based programs are 
very likely to misread the target sequences or completely miss an important domain, 
which can lead to biased prediction results. The reliability and coverage of 
bioinformatics prediction is further discussed in section 3.4.2. 
3.4.2  Choosing the right prediction programs 
With many free and commercial bioinformatics tools available for gene localization 
and function predictions, choosing the right programs is crucial in bioinformatics 
interpretations of proteome data. In this study, prediction programs were carefully 
selected. SignalP and TMHMM are commonly used in many studies as reliable 
prediction tools [265, 325-327]. They are also used in all EuPathDB online databases 
as standard prediction programs [112, 328-330], which allow the comparison of the 
proteomic data acquired in this study with T. gondii genome prediction on ToxoDB 
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feasible. For functional and subcellular localization predictions, evidence from 
universal prediction programs such as BlastP and WoLF PSORT as well as 
specifically designed Apicomplexan prediction programs such as PATS and PlasMit 
have been collectively used to achieve a more accurate prediction result. 
However, bioinformatics interpretation based largely on sequence and structural 
similarities to previously characterized proteins has its own drawbacks. The results 
of the present study illustrate the difficulty in predicting functional information for 
novel proteins in species where no similarities can be found.  For example, 36% of 
the expressed proteome has no functional annotation.  It also has been reported that 
proteins with highly similar sequences can have different functions in vivo, and, 
conversely, proteins may show similar activities while lacking apparent sequence or 
structural similarity [331].  
Different from functional assignment predictions where little information is available 
about novel proteins, subcellular localization prediction programs will give a 
prediction result on any sequences queried. The universal subcellular localization 
prediction program WoLF-PSORT used in this study gives a likelihood score of 
localization in percentage. A stringent parsing standard was applied in this study that, 
to be considered a valid prediction result the possibility percentage of the first 
localization result must be at least twice that of the second localization percentage. 
However, as discussed in section 3.4.1, comparing to the results of sub-protoeme 
studies, confilicts can still be found by using a univeral bioinformatics prediction. 
Using more species specific prediction tools with a better defined training dataset 
provides a more accurate prediction. As mentioned in previous sections, PATS used 
in this study, which is trained with P.falciparum sequences, is the closest program 
Chapter 3-Bioinformatics interpretation of the proteomic data 
 
103 
 
available that can predict apicoplast sequences for T. gondii. However, although both 
parasites are within the Apicomplexan phylum and share a lot of similarities, using 
PATS on T. gondii sequences can still cause potential problems. The successful 
prediction of an apicoplast sequence is based on the recognition of two sequence 
components, a typical endomembrane signal peptide and a plant-like transit peptide 
[290, 317]. While the first canonical signal peptides are similar, T. gondii transit 
sequences are enriched for serine and threonine [332] while P.falciparum transit 
peptides are enriched for asparagine and lysine residues [319]. Since PATS was 
primarily trained with P.falciparum sequences, the difference of transit peptides 
compositions may lead to false predictions in T. gondii sequences and a T. gondii 
specific prediction tool is needed in this case. 
Another useful approach is to simplify the prediction effort by pre-fractionating a 
complex sample according to different biological properties, and characterizing the 
resulting sub-proteome. This will provide a useful training dataset for computer 
learning programs and result in a more focused and accurate bioinformatics 
interpretation. Several sub-proteome studies of Apicomplexan parasites are available 
[84, 253, 333, 334] and can be used to facilitate better bioinformatics program design. 
3.4.3  Choosing the right categorization system 
In addition to choosing the right prediction programs, another issue is to use the right 
categorization system. While subcellular localizations of proteins can be sorted on a 
relatively standard system with similar terminologies used, previous publications that 
study functional categorization of proteomic results often developed their own 
systems [335-337]. Several functional annotation schemes are available including the 
Riley scheme [338], MIPS FunCat [305] and GO [339]. 
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The Riley schema was originally proposed for the functional annotation of E.coli 
however it lacks categories that cover parasite specific functions. MIPS FunCat and 
GO are better candidates since they both have a larger spectrum of functional 
category coverage. 
MIPS FunCat was used in the study to categorise protein functional assignments. 
Although Gene Ontology provides organizing principles such as biological process 
and molecular function which make it a valid scheme for functional categorization, 
the MIPS catalogue has several advantages in this study.  
Firstly, despite the considerable effort which has been made to assign GO annotation 
to T. gondii genes, the coverage of GO annotation is still quite low (i.e. around 23% 
for annotated GO molecular function category). Manually assigning a putative GO 
biological process and molecular function annotation to a gene would cause potential 
bias in the following categorization. 
Secondly, with both “molecular function” and “biological process” annotation 
domains available in GO scheme, confusion might be caused whether to categorise 
protein functions based on their basic molecular functions or towards a broader 
system level classification of biological process. Although “biological process” was 
used in favour of “molecular function” in this study to represent a better system 
biology view, by only accepting one annotation category would make the GO 
coverage even lower.  
Moreover, GO annotation is supported by MIPS FunCatDB where GO numbers can 
be queried against MIPS FunCat. Proteins with valid GO annotations on ToxoDB 
have been assigned to correlating MIPS category directly in this study.  
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In addition to those points, MIPS FunCat is a stable scheme and only four major 
extensions have been made since 1996 [305] compared to the constantly evolving 
and changing GO. MIPS FunCat has been used by several large-scale transcriptomic 
and proteomic studies [234, 340-342] including studies on Apicomplexan parasites 
C.parvum and P.falciparum [261, 265].  
3.4.4  Conclusion 
Bioinformatics interpretation is the first step towards understanding the biological 
roles of the expressed proteome. Despite a few drawbacks of sequence similarity-
based prediction programs, they provide valuable inspections of the expressed 
proteins and enlighten further detailed studies on proteins of interest. 
The following chapters will examine and compare the proteome data with other 
genomic expression data and make use of the experimental protein expression 
evidence to improve genome annotation methods. 
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4.1  Introduction 
In previous chapters, the importance of the proteomic data in expanding the current 
knowledge of protein expression as well as understanding biological functions using 
bioinformatics interpretation have been investigated and discussed. The standalone 
proteomic expression data have already added valuable input to the understanding of 
T. gondii biology. In this chapter, an effort has been made to investigate the benefit 
to the global research community of the integration of the proteomic data with other 
genomic and proteomic resources. 
4.1.1  MS data repository 
Several public repositories are actively hosting proteomic data for the research 
communities, such as the Proteomics identifications database (PRIDE) [192], the 
Global Proteome Machine databases (GPMDB) [197], PeptideAtlas [201], and 
Tranche [204]. As reviewed in section 1.2.5.2.2, data storing options offered by the 
first three platforms involve additional data processing using pipelines developed 
specifically for that repository. Compatibility issues have emerged due to the lack of 
a standardized data format for raw MS data. While collaborations between HUPO-
PSI and the Institute for Systems Biology have resulted in a new data format, mzML, 
being proposed [191], more efforts are required for the new data formats to be 
developed and adopted.  
This limitation made Tranche a good option for storing raw MS data. Firstly, any 
type of data file can be stored by the Tranche network. This allows the raw MS data 
generated from the various proteomic platforms used in this study to be hosted in one 
place. The valuable information embedded in raw MS data can be preserved for 
improved data analysis algorithms in the future. Secondly, by providing permanent 
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storage and  “peer-to-server-to-peer” distributed network, the Tranche network 
addresses the problem of data loss through computer hardware failure or changes in 
staff in individual groups as well as providing a rapid data sharing platform for the 
research communities [195].  
4.1.2 Integration of proteomic data onto ToxoDB and genome annotation 
While raw MS data can be safely stored in the publically accessible Tranche network, 
the integration of proteomic data with organism specific genomic and proteomic 
resources provides further biological and technical advantages to T. gondii research. 
ToxoDB (http://toxodb.org/toxo/) provides such a platform that is ideal for the 
integration of the proteomic data generated in this study. Various components of 
ToxoDB such as genome annotation, gene description and GO annotation have been 
used to facilitate this proteomic study. The addition of detailed whole proteome 
expression data within these integrated workspaces is able to assist the on-going 
annotation of the genome of T. gondii as discussed in this chapter, as well as 
enabling the examination of the value of protein expression data in interpreting 
global gene expression, a topic which is investigated and discussed in Chapter 5. 
While a typical bottom-up protein identification based proteomic study relies upon 
accurate predicted sequence databases, in chapter 2, we have shown the expression 
evidence for 394 non-redundant alternative gene models and ORFs that cannot be 
matched to release 4 gene models. This highlighted the incomplete nature of the 
release 4 genome annotation provided by ToxoDB. The integration of the proteomic 
data into ToxoDB has provided a good platform to systematically validate the 
accuracy of release 4 genome annotations such as providing evidence for the 
existence of genes and confirming exon-intron boundaries. With the ability to 
visualise proteomic data in a genomic context, discrepancies between proteomic 
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expression data and release 4 gene models can be examined in more detail leading to 
the confirmation of alternative gene models or previously unpredicted exons and 
genes. 
In this chapter, the methods of storing and sharing raw MS data and integrating the 
proteomic data with other genomic sources on ToxoDB are examined. With the 
facilities provided by ToxoDB, the possibilities and applications of proteomic data in 
the field of proteogenomics are discussed.  
During the production of this manuscript, ToxoDB release 5, the latest version of 
ToxoDB was released and a new version of genome annotation has been published. 
The proteomic data generated in this study have been integrated on ToxoDB using 
the same algorithm described here, followed by the addition of several latest 
proteomic studies [108]. In order to keep the consistency of nomenclature with 
analyses carried out in the previous chapters, ToxoDB release 4 was used in the 
examples shown this chapter. As an on-going effort of genome annotation, the 
implication of the proteomic data in the latest ToxoDB release 5 is discussed in 
section 4.4.1. 
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4.2  Materials and methods 
4.2.1  Data depository on Tranche 
A java based client was downloaded and installed from the Tranche website 
(https://proteomecommons.org/tranche/) onto a local computer. Following online 
instructions, MGF files generated by 1-DE and 2-DE experiments and MS2 files 
generated by MudPIT experiments were uploaded onto the Tranche network under 
the project name „Toxoplasma Proteome Liverpool‟. 
4.2.2  Peptide mapping for ToxoDB 
4.2.2.1  Collection of peptide expression evidence 
Proteomic data acquired in this study and from the C.parvum proteomic study 
performed by Dr. S.J. Sanderson ([265] and Appendix X), were mapped onto the 
genome scaffold on a peptide level at ToxoDB and CryptoDB, respectively. 
Identified peptides were collected by computer scripts written by Mark Heiges, 
University of Georgia (CryptoDB) and Brian Brunk, University of Pennsylvania 
(ToxoDB). For 1-DE and 2-DE results, the peptides identified were collected from 
the Mascot html result page of each individual protein identified. Peptides identified 
from MudPIT experiments of soluble and insoluble fractions were directly collected 
from Microsoft Excel spreadsheet results reported for the entire run. Each peptide 
identified was regarded as an individual entry and tagged with the identified protein 
and the related experimental platform that generated the data. 
4.2.2.2  Mapping peptide entries onto the genome scaffold 
The collected peptide entries were mapped onto the genome scaffold and aligned 
with other features (i.e. gene models, ORFs and other genome sources) by Mark 
Heiges from CryptoDB and Brian Brunk from ToxoDB. The following rules of 
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mapping were developed based on discussions between the Wastling group and 
developers from ToxoDB and CryptoDB. For the C.parvum proteomic data, only one 
gene prediction model is available; peptides which identified a gene were directly 
mapped and the rest of the peptide entries were mapped to ORFs. For the T. gondii 
proteomic data, peptides that hit release 4 gene annotations have been directly 
mapped onto the ToxoDB genome scaffold. The rest of the peptide entries that hit 
alternative gene models or ORFs (collectively termed as alternative models) were 
sent through a six step mapping algorithm, successful mapping at any step would 
finish for that entry. 
Step 1, if all peptides from an alternative model could be mapped to an official 
release 4 gene, the release 4 gene was adopted and this is termed a 100% match; Step 
2, if more than 50% of the peptides from an alternative model could be mapped to a 
release 4 gene, this was considered a valid mapping and the matching peptides were 
aligned with the corresponding release 4 gene; Step 3, if a certain set of peptides 
from an alternative model could be mapped to more than one release 4 gene, the 
gene that could host most peptides was reported; Step 4, alternative models not 
conforming to step 2 were mapped to ORFs; Step 5, an alternative model can be 
mapped to an ORF only if 100% of the peptides can be mapped; Step 6, if any of the 
peptides from the alternative model cannot be mapped to a release 4 gene or an ORF 
by step 2-5, the peptides were mapped to the alternative gene models (i.e. 
TgTwinScan, TgTigrScan and TgGlimmer). 
4.2.3  ToxoDB integration and visualization 
Following discussions between the Wastling group and collaborators from ToxoDB 
and CryptoDB, the data integration and visualization process was performed by 
developers at ToxoDB and CryptoDB. In brief, the following steps were carried out 
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for T. gondii proteomic data generated in this study. Upon the completion of the T. 
gondii proteomic data mapping on the ToxoDB genome scaffold, peptide 
identifications were integrated into individual gene report pages. A separate tool has 
been created for querying protein expression data based on mass spectral evidence. 
The peptide identifications were also integrated into the ToxoDB genome browser 
(GBrowse) interface [343], where expressed peptides can be visualized in relation to 
various gene models and the genomic region from which the sequence is predicted to 
have been produced. 
4.2.4 Validation of release 4 genome annotation by peptide expression data 
Peptides identified that align across splice boundaries were reported by developers at 
ToxoDB during the mapping process. ToxoDB GBrowse was used in this study to 
visually confirm the correct predictions of gene models via peptide evidence as well 
as to examine discrepancies between gene predictions and peptide expression data. 
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4.3  Results 
4.3.1  Data repository for raw MS data 
All the raw MS data associated with this study can be viewed and downloaded from 
ProteomeCommons.org Tranche network [204] at 
https://proteomecommons.org/tranche/, using the following hash:   
Ulv/yTYTaaHin5Tv4InpsgoUY1uTJQtdoLRi9HbdtypXqztv+BiVE/wZieBkqu6d3k
U20Vyejo0HYCfswgwiGyPHQPAAAAAAAAOhng== 
A brief work flow to retrieve the data is shown in Figure 4.1. 
 
Figure 4.1 Data repository for raw MS data on ProteomeCommons.org 
Tranche network. All the raw MS data associated with this study have been 
stored on ProteomeCommons.org Tranche network at 
https://proteomecommons.org/tranche. The java interface of Tranche can be initiated 
by clicking „Launch Tranche!‟ on the homepage. Inside the java interface, raw data 
can be viewed by using the following workflow: View Contents By Hash/Input 
Tranche Hash 
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(Ulv/yTYTaaHin5Tv4InpsgoUY1uTJQtdoLRi9HbdtypXqztv+BiVE/wZieBkqu6d3k
U20Vyejo0HYCfswgwiGyPHQPAAAAAAAAOhng==)/Browse Project. Individual 
MS files output from each proteomic platforms can be browsed and downloaded 
under „Toxoplasma Proteome Liverpool‟ project. 
4.3.2  Data integration on ToxoDB 
The proteomic data was first published on ToxoDB release 4.2 in June 2007. The 
peptide sequences identified were aligned with release 4 genes and alternative gene 
models as described in Section 4.2.2. In total, peptide identifications have been 
mapped to 2252 release 4 genes, and the 394 alternative gene models and ORFs 
identified have been mapped to 226 ORFs sequences. Peptide identifications can be 
viewed on individual gene report pages under the “Protein/Protein Features” section. 
The summary of the dataset can be viewed on ToxoDB through “Queries and 
Tools/Protein Expression/Mass Spec. Evidence”. Proteomic data can be queried 
based on individual experimental platforms. Parameters can also be set with the 
minimum number of unique peptide sequences and /or spectra found that match a 
gene for it to be returned by the query. A related query “Identify ORFs based on 
Mass Spec. Evidence” is also created to view the peptide identifications that could 
not be mapped onto release 4 gene models. 
The peptide identifications have also been mapped as individual tracks onto the 
interactive GBrowse on ToxoDB, which hosts approximately 50 GBrowse tracks 
including predicted gene models, EST alignments, and Affymetrix Probes, etc [112]. 
The peptide identifications can be viewed by selecting the option “Mass Spec 
Peptides (Wastling, et al.)” for peptides mapped onto release 4 genes and “Mass 
Spec Peptides (Alternative Models)” for peptides mapped onto alternative gene 
models and ORFs (see Figure 4.2). 
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Figure 4.2 Visualization of peptide identifications on the ToxoDB Genome 
Browser. The peptide identifications are mapped onto ToxoDB GBrowse as 
individual tracks. Peptides that mapped onto release 4 genes or alternative gene 
models and ORFs can be viewed by selecting the option “Mass Spec Peptides 
(Wastling, et al.)” and “Mass Spec Peptides (Alternative Models)”, respectively. 
4.3.3  Examining the accuracy of the release 4 genome annotation 
For the majority of the 2252 release 4 gene models identified, the peptide 
identifications have confirmed the correct ORFs and the positioning of start and stop 
codons. The current study has also identified 2477 intron spanning peptides in the 
official release 4 genome annotation, comprising 1110 unique release 4 genes. This 
has provided important supporting evidence that these exon-intron (splice) sites have 
been correctly predicted. Examples of peptides spanning splice site can be seen in 
Figure 4.2. 
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 However, a significant number of peptides do not agree with the splice site 
predicted by the release 4 gene models. Peptide identifications have confirmed 421 
splice sites that are only predicted by alternative gene models, which suggests either 
incorrect predictions for the release 4 gene models or possibly, alternative splicing 
events. 
By using the GBrowse function, three types of discrepancies between the peptide 
identification data and release 4 gene models were discovered by this study. Firstly, 
peptide evidence can be used to indicate the expression of ORFs where release 4 
genome annotations failed to predict coding sequence. Secondly, peptide evidence 
can also support an alternative frame shift or strand orientation to the release 4 gene 
model predictions. Thirdly, other discrepancies involve the positioning of the exon-
intron boundaries as discussed above. 
An example of a region of the genome scaffold where peptide evidence supports the 
presence of an expressed ORF but no release 4 gene is predicted is shown in Figure 
4.3. Eleven peptides map to TgGlmHMM_3355 and TgTigrScan_5280, on the 
largest exon (ORF X-3-4725402-4726856) displayed in the figure. However, no 
annotated gene has been assigned to this region by the release 4 genome annotation. 
Additional peptides in this region map to the first exon of the neighbouring gene 
46.m02877. Importantly, there are four intron spanning peptides identified that link 
the extra exon predicted by TgGlmHMM_3355 to the first exon of 46.m02877, 
indicating that release 4 gene 46.m02877 could have an incorrect start methionine 
and be missing an amino-terminal exon. Indicated by the peptide expression 
evidence, the most successful gene prediction model in this region would be 
TgGlmHMM_3355. Both TgGLEAN_5869 and TgTwinScan_2711 failed to predict 
the full length of the first exon (ORF X-3-4725402-4726856) that is supported by the 
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11 peptides. The second exon also reflected some prediction challenges, where 
neither TgGLEAN_5869 nor TgTwinScan_2711 hosted the full length of the exon 
supported by the peptide evidence and TgTigrScan_5280 completely failed to predict 
the existence of the first exon of gene 46.m02877. 
 
Figure 4.3 Peptide evidence indicating a missing amino-terminal exon 
predicted by release 4 genome annotation.  The position of ORF X-3-
4725402-4726856 in the genome scaffold is indicated by a red line on the overview 
track at the top of the figure and a detailed view is expanded below with the red 
triangle demarking the ORF length. Different gene annotation models are presented 
and predicted exons are indicated as blue boxes, linked by zigzag lines to indicate 
the position of exon/intron boundaries. Part of the predicted sequence for 
TgGlmHMM_3355 is shown as an insert; sequence for which there is identified 
peptide evidence is shown in red. The intron spanning peptide is shown in purple. 
Peptides aligning with this region are shown in yellow and the detailed MS 
information for one example is shown. EST evidence is shown as dark blue or brown 
boxes. 
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The second type of discrepancy is shown in Figure 4.4. Here peptide evidence is able 
to identify errors in the predicted reading frame or strand orientation. Twelve 
peptides derived from 35 individual spectra originating from 1-DE and MudPIT 
approaches provided matching hits to TgGlean_7850, TgTwinScan_4462 and 
TgGlmHMM_1717, although the various alternative gene models in this region 
differ in the length and number of exons. The release 4 genome annotation assigned 
gene 50.m05694 in this region but it is predicted to lie on the opposite strand and 
TgTigrScan_8273 uses a different reading frame. In this example, peptide expression 
data have provided supporting evidence for the correct reading frame and the large 
number of peptide hits to one region only indicates that the gene is likely to comprise 
a single exon.  
 
Figure 4.4 Peptide evidence indicate alternative frame shift.   
The position of ORF XII-4-5562689-5562144 in the genome scaffold is indicated by 
a red line on the overview track at the top of the figure and a detailed view is 
expanded below with the red triangle demarking the ORF length. Different gene 
annotation models are presented and predicted exons are indicated as blue and red 
boxes, representing different strand orientation. Exons are linked by zigzag lines to 
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indicate the position of exon/intron boundaries. Predicted sequences for 50.m05694 
and part of TgGlmHMM_1717 are shown as inserts. Sequence for which there is 
identified peptide evidence is shown in red. Peptides aligning with this region are 
shown in yellow and the detailed MS information for one example is shown. 
An example of the third type of discrepancy is shown in Figure 4.5, where peptide 
evidence indicates alternative exon-intron boundaries to that predicted by the release 
4 genome annotations. In Figure 4.5, 12 peptides identified using the MudPIT 
approach map to a region of the genome scaffold (X: 3917326-3920484) that is 
annotated with release 4 gene 28.m00300, comprising two exons. Five of twelve 
peptides match the second exon of gene 28.m00300. Of the remaining peptides, one 
maps to the predicted intron region of gene 28.m00300 and although it appears that 
six peptides match the scaffold in the region of the first exon of 28.m00300, these 
peptides actually relate to a different frame translation. Alternative gene models also 
vary considerably in this region in both the number and positioning of the exons, 
which indicates the difficulty in the prediction of splice sites in this region. All 12 
peptides identified in this study only appear in TgGlmHMM_2666, which does not 
have an intron at this location, providing evidence that this model is most likely to be 
correct. 
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Figure 4.5 Peptide evidence indicating alternative exon positioning and 
splice site. The position of ORF X-1-3917326-3920484 in the genome scaffold is 
indicated by a red line on the overview track at the top of the figure and a detailed 
view is expanded below with the red triangle demarking the ORF length. Different 
gene annotation models are presented and predicted exons are indicated as blue 
boxes, linked by zigzag lines to indicate the position of exon/intron boundaries. 
Peptides aligning with this region are shown in yellow. The predicted sequence for 
ORF X-1-3917326-3920484 is shown as an insert and sequence that is identical to 
exon 2 of gene 28.m00300 is shown in blue. Sequence for which there is matching 
peptide evidence is shown in red. Purple lettering indicates the positioning of the 
'intron-located' peptide, the detailed MS information for which is shown in the right 
hand insert. 
  
Chapter 4-Repository, integration of proteomic data and the validation of genome annotation 
121 
 
4.4  Discussion 
In this chapter, efforts have been made to present the proteomic data within a 
broader application. Raw MS data have been made publically accessible online and 
peptide identification data have been integrated with other genomic resources on 
ToxoDB. The integration of the proteomic data into ToxoDB revealed an important 
application of the data to genome annotation, demonstrating the incomplete status of 
current genome annotation. 
By uploading the raw MS data onto the Tranche network, this valuable protein 
expression information is directly accessible to the research community. Moreover, 
storing the MS data in its raw format preserves important information about the 
biological sample and labour involved in the experiments, and enables future 
analysis to be carried out easily. For example, when the new standardized data 
format, i.e. mzML, becomes more established, the raw MS data generated from this 
study can be directly adapted into the new data processing pipelines. The Tranche 
facility also allows the raw MS data to be searched against the latest gene prediction 
models using improved search engines, the importance of which is further discussed 
in section 4.4.2. 
4.4.1  Data integration 
The integration of proteomic data with other genomic resources on ToxoDB was 
carried out on a peptide level. Since the genome sequence remains reasonably stable, 
matching the peptide identifications onto the corresponding genome scaffold avoids 
continual updating of peptide data mapping each time a new version of genome 
annotation is released. Peptide expression data can be directly mapped onto the new 
gene models according to their coordinates. However, as discussed in section 2.4.3, 
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multiple gene model databases have been used in the study to maximize protein 
identification. Although the benefit of including alternative gene models has been 
demonstrated in this chapter where in many cases peptide evidence supports the 
prediction made by alternative models, several technical issues in handling multiple 
gene models have been observed through the peptide mapping process. 
Firstly, the script used in this study can efficiently collect peptide identifications 
from various gene models and ORFs expressed. However, due to the requirement of 
integration with other genomic resources that are already stored on ToxoDB, the 
peptide mapping algorithm designed was orientated towards release 4 genome 
annotation. Particular examples are step 2 and step 3 used in the mapping algorithm, 
where priorities have been given to release 4 gene models during mapping.  
Step 2 states that if more than 50% of the peptides from an alternative model could 
be mapped to a release 4 gene, this was considered a valid mapping and the matching 
peptides were aligned with the corresponding release 4 gene. The remaining non-
matching peptides were separately mounted on the scaffold, aligned with the 
alternative model. Step 3 states that if a certain set of peptides from an alternative 
model could be mapped to more than one release 4 gene, the gene that could host 
most peptides was reported. Again, the remaining peptides were separately mounted 
on the scaffold, aligned with the alternative model. As shown in this Chapter, 
peptides identified in the neighbouring region of a release 4 gene model are of great 
interest to gene expression research as well as genome annotation. They provide 
strong evidence of alternative splice sites; missing exons and different positioning of 
start or stop codons, which could alter the function of the gene when expressed. 
However, due to the peptide mapping algorithm that was orientated towards release 
4 genome annotation, these important peptides have been mapped separately to 
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alternative gene models. Unfortunately the current version of the ToxoDB interface 
does not allow the user to query thesis alternative gene models. In other words, 
where once readily available, these peptides are no longer searchable. 
Additionally, steps 4, 5, and 6 state that peptides identified from an alternative model 
can be mapped to an ORF or alternative gene model only if 100% of the peptides can 
be mapped. The stringent threshold set here was due to the consideration that 
previous versions of EST and ORF databases used in MS data searching contain 
small sequencing errors that are not consistent with the release 4 gene models and 
ORFs. In total, there were 220 TgEST sequences and 184 ORF sequences identified 
in this study that cannot be mapped onto ToxoDB due to this reason, representing 4.9% 
of the total number of sequences mapped. This reflected the existence of sequencing 
errors in previous versions of EST and ORF databases. However, this also resulted in 
the loss of genuine peptide identifications that mapped to the correct part of the EST 
or ORF sequence. In addition to this, it was not possible to map peptides identified 
from 163 alternative gene models in this study (74 of TgGlmHMM, 58 of 
TgTwinScan and 31 of TgTigrScan) to the release 4 gene models and ORFs. While 
these peptides are presented on ToxoDB, it is not possible to query MS evidence for 
older gene models such as TgTwinScan, which means that this subset of peptide data 
is effectively “lost” to the wider research community. Solutions to this problem are 
discussed in the next section. 
Despite the limitations of the peptide mapping approach due to the multiple gene 
models and ORF database used, the integration of the proteomic data generated in 
this study onto ToxoDB has already assisted the genome annotation process by 
confirming the correct predictions of 2477 intron spanning peptides in the official 
release 4 genome annotations. More importantly, the discrepancies between the 
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proteomic data and the release 4 gene models also demonstrate the incompleteness of 
the release 4 genome annotation. The peptide identification data provided evidence 
for the expression of 394 alternative models, which were mapped to 226 ORFs, as 
well as 421 splice sites that have not been predicted by the release 4 genome 
annotation. In fact, even in the latest release 5.2 genome annotation which was 
recently published in July 2009, there is strong peptide evidence for the expression 
of alternative models that were mapped to 203 ORFs. The reduced number of ORFs 
that have peptide evidence from 226 to 203 reflects the improvement of release 5.2 
genome annotation where peptides previously mapped to 23 ORFs are now able to 
be mapped to release 5.2 genes. However, peptides mapped to those 203 ORFs still 
possess valuable information for the improvement of release 5.2 genome annotations. 
Moreover, if the “lost” peptide identifications during the mapping process were to be 
mapped onto ToxoDB, an even larger discrepancy between expression data and 
predicted gene models would be evident. This work has highlighted the importance 
of proteogenomic research which directly incorporates proteomic data into the 
genome annotation process. It has also highlighted the on-going problem for 
proteomic analysis of the need to re-submit raw MS data against the latest genome 
annotations, in order to obtain the highest quality dataset.  This is a time-consuming, 
manual task but which is of significant importance, if one is to avoid the situation of 
“lost”, out-dated and inaccessible annotations. 
4.4.2 The application of proteogenomics in T. gondii genome annotation 
As discussed in section 1.2.6.1, proteomic data can be used in various aspects of the 
genome annotation process such as validating predicted gene models and detecting 
novel genes as well as validating alternative splicing variants [213, 215, 218, 220, 
221, 344]. In this study, three examples have been shown to demonstrate the 
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potential usage of proteomic data in indicating missing exons, alternative frame 
shifts, as well as alternative exon positioning. 
The proteomic data acquisition in this study can be used to assist the development of 
new genome annotation pipelines. Firstly, protein expression data can be used as a 
valuable training set to improve the prediction of integrative gene prediction 
programs such as GLEAN [282] and TwinScan [280]. This application is particularly 
important for microbial genome annotation such as T. gondii, where few homologies 
have been characterized in comparison to the human genome. By analysing the 
composition and statistical properties of the expressed peptides, programs can be 
tuned to predict novel genes which homologies have not been previously identified 
in other organisms. 
Secondly, by searching the raw MS data against the latest update of genome 
annotation in the pipeline, peptide expression data can be directly used to validate 
the accuracy of the predictions. This information can then be fed back to the 
automated pipeline and generate an improved version of genome annotation, which 
can be validated by the raw MS data again. By performing this cycle several times, 
the accuracy of genome annotation can be rapidly improved. This automated pipeline 
will also significantly speed up the current proteomic research workflow, where 
successive upgrades of genome annotation require the raw data to be re-submitted in 
a slow manual fashion at the moment, as highlighted in the previous section. The 
pipeline will also resolve the peptide mapping problem on ToxoDB, for example, the 
raw MS data used to identify those 220 TgEST sequences and 184 ORF sequences 
that were not able to be mapped on ToxoDB would be preserved and searched 
against the new annotations. Likewise, the peptide identifications from those 163 
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alternative gene models that are no longer available for querying on ToxoDB could 
also be directly entered into the automatic pipeline. 
Of course, in order to efficiently initiate the cycle, large scale sampling of peptide 
identifications from the genome is required. This will enable the maximum number 
of peptide features to be picked up by gene prediction programs and preserved in the 
subsequent annotation cycles. Currently, the best approach to achieve the biggest 
coverage of peptide identifications in a genome is to search the MS data against all 
the ORFs with a length greater than 50 amino acids from the whole genome 
sequence database.  
Theoretically, the collection of all the ORFs covers the entire potential protein 
coding sequence (CDS) in the genome. However, the current program setup for ORF 
marking in the genome only processes the same region of sequence once and 
identifies a specific ORF as starting from the first start codon it encounters until it 
comes across a stop codon [112, 345]. This approach is particularly efficient in 
marking ORFs in organisms with no introns, such as prokaryotes. However, it has 
several limitations in covering the entire potential coding sequence in a typical 
eukaryotic gene which contains multiple exons. Firstly, the algorithm marks every 
ORF from the first start codon to the first stop codon, no matter how many other start 
codons are within the ORF. This prevents the identification of the second exon 
starting within the length of the original ORF. Secondly, in a gene that contains 
multiple exons, a frame shift between different exons means the coding sequence 
cannot be hosted within a single ORF. This particularly prevents the identification of 
intron-spanning peptides in the proteomic research which also contains critical 
information for genome annotation. 
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In fact, the 163 alternative gene models which could not be mapped onto release 4 
gene models and ORFs partly reflected the second limitation of the current ORF 
marking algorithm, where no single ORF could host 100% of the peptides identified 
to an alternative gene model. A new algorithm approach to design ORF databases for 
MS data searching is under development in the Wastling group in collaboration with 
Dr. Andy Jones, University of Liverpool. 
The new ORF database cannot be a simple collection of all the direct translations of 
genomic sequences from all the start codons which exist, as this would result in a 
giant sequence database which would require tremendous computing power for MS 
data searching and which would increase the false discovery rate. One possibility is 
to harness the latest development in the transcriptome, RNA-Seq. By using the high-
throughput sequencing approach offered by RNA-Seq, a genome-scale transcription 
map can be rapidly achieved [229]. The information can then be used as a reference 
map for the selection of gene coding ORFs and subsequently reduce the size of the 
ORF database for MS data searching. An on-going collaborative project between the 
Wastling group and Dr. Arnab Pain, at the Wellcome Trust Sanger Institute, 
Cambridge is developing a method for the integration of proteomic and 
transcriptome data in the genome annotation process for T. gondii and Neospora 
caninum. 
4.4.3  Conclusion 
In this chapter, the proteomic data acquired in this study have been placed in a 
broader platform. The raw MS data have been stored in the publically accessible 
Tranche network. The expression data have been integrated on a peptide level with 
other genomic resources on ToxoDB. Inspired by the issues raised during peptide 
mapping and the examination of the accuracy of the release 4 genome annotations 
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using these peptide identifications, the incompleteness of the release 4 genome 
annotation was highlighted and the potential application of a new genome annotation 
pipeline was discussed.  
In a conventional bottom-up protein identification based proteomic project, peptide 
identification relies on the predicted gene models. Successive upgrades of genome 
annotation mean that the proteomic researcher may have to re-submit the data which 
is a time consuming process. By using the new genome annotation pipeline 
discussed in this chapter, the manual re-submission can be carried out automatically 
and proteomic expression data can be directly used to improve genome annotation. 
Together with the information contained within the transcriptome, a near “perfect” 
genome annotation can be expected in the near future. 
In addition to the application of proteomic data in the field of proteogenomics, the 
integration of proteomic data into ToxoDB also allows an important comparison to 
be made, that of the transcriptomic data. This comparison will reveal implications of 
important biological processes such as protein degradation and post-transcriptional 
regulation. This interesting subject is investigated and discussed in chapter 5. 
 
  
 
 
 
 
 
 
 
Chapter 5 
A comparison of the proteome and transcriptome of 
Toxoplasma and other Apicomplexa parasites 
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5.1  Introduction 
In the previous chapter, the methods for the integration of proteomic data onto 
ToxoDB were investigated and the potential for directly using proteomic data in 
genome annotation was discussed. The integration with another genomic resource in 
the context of ToxoDB has led to another important application of proteomic data, 
that of the comparison of the proteome and transcriptome of Toxoplasma. 
As discussed in section 1.2.6.2, transcriptomic studies were used to infer putative 
functions of proteins under the commonly accepted „guilt-by-association‟ hypothesis 
[233]. However, with the increasing number of proteomic studies, data from several 
recent studies have suggested a relatively weak correlation between mRNA 
expression and protein expression in plant seeds [235], mouse embryonic stem cells 
[236], yeast [237], and even in Apicomplexan parasite Plasmodium [238, 239]. The 
discrepancies observed not only weaken the application of protein function 
assignments using transcriptomic data, but also highlight the requirements for more 
research which would allow a better understanding of basic biological processes. 
With the first example of a whole cell lysate proteome for Toxoplasma acquired in 
this study, the relationship between proteins and their mRNA can be examined in T. 
gondii. 
Several large scale transcriptomic analyses have been carried out on T. gondii and 
the data have been integrated on ToxoDB release 4 under the same genome scaffold 
and identifiers as used for proteomic data [112]. These large scale transcriptomic 
studies include transcript expression with microarray evidence, expressed sequence 
tag (EST) evidence and serial analysis of gene expression (SAGE) tag evidence. The 
microarray expression profiling of the three archetypal T. gondii lineages has been 
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carried out by Dr. PH Davis and Prof. DS Roos, University of Pennsylvania, USA 
and the data have been released on ToxoDB pre publication. The EST evidence is 
mirrored from the dbEST (http://www.ncbi.nlm.nih.gov/dbEST/) site onto ToxoDB 
which contains various libraries of different strains and life stages. SAGE tag 
libraries were generated from T. gondii parasites at specific stages of development, 
representing key developmental transitions in primary parasite populations and in 
three laboratory strains [272]. The large amount of T. gondii transcriptomic data and 
the integration of these data and proteomic data on ToxoDB have made a systematic 
comparison between proteome and transcriptome of this important parasite feasible. 
In addition to the extensive coverage of T. gondii, a large amount of proteomic and 
transcriptomic data have also been acquired for other important Apicomplexan 
parasites, which enables a cross species comparison that would highlight common 
features between proteome and transcriptome in Apicomplexa. As reviewed in 
chapter 2, large scale proteomic studies have been carried out on several species of 
Plasmodium [238, 239, 261-263] and Cryptosporidium parvum sporozoites [264, 
265]. On-going whole cell proteomic studies are also being carried out in Neospora, 
Theileria and Eimeria by the Wastling group, University of Liverpool, UK. Large 
scale transcriptomic expression profiling projects have also been carried out. dbEST 
[346] and EuPathDB [347] host the largest collection of EST data for the 
Apicomplexa. SAGE projects have been carried out for P. falciparum [348-350] and 
microarray expression data are available for P. falciparum and P. berghei [238, 351-
353].  
Most of the proteomic and transcriptomic data here have been uploaded to 
corresponding component sites of EuPathDB, such as CryptoDB, PlasmoDB and 
ToxoDB [347]. EuPathDB provides a large collection of published data and hosts 
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valuable data from several unpublished studies that further expand the coverage of 
expression data for Apicomplexa. Moreover, similar to the process discussed in 
Chapter 4, great efforts have been made to integrate expression data generated from 
different experimental platforms together under the same identifier system.  
In this chapter, equipped with the large amount of expression data and valuable 
support from EuPathDB, a systematic comparison of the proteome and transcriptome 
of Toxoplasma and other Apicomplexa parasites has been carried out. Explanations 
for observed discrepancies and the potential applications of the interaction of 
proteomic and transcriptomic data were also discussed. 
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5.2  Materials and methods 
To facilitate a genome wide comparison between proteome and transcriptome, 
relative expression data were collected primarily from component sites of EuPathDB 
(formerly known as ApiDB) [347]. 
5.2.1   Proteomic and transcriptomic data collection for T. gondii 
The 2252 release 4 genes identified in this study were used as the T. gondii 
tachyzoite proteomic dataset for the comparison. The collection of EST, SAGE and 
microarray data was carried out using ToxoDB (release 4.2) [112]. To identify the 
genes that have EST evidence, all tachyzoite EST libraries were selected in the query 
“ToxoDB Queries and Tools/Transcript Expression/Identify Genes based on EST 
evidence”, with default settings applied. The SAGE expression data were collected 
using the query “ToxoDB Queries and Tools/Transcript Expression/Identify Genes 
based on SAGE Tag evidence” with “T. gondii 3p SAGE tag frequencies_d6” and “T. 
gondii 3p SAGE tag frequencies_rh” libraries selected and default parameters were 
applied. The microarray expression percentile for T. gondii genes were collected 
using the query “ToxoDB Queries and Tools/Transcript Expression/ Identify Genes 
by Microarray Evidence/ Identify Genes based on Expression Percentile (T.g.)”. 
Data comparisons were carried out either on ToxoDB using the “My Query History” 
function or in Microsoft Office Excel with data downloaded from ToxoDB. 
5.2.2  Proteomic and transcriptomic data collection for other 
Apicomplexan parasites 
In order to identify Apicomplexa genes which exhibit discrepancies between 
transcriptomic data and proteomic data, a similar data collection process was carried 
out on C. parvum sporozoites using CryptoDB [330], and P. falciparum (all life 
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stages) using PlasmoDB [329]. All the published gene identifications from major 
proteome projects listed in CryptoDB (release 3.7) and PlasmoDB (release 5.4) were 
included in the analysis. Comparative EST libraries were used to collect EST 
evidence for C. parvum and P. falciparum and microarray expression data were 
collected for P. falciparum. Data comparisons were carried out either on CryptoDB 
and PlasmoDB using the “My Query History” function or in Microsoft Office Excel 
with data downloaded from CryptoDB and PlasmoDB. 
For N. caninum tachyzoites, preliminary proteome profiling results from a MudPIT 
experiment generated by the Wastling group was used for the comparison 
(unpublished). Briefly, N. caninum tachyzoites were collected from cell culture by 
Rebecca Norton. Sample preparation, mass spectrometric analysis and MS data 
searching of MudPIT analysis were performed by Dr. Judith H. Prieto from John R. 
Yates‟s lab, Scripps Research Institute, La Jolla. Proteomic expression data were 
obtained for 660 of the gene models in the latest set of gene predictions (available 
via GeneDB at http://www.genedb.org/) at the time of comparison (July, 2008). EST 
evidence for N. caninum was collected from NCBI dbEST 
(http://www.ncbi.nlm.nih.gov/dbEST/).  The alignment of EST evidence to genes 
that have proteomic evidence was carried out by Amandeep Sohal in Dr. Arnab 
Pain‟s group at the Wellcome Trust Sanger Institute, Cambridge. Briefly, EST 
evidence was mapped onto the genome using the Exonerate software [354] with the 
following parameters: “exonerate_farm --bestn 1 --showtargetgff yes --showvulgar 
no --showalignment no --query NeosporaESTsequences.fasta --target sequence.dna”. 
Artemis software [355] was then used to highlight the intersections of gene models 
and EST evidence. 
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5.2.3 Method for data comparison between three Apicomplexan parasites 
The comparison between proteomic and transcriptomic data was carried out at the 
individual parasite level using their own identifier systems. To determine the number 
of genes in the intersections between each parasites, OrthoMCL software [169] was 
used and the analysis was carried out by Amandeep Sohal at the Wellcome Trust 
Sanger Institute, Cambridge. Briefly, 5460 P. falciparum genes, 7793 T. gondii 
genes and 5589 N. caninum genes were used in the analysis and 5147 orthologue 
groups were formed. 
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5.3  Results 
5.3.1  Comparison of gene expression at the transcriptional and 
translational level in T. gondii 
A comparison of transcriptomic and proteomic data of T. gondii was done in two 
stages. Firstly, the proteomic data were compared with the entire microarray 
expression data. Since the microarray data have the largest coverage of the genome 
in all the current gene expression experiments, this comparison provides a good 
indication of the level of proteomic sampling. Secondly, the proteomic data were 
compared with various transcriptomic experiments such as microarray expression 
data (over 25 expression percentile), SAGE expression data and EST data. The 
SAGE data provide a more accurate measure of transcripts than microarray data and 
while providing direct evidence of gene expression, the application of EST data in 
genome annotation [112] has made it an important transcriptomic dataset. By 
comparing the proteomic data with all the three large scale transcriptomic datasets 
available, discrepancies between the transcriptional and translational levels of gene 
expression can be examined. 
5.3.1.1  Comparison with entire microarray expression data 
Microarray data provide extensive coverage of the genome; 7764 release 4 genes 
(99.5% of the genome) were assayed. Four release 4 genes (25.m01905, 8.m00178, 
80.m05040 and 83.m00013) which were identified by the proteomic data were not 
assayed by microarray and for this reason were not included in this comparison. T. 
gondii tachyzoites were assayed and all 7764 genes on the array exhibit some signal. 
It is difficult to determine the correct signal: noise ratio above which mRNA levels 
can be considered to be indicative of a gene being switched on since not all genes 
would be expected to be expressed in the tachyzoite stage. 
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 For the purposes of this comparison, in this study 7764 release 4 genes were divided 
into quartiles according to the mRNA expression levels determined by microarray. 
Those genes in the bottom 25% were considered as having zero detectable mRNA 
above the baseline while those genes in the top 75-100% were the genes that have 
the highest mRNA expression levels. Figure 5.1illustrates the number of genes in 
each microarray expression percentile which have been identified by this proteomic 
study. 
 
Figure 5.1 Comparison of proteomic data with microarray expression data. 
Release 4 genes assayed by microarray were divided into quartiles according to 
mRNA expression levels. The bar chart shows the number of genes also identified by 
proteomics for each of the four percentile ranges, 0-24%, 25-49%, 50-74% and 75-
100%. 
While the number of genes contained in each of the quartile ranges is the same (i.e., 
1941), there is a general trend for more proteins to have been detected for genes with 
higher mRNA expression levels (972 genes (50.1%) in the top mRNA expression 
range 75-100% and 644 genes (33.2%) in the second highest mRNA expression 
range compared with 22.1% and 10.5% in the lower two percentiles). This may 
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reflect a correlation between mRNA abundance and protein abundance, and that 
higher abundance proteins are easier to detect by proteomic approaches.  
Proteomic data also provided important expression evidence for 204 genes from the 
bottom 25% microarray expression range. This highlighted the discrepancies 
between proteomic expression and microarray expression data where genes in the 
bottom 25% microarray expression range were described as zero detectable mRNA 
above baseline. The discrepancies between protein level of expression and 
transcriptional level of expression were further demonstrated when EST data were 
included in the comparison. 
5.3.2  Comparison of proteomic data with microarray expression data 
(over 25 expression percentile), SAGE expression data and EST data 
The comparison of proteomic data with microarray expression data demonstrated the 
sensitivity of the proteomic approach and a general correlation between the number 
of proteins detected and mRNA expression levels. Whilst it is hard to decide a 
definitive microarray expression percentile for a gene to be considered expressed, 25% 
was used as a cut-off assuming 75% of the release 4 genes are expressed in the 
tachyzoite stage. Other important evidences of transcript expression provided on 
ToxoDB are EST and SAGE. In this study, cDNA evidence from all the tachyzoite 
EST libraries was collected, which represents a total coverage of 68.4% of all release 
4 genes. Expression evidence from laboratory strain RH library and primary VEG 
strain Day-6 library, which has the closest correlation with RH strain [272], were 
collected, representing the equivalent sampling of this study. The 1453 genes 
detected by these two SAGE libraries represent a total coverage of 18.6% of all 
release 4 genes. The comparisons between 2252 genes identified by proteomic data 
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and genes identified by various transcriptomic experiments are shown in Figure 5.2 
(Detailed gene identifications are listed in Appendix VI). 
 
Figure 5.2 Genes with proteome and transcriptome evidence in T. gondii.  
The relationships between proteomics and various transcriptomic techniques such as 
Microarray, EST, SAGE and total transcriptomic expression data in T. gondii are 
shown in separated columns. Genes identified by this proteomic study are compared 
with genes that have transcriptome evidence. The blue portion indicates proteins 
without transcriptome evidence, the red portion indicates proteins that have both 
proteome and transcriptome evidence, and the green portion indicates genes without 
proteome evidence.  
When considering all four platforms included in the comparison, 572 genes have 
expression evidence from all platforms which may reflect their strong expression at 
both transcriptional and translational levels. Proteomic data has provided protein 
expression evidence for 204 genes in the bottom 25% microarray expression range, 
266 genes that have no EST evidence and 1606 genes that have no SAGE evidence. 
Furthermore, 60 tachyzoite genes are exclusively identified by proteomic data and 
have no corresponding transcript expression evidence. 
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The identification of these 60 genes is of great research interest. This illustrates that 
some genes with zero or very low mRNA expression can still be identified by 
proteomic approaches, which may reflect the high sensitivity of the proteomic 
approach. One clear biological explanation is that these proteins were extant before 
the tachyzoite differentiated. Or these could be highly stable proteins, with low 
turnover rates which require low levels of transcription to be maintained in the cell. 
Another explanation is that substantial quantities of protein can be produced from 
very low abundance mRNA. In fact, many of those 60 genes were identified by large 
numbers of peptide identifications which usually indicates high protein abundance. 
As such these 60 genes represent interesting candidates for understanding the 
relationship between mRNA and protein abundance levels in Toxoplasma. Three 
examples from this group are „tubulin beta chain, putative‟ (28.m00301, 128 peptide 
hits), „thioredoxin, putative‟ (42.m03331, 57 peptide hits) and „coatomer protein 
gamma 2-subunit, putative‟ (59.m00090, 53 peptide hits).  
To further understand the properties of genes that only have proteomic data, a 
proteomic data based comparison was carried out with transcriptomic data across 
four species of Apicomplexa. As shown in Figure 5.2, the SAGE data provide a 
much smaller overlap with the proteomic data than that of EST and microarray data. 
In fact, when the SAGE data were excluded from the comparison, 1850 genes were 
shared among proteomic, EST and microarray experiments which are considerably 
more than 572 genes when all four platforms are included. The smaller overlap 
observed between SAGE and proteomics is very interesting, and may represent 
genuine biological discrepancies or differences in the experimental sampling and 
detection sensitivities (further discussed in section 5.4.2). However, including the 
SAGE data to the proteome and transcriptome comparison across four species of 
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Apicomplexa will add more complexity to the discrepancies while not adding much 
more value to the whole proteome and transcriptome comparison. Only 77 genes 
identified by SAGE were not detected by EST and microarray in T. gondii and 
SAGE data are not readily available across other Apicomplexa except Plasmodium. 
Due to the above considerations, the SAGE data were not included in the comparison 
across Apicomplexa. 
5.3.3  Proteome and transcriptome comparisons across four species of 
Apicomplexa 
Given the large amount of good quality transcriptional and translational data across 
the Apicomplexa, a general comparison was carried out to examine the relationship 
between proteins and their mRNA. The proteomic data based comparison allows us 
to identify the subsets of proteins for which no transcriptional evidence was acquired. 
Comparative EST libraries and microarray expression data (no microarray data were 
available for Neospora or Cryptosporidium) were compared with their respective 
proteomic datasets for four species of Apicomplexa including T. gondii tachyzoites, 
C. parvum sporozoites, P. falciparum (all life stages) and N. caninum tachyzoites 
(see Figure 5.3).  
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Figure 5.3 Proteome and transcriptome comparisons across four species of 
Apicomplexa. The numbers of proteins identified by peptide evidence in 
Toxoplasma gondii tachyzoites, Cryptosporidium parvum sporozoites, Plasmodium 
falciparum (all life-stages) and Neospora caninum tachyzoites are shown. The red 
portion indicates proteins without EST evidence and the green portion indicates 
genes without EST or microarray evidence (less than 25 expression percentile). No 
microarray data were available for Neospora or Cryptosporidium at the time of 
comparison. 
Each column represents the total number of proteins identified by proteomics, with 
the red portion indicating proteins without any EST evidence and the green portion 
showing proteins without either EST or microarray data. These data show that except 
for C. parvum, a large number of genes identified by proteomics were also identified 
at the transcriptional level. Importantly, in addition to those 72 genes identified in T. 
gondii, 103 of P. falciparum genes detected by proteomics have neither EST nor 
microarray evidence over and above the 25% cut-off. There were also proteomic 
evidence for 968 of C. parvum genes and 181 of N. caninum genes where no EST 
evidence existed. The large percentage of C. parvum genes (73%) which have 
proteomic evidence but no EST evidence is likely to represent a relatively poor EST 
coverage for C. parvum. Given this common discrepancy observed between 
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proteomic data and transcriptomic data across four Apicomplexa species, further 
analyses were carried out to test if these proteins that have no, or relatively low 
levels of transcription were related at the level of orthology. 
5.3.4  Apicomplexa genes which exhibit discrepancies between 
transcriptomic data and proteomic data 
Proteomic and transcriptomic data for P. falciparum, T. gondii and N. caninum were 
collected as described in section 5.2.2. C. parvum data were not included because the 
relatively poor EST coverage is likely to bias the comparison. Genes were sorted into 
the following three categories (a) transcript present but no protein detected, (b) 
protein detected but no EST evidence and no transcript detected by microarray at ≥ 
25% threshold, and (c) protein detected but no EST evidence. In each category, the 
numbers of genes which are shared between each species were determined by 
orthologue mapping using OrthoMCL [169] and the results of the comparison are 
shown in Figure 5.4 (Detailed gene identifications are listed in Appendix VII). 
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Figure 5.4 Genes from three Apicomplexa which exhibit discrepancies 
between transcriptional data and proteomic data. Each circle represents 
the number of genes for which a discrepancy was seen between transcriptomic and 
proteomic data for Plasmodium falciparum, Toxoplasma gondii and Neospora 
caninum based on: (a) transcript present but no protein detected, (b) protein detected 
but no EST evidence and no transcript detected by microarray ≥ 25% threshold, (c) 
protein detected but no EST evidence. The numbers of intersections were determined 
by orthologue mapping using OrthoMCL. 
Figure 5.4a shows that of the genes which have transcriptomic evidence but lack 
proteomic evidence, significant numbers (34% in Plasmodium, 39% in Toxoplasma 
and 63% in Neospora) had orthologues in other species, and 313 genes were 
common between all three species although no specific class of genes can be 
highlighted. This is perhaps a less surprising result, since low levels of protein 
synthesis or high rates of protein turnover and degradation may contribute to the 
under-representation of proteomic coverage and the ≥ 25% microarray expression 
criteria used in this study is rather loose and likely to include transcripts that have 
not been expressed. Figure 5.4b shows that there are 356 genes across all three 
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species which have proteomic data but no transcriptomic evidence. However, only 
several genes are shared between any two species as orthologues. Figure 5.4c shows 
the comparison only between proteomic and EST data. A larger number of proteins 
are shared, including two orthologues seen across all three species („small nuclear 
ribonucleoprotein, putative‟, 57.m01848 and „thioredoxin, putative‟, 42.m03331; 
ToxoDB annotation). These data revealed that there is little overlap across the three 
datasets for orthologous genes for which there is proteomic evidence, but little or no 
transcriptomic expression evidence (detected by ESTs or microarrays). 
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5.4  Discussion 
Following the effort of data integration discussed in chapter 4, in this chapter, the 
proteomic data generated from this study have been compared with various 
transcriptomic expression data using ToxoDB. A broader comparison of proteomic 
data and transcriptomic data across four species of Apicomplexa was also made 
available with the data and tools provided by EuPathDB. This has further highlighted 
the importance of data integration in the post-genomic era where large scale genome 
wide studies can be viewed and analysed together in a way that was not readily 
accessible before. The study of gene expression has been dominated by 
transcriptomic approaches where the level of mRNA expression is measured. Now, 
supplemented with the latest addition of proteomic data, a dynamic view of gene 
expression pattern can be analysed for the first time on T. gondii and other 
Apicomplexan parasites through the comparison of proteomic data and 
transcriptomic data. 
5.4.1 A weak correlation observed between proteome and transcriptome 
In T. gondii, the comparison of proteomic data with microarray data has revealed a 
weak correlation between mRNA abundance and protein abundance, where more 
genes in the higher microarray expression percentile range have been detected by 
proteomic approaches than those genes in the lower percentile range. In fact, a quick 
analysis of the number of EST counts and the number of peptide counts for genes 
that were identified by this proteomic study has revealed a spearman's rank 
correlation value of 0.29, which also indicated a weak correlation between mRNA 
abundance and protein abundance.  
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Of course, caution needs to be made when using both peptide counts and the number 
of proteins identified as direct indications of protein abundance. Firstly, variations 
introduced in the protein separation and digestion steps would affect the distribution 
of the peptide mixture and, the kinetics of peptides varies during MS analysis. 
Actually, it has been noted that only a few so-called „proteotypic‟ peptides are 
repeatedly and consistently identified for any given protein present in a mixture in 
relation to their different physicochemical properties [356]. Secondly, the length of 
the peptide identifications and the size of the protein are also a source of variations. 
Larger proteins would generally produce more peptides than proteins of a smaller 
size and depending upon the fragmentation, two short peptides identified from a 
protein does not guarantee a two times abundance over a protein identified by a 
single long peptide. Considering the above limitations, peptide counts are only able 
to provide a crude indication of the protein abundance. Quantitative approaches can 
be used for future investigation such as MS-based isotope labelling or lable free 
methods, as well as gel-based technique differential gel electrophoresis (DIGE), 
which is further investigated in chapter 6. Nonetheless, proteomic identifications can 
provide important evidence for the translational level of gene expression. The large 
number of genes identified by both proteomic and transcriptomic techniques and the 
general trend of a correlation between them reflected the comparable sensitivity of 
both techniques.  
5.4.2 The significance of discrepancies between proteome and transcriptome 
The correlation between proteomic data and transcriptomic data increased the 
confidence of the feasibility of the comparison between the two techniques and 
follows the central dogma of Gene-Transcription-Translation. However, perhaps 
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more significant finding was the discrepancies between proteomic data and 
transcriptomic data. 
The presence of proteomic evidence in the absence of detectable transcriptomic 
evidence has been noted in several other studies [235-237], as well as in Plasmodium, 
Cryptosporidium and Neospora as shown in this chapter. The detection of these 
genes by proteomic studies reflected the high sensitivity of the proteomic approaches. 
In the case of T. gondii, by combining expression evidence from microarray, EST 
and SAGE, there were 6736 release 4 genes which have transcriptomic evidence, 
representing 86.4% of the entire genome. It is unlikely that all those 6736 genes are 
expressed in the tachyzoite stage, especially with the inclusion of 75% of all the 
genes assayed on microarray; it is likely to include genes expressed in other life 
stages. Considering the vast coverage of transcriptomic data, the identification of the 
60 T. gondii genes for which no transcripts were observed is more fascinating. 
One possibility of the cause of discrepancies between proteomic data and 
transcriptomic data is technical limitations, whereby the same level of analytic 
resolution is hard to reach between the two techniques. Other possibilities involve 
biological explanations such as selective protein degradation and variations in 
protein turn-over rates [240, 241] as well as post-translational regulations such as 
mRNA decay and translational repression [242-244].  
Three examples of those 60 genes that have exclusive proteomic evidence indicated 
in section 5.3.2 were „tubulin beta chain, putative‟ (28.m00301, 128 peptide hits), 
„thioredoxin, putative‟ (42.m03331, 57 peptide hits) and „coatomer protein gamma 
2-subunit, putative‟ (59.m00090, 53 peptide hits). These three genes were identified 
by large numbers of peptide identifications in the absence of transcript evidence in 
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tachyzoite stage. Interestingly, although no evidence have been found from Day 6 
and RH libraries of SAGE experiment, both the tubulin beta chain, a component of 
microtubule that is critically important for shape and apical polarity [357, 358] and 
thioredoxin, a vital component in the antioxidant system of T. gondii, which is 
essential for the adaption and survival of the parasites in macrophages and other 
immune effecter cells [359] were detected in an earlier library-Day 4 (a VEG 
primary library representing a mixture of sporozoites and early stage of tachyzoites 
gene expression). It is possible that sufficient mRNA was produced in the early stage 
of tachyzoites to retain the required level of protein expression whereby no further 
mRNA is required in the later stage of the development.  
This observation coincides with the finding of the SAGE study that a major shift in 
gene expression happens from Day 4 to Day 6 libraries [272]. In fact, another 11 
genes out of those 60 genes have been detected in the Day 4 SAGE library, including 
a cell cycle control protein, putative (641.m01576, 7 peptide hits). The major shift in 
gene expression patterns could also partly explain the smaller size of the SAGE 
dataset and the reduced overlap with proteomic data compared to EST and 
microarray data, as shown in Figure 5.2. The SAGE data provided a more accurate 
measurement of mRNA expression at the specific Day 6 time point (and closely 
correlated RH strain [272]), while EST data were collected from a larger collection 
of various time points within the tachyzoite stage, and the arbitrary 25% cut-off used 
for microarray dataset is likely to include and exclude some genes that are not 
expressed at this life stage, as discussed earlier.  
Interestingly, while the SAGE study indicated the closest correlated mRNA 
expression to the laboratory strain RH library was the Day 6 library, the proteomic 
data actually had a larger overlap with an earlier Day 4 SAGE library. In total, 762 
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genes detected by proteomic data were shared with Day 4 SAGE library while only 
428 genes were shared with Day 6 SAGE library. The finding that the expression 
profile of proteomic data is closer to an earlier time point of transcriptomic data is 
likely to reflect the rapid changes in gene expression profiles and the temporal 
differences between mRNA and protein levels. 
While the discrepancies between transcriptome and proteome have been observed in 
T. gondii and other Apicomplexan parasites in this study, the analysis that was 
designed to check for common features of proteins with low levels of transcription 
across Apicomplexa have only identified a few candidates at the level of orthology. 
The larger overlap of orthologues observed between T. gondii and N. caninum than 
the overlaps with P. falciparum in all three comparisons shown in Figure 5.4 is likely 
to reflect a closer phylogenetic distance between T. gondii and N. caninum, although 
no specific class of proteins can be highlighted. In all the three Apicomplexan 
parasites analysed, there was no apparent underlying rule that can explain the 
discrepancies between proteomes and transcriptomes. 
There were some interesting candidates in the comparison, such as a coatomer 
protein gamma 2-subunit, putative, 59.m00090; ToxoDB annotation. It has been 
shown in T. gondii that although no transcript evidence has been found with 
microarray, EST and the three libraries of SAGE, convincing peptide evidence (53 
peptide hits) were detected. The protein orthologues of this gene have been 
consistently detected in P. falciparum, N. caninum and C. parvum but no EST 
evidence has been found in N. caninum and C. parvum, and only a single 
corresponding EST has been seen in a P. falciparum blood-stage EST library. 
Coatomer protein gamma 2-subunit resides in Golgi-derived vesicles which mediate 
both selective and non-selective transport between the ER and Golgi and/or within 
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the Golgi cisternae [360, 361]. It is possible that this protein has a very long turn-
over rate or an extremely high copy number from a single transcript. The precise 
reason of the consistent discrepancies observed between proteome and transcriptome 
of this gene across several Apicomplexan parasites and various life stages is very 
interesting and requires further investigation. 
5.4.3  Conclusions and future directions 
In this chapter, proteomic data and transcriptomic data have been compared in a 
systematic way across several Apicomplexan parasites. The general trend of 
correlations between mRNA abundance and protein abundance identified by both 
techniques has provided valuable experimental evidence for gene expression 
following the central dogma of Gene-Transcription-Translation. However, perhaps 
more importantly is the finding of discrepancies between these two datasets, which 
could result from either technical limitations or genuine biological phenomena. 
The observation that the proteomic data of T. gondii better overlaps the Day 4 SAGE 
library rather than the Day 6 and RH SAGE libraries is particularly interesting. It 
highlighted the potential latency of the changes to protein expression profile after the 
mRNA expression has been altered. Combined with many cases where strong 
proteomic evidence exists in the absence of transcriptomic evidence, the proteomic 
data have highlighted the limitations of using transcriptomic data in protein function 
assignments under the largely applied “guilty-by-association” hypothesis [233]. 
Both proteomics and transcriptomics are still relatively new technologies, 
representing some of the first generation of genome-wide data to follow the 
Apicomplexan genome sequencing projects. The attempt to find common features 
amongst genes that show discrepancies between transcriptome and proteome has 
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highlighted several interesting observations, but has not reached an overall 
conclusion due to the limitation of the data coverage and the lack of quantitative data.  
As the technology evolves, more sensitive and absolute quantitative proteomic data 
would provide accurate measurements of protein abundance, which together with 
more accurate and thorough coverage of transcriptomic expression provided by the 
latest RNA-Seq technique, a more meaningful comparison between transcriptome 
and proteome can be made. More importantly, with more temporal data models 
analysed, a dynamic and comprehensive understanding of the basic biological 
process involved in gene expression can be achieved in the near future.  
Knowing the importance of quantitative data and encouraged by the good proteomic 
coverage of metabolic pathways shown in chapter 3, a quantitative proteomic study 
has been carried out in the next chapter to characterize differential protein expression 
in T. gondii under different growing conditions. 
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6.1  Introduction 
In the previous chapter, the importance of quantitative proteomic data in the 
integration with other gene expression data was highlighted by the comparison of the 
proteome and transcriptome of Toxoplasma and other Apicomplexa parasites. In this 
chapter, a preliminary case study has been developed to test the applications of a 
quantitative proteomic method differential gel electrophoresis (DIGE), in 
understanding the changes of protein expression profiles of T. gondii between 
different growth conditions. 
Traditionally, a gel-based method for quantitative protein expression analysis relies 
on the statistical analysis of a number of replicate sets of one-sample-one-gel for 
samples of different status. Due to the poor reproducibility of 2-DE, this approach 
requires several replicate gels to overcome variations in gel running and therefore is 
very labour intensive and prone to experimental errors [362]. In 1997, an alternative 
technique which uses optical detection of proteins with a fluorescent tag in 
conjunction with 2-DE was developed and named DIGE [363]. Figure 6.1 shows a 
schematic representation of the DIGE workflow.  
 
Figure 6.1 Schematic representation of the DIGE workflow. 
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Equal protein amounts of sample A, sample B and a pooled internal standard are 
separately labelled by three spectrally distinct fluorescent dyes: Cy2, Cy3 and Cy5. 
The labelled samples are then mixed and subjected to 2-DE separation followed by 
fluorescence imaging. Computer-aided image analysis is then performed where the 
volumes of each spot detected from differentially labelled samples are compared. 
Four gels that contain four pairs of biological replicates are needed for each 
experiment to minimize the influences of biological variations in the statistical test. 
The pooled internal standard is used to calibrate gel-to-gel variations due to 
heterogeneities during acrylamide polymerisation, gel running and variable 
precipitation of samples in the first dimension. 
The ability of the 2-DE technique in identifying proteins with a broad range of 
functions and key components of metabolic pathways has been demonstrated in 
chapter 3. The extended utility of sensitive quantitation of protein expression offered 
by DIGE has inspired a case study to quantitatively compare changes in the protein 
expression profile between T. gondii grown in the presence and absence of glucose 
in the cell culture medium. 
It has been observed by Dr. Dhanasekaran Shanmugam (University of Pennsylvania, 
USA) that T. gondii tachyzoites are able to grow and replicate for several passages in 
the total absence of glucose in the growth medium (personal communication). The 
growth kinetics test of these parasites has revealed that the parasites growing in the 
absence of glucose are slower than those growing in the presence of glucose by an 
average of one round of parasite doubling after 48 hrs. Gene expression profiles have 
been compared between +/-glucose samples and no difference among genes involved 
in key metabolic pathways for glucose utilization and energy production has been 
observed (personal communication with Dr. Dhanasekaran Shanmugam). 
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Metabolomic analysis on +/-glucose samples is also in progress under the 
collaboration with Dr. Manuel Llinás from Princeton University, USA. 
As part of this collaborative project, a preliminary DIGE experiment was carried out 
and is reported in this chapter. The application and importance of the DIGE 
technique in the quantitative protein expression profiling and the role of proteomic 
data in understanding gene expression changes in the context of system is discussed. 
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6.2  Materials and Methods 
DIGE experiments were performed using an Ettan
TM
 DIGE platform, GE Healthcare. 
The DIGE experiment briefly included the following steps: sample preparation, 
DIGE labelling, 2-DE, gel imaging, gel analysis using DeCyder
TM
 software and MS 
analysis. 
6.2.1  Sample preparation 
Cell culture was carried out by Dr. Dhanasekaran Shanmugam, University of 
Pennsylvania, USA. Briefly, four pairs of (+) glucose/(-) glucose biological 
replicates of T. gondii tachyzoites were grown in DMEM medium (GIBCO, 
supplemented with 5.5 mM glucose and 4 mM glutamine for (+) glucose medium, 
and 4 mM glutamine for (-) glucose medium) on the same batch of confluent HFF 
host cells plated on T175 tissue culture flasks. For (+) glucose samples, parasites 
from 1 T175 flask were collected for each replicate while for (-) glucose samples, 
parasites from 2 T175 flasks were collected for each replicate. All the flasks were 
inoculated at the same time and 6 hours later the flasks were exchanged with fresh 
media (either +/-glucose containing as required) to wash out extracellular parasites 
that had not invaded host cells. Parasites were purified and harvested 48hrs after 
inoculation using the same method described in section 2.2.1. The frozen samples 
were then delivered on dry ice. 
To each sample (typically containing 2×10
8
 parasites), an aliquot of 60 µl of DIGE 
lysis buffer (8M urea, 4% (w/v) CHAPS, 40 mM Tris-base) was added together with 
10µl DNase mix and 5µl of protease inhibitors (Roche). Three cycles of freeze and 
thaw were performed; each cycle comprised 2 min of vigorous vortexing, followed 
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by fast freeze with liquid nitrogen and quick thaw to room temperature. The sample 
was centrifuged at 16,000×g for 30 min at 4 °C.  
The 2-D Clean-Up Kit (GE Healthcare) was used to precipitate protein and remove 
inferring contaminants such as detergents, salts, lipids, phenolics and nucleic acids. 
Protein samples were then resuspended in DIGE lysis buffer and the concentrations 
were adjusted to 5 mg/ml, as determined by 2-D Quant Kit (GE Healthcare). The pH 
of the sample was adjusted to pH8.5 using 1M NaOH for optimal CyDye
TM
 labelling. 
6.2.2  DIGE Labelling 
A pooled aliquot of sample A, (+) glucose and sample B, (-) glucose from all batches 
was prepared as an internal standard. The commercial kit CyDye
TM
 (GE Healthcare) 
was used for DIGE labelling. The kit contains three different fluorescent dyes Cy2, 
Cy3 and Cy5. Table 6.1 shows the sample labelling assignments of CyDyes in a 
typical two sample group comparison setup. 
Table 6.1 DIGE labelling Methods 
Gel Number Cy2 Cy3 Cy5 
1 Pooled Standard Sample A 1 Sample B 4 
2 Pooled Standard Sample B 3 Sample A 2 
3 Pooled Standard Sample B 2 Sample A 3 
4 Pooled Standard Sample A 4 Sample B 1 
 
To each CyDye channel, 50 µg of sample was prepared and 1 µl (400 ρmols/µl) of 
appropriate working dye (Cy2/Cy3/Cy5) was added and vortexed to mix. The sample 
was then centrifuged briefly and left on ice for 30 min in the dark. To stop the 
labelling reaction, 1 µl of 10 mM lysine was added to each sample; the sample was 
centrifuged briefly and left on ice for 10 min. The appropriate Cy2, Cy3 and Cy5 
labelled samples were combined into a single tube and vortexed to mix. 
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6.2.3  2-D gel electrophoresis (2-DE) 
First dimension IEF was carried out on 24 cm IPG strips (pH 4-7) following the 
procedure described in section 2.2.4.3. After the two step equilibration described in 
section 2.2.4.4, a modified second dimension separation was carried out as DALT 
precast gels are not compatible with DIGE due to the interference to fluorescent 
scanning from the plastic back. Low-fluorescence Glass Plates, 27 × 21 cm (GE 
Healthcare) were used to assemble manually casted gel. All glass plates were 
thoroughly cleaned with 1% (v/v) decon. The back plates were treated with bind-
silane solution (80% (v/v) EtOH, 18% (v/v) dH2O, 2% (v/v) acetic acid, 0.1% (v/v) 
γ-methacryloxypropyltrimethoxysilane), which sticks the gel to the glass plate, and 
left to dry for a minimum one hour at room temperature. Reference markers were 
applied to the back glass plate and the glass plates were assembled in the gel cast 
container supplied. SDS-PAGE gels were cast overnight with 30% (w/v) acryalmide, 
1.5 M Tris-HCl (pH 8.8), 10% (w/v) SDS, 10% (v/v) TEMED and 10% (w/v) APS. 
The equilibrated IPG strips were then assembled onto cast gels and sealed with 
agarose sealing solution (0.5% (w/v) agarose, trace bromophenol blue). The Ettan 
DALTsix System was setup according to the product handbook using the 
electrophoresis buffer kit supplied. The gel was run at 20°C with an initial wattage of 
3 W for 0.5 hour and 17 W per gel thereafter. 
A preparative gel was separately prepared with 400 µg of pooled sample from all 
sample A and sample B replicates. The preparative gel was run together with 4 
DIGE gels under same running conditions. The preparative gel was matched to other 
DIGE gels after the gel analysis and protein spots were picked from the preparative 
gel for further MS analysis. 
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6.2.4  Post stain-SYPRO
®
 Ruby 
To visualize the proteins present on the preparative gel, SYPRO
®
 Ruby protein gel 
stain (Invitrogen) was used. The gel was fixed in 40% (v/v) MeOH, 10% (v/v) acetic 
acid for one hour and stained with SYPRO
®
 Ruby gel stain overnight. The gel was 
then washed in 10% (v/v) MeOH, 7% (v/v) acetic acid for one hour followed by two 
5 min washes in dH2O prior to gel imaging. 
6.2.5  Gel imaging 
Both the preparative gel and all four DIGE gels (the latter using three channels of 
Cy2, Cy3 and Cy5) were scanned using the Ettan
TM
 DIGE Imager (GE Healthcare) 
following the instructions provided by manufacturer. The gels were scanned at the 
wavelengths which correspond to the dyes used as shown in Table 6.2. 
Table 6.2 The appropriate filter for gel imaging using the Ettan
TM
 DIGE 
Imager 
Dye Excitation Filter Emission Filter 
Cy2 480/30 nm 530/40 nm 
Cy3 540/25 nm 595/25 nm 
Cy5 635/30 nm 680/30 nm 
SYPRO
®
 Ruby 480/30 nm 595/25 nm 
 
To perform the analytical scan, the pixel size was set to 100 µm required by the 
image analysis software DeCyder
TM
. 
6.2.6  Gel image analysis using the DeCyder
TM
 software 
The DeCyder™ image analysis software (GE Healthcare) was used for the analysis 
of DIGE images. The software consists of five modules. (1) Image Loader: Imports 
gel image files into the DeCyder database making them accessible for the other 
modules; (2) DIA (Differential In-gel Analysis): protein spot detection and 
quantitation on a pair of image channels from the same gel; (3) BVA (Biological 
Variation Analysis): matches multiple images from different gels to provide 
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statistical data on differential protein expression levels between multiple groups; (4) 
Batch Processor: automated image detection and matching of multiple gels without 
user intervention; and (5) XML Toolbox: generates user specific data reports. 
Twelve gel images generated from three channels of four DIGE gels were loaded 
onto the DeCyder software and the DIA module was used to calculate the number of 
spots on one gel. All spots in every gel were then detected using the batch processor 
and the output files were then opened in the BVA module. Gel to gel matching of 
spots was carried out in the BVA module using the match detection algorithm 
allowing quantitative comparisons of protein expression across multiple gels. One of 
the Cy2 images representing internal standard was assigned master gel status and all 
other images were then matched to it either by automated Batch Processor or manual 
curation, identifying common protein spots across the gels. The student‟s T-test was 
used to determine whether changes in volume of specific spots were significant 
between samples from different experimental groups. Protein spots which appeared 
in at least 9 out of 12 images with greater than 1.3 fold changes (p<0.05) between (+) 
glucose and (-) glucose samples were reported. The preparative gel was loaded onto 
the DeCyder software and assigned as the pick gel in the BVA module. The protein 
spots of interest were matched onto the pick gel and a pick list was exported by 
DeCyder software. 
6.2.7  Protein identification 
The protein spots of interest were picked from the preparative gel by the Ettan
TM
 
Spot Picker (GE Healthcare). Manual tryptic digestion was carried out on individual 
protein spots as described in section 2.2.5. The LTQ (LC-MS/MS) analysis and 
Mascot searching were performed to acquire protein identifications of each spot 
using the process described in sections 2.2.6 and 2.2.7. 
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6.2.8  Protein function annotation 
The functional annotation of the proteins identified was carried out using ToxoDB 
annotation (http://toxodb.org/toxo/), BlastP (http://www.ncbi.nlm.nih.gov/BLAST/), 
AmiGO (http://amigo.geneontology.org/cgi-bin/amigo/go.cgi) and categorized using 
MIPS FunCat (http://mips.gsf.de/projects/funcat). The details of each process were 
described in section 3.2. 
6.2.9  Metabolic pathway coverage 
Conversion of T. gondii genes to key pathway components was determined using the 
information provided by ToxoDB (http://toxodb.org/toxo/). The enzymes identified 
in this study were mapped onto KEGG pathways using “Color Objects in KEGG 
Pathways” tool provided by KEGG 
(http://www.genome.jp/kegg/tool/color_pathway.html). 
6.2.10  Comparison with Microarray data 
Microarray expression data of +/-glucose samples were acquired from ToxoDB v4.3 
using the query “ToxoDB Queries and Tools/Transcript Expression/ Identify Genes 
by Microarray Evidence/ Identify Genes based on Differential Expression (T.g.)”. 
The expression library “RH (Type I) in High Glucose vs. RH (Type I) with No 
Glucose” was selected and the confidence value of ≥0.9 was used. A list of genes 
showing absolute microarray expression values in the +/-glucose experiment was 
also downloaded from ToxoDB and compared with DIGE results using Microsoft 
Office Excel.  
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6.3  Results 
6.3.1  Differential In-gel Analysis 
Four biologically replicated pairs of T. gondii tachyzoites grown in +/- glucose 
medium were resolved on four DIGE gels. Around 3800 spots were detected on each 
gel by the DIA module of DeCyder software. Using separated images generated 
from different fluorescent dyes on the same gel, the number of differentially 
expressed proteins on a single gel was determined. Table 6.3 shows the number of 
gel spots that have greater than a two-fold change between (+) glucose and (-) 
glucose samples on each of the four DIGE gels. 
Table 6.3 Result of individual gel analysis using DIA module of DeCyder 
 
Up-regulated in  
(-) glucose 
sample 
Down-regulated 
in (-) glucose 
sample 
Overall 
differentially 
expressed 
Spots detected 
on the gel 
Gel 1 55 116 171 3898 
Gel 2 49 20 69 3769 
Gel 3 29 38 67 3890 
Gel 4 28 51 79 3962 
6.3.2  Biological Variation Analysis 
In order to verify the statistical significance of the differentially expressed proteins 
determined by the DIA module across all the gels, the BVA module of DeCyder 
software was used. After matching all the 12 gel images generated from four gels, 
gel spots that appeared in at least 9 images were considered qualified candidates. 
Several thresholds were tested to decide the cut-off value to be used for the 
indication of gene regulation. The higher cut-off value would represent more 
significant changes between two sample groups but would also decrease the number 
of gel spots that can be qualified, while choosing a lower cut-off value would allow 
more gel spots to be analysed but inevitably weaken the significance of changes 
observed. In this study, if a 2.0 fold change is required, only 3 gel spots would be 
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qualified to be regulated and only 9 gel spots would be qualified if the threshold is 
set to a 1.5 fold change. Finally, a threshold of a 1.3 fold change was adopted as it 
allowed more gel spots to be analysed which would provide a clearer trend of 
expression profile changes and at the same time, the fold difference was still 
statistically significant. In total, 27 gel spots showed a greater than 1.3 fold change 
(p<0.05) between (+) glucose and (-) glucose samples, with 10 gel spots up-
regulated in (-) glucose sample and 17 gel spots down-regulated in (-) glucose 
sample. One example of the gel spot is shown in Figure 6.2. 
 
Figure 6.2 Screenshot of the BVA workshop in the Protein Table mode.  
The screen is split into 4 sections. The top left section is the gel image view which 
shows a Cy3 labelled image of (-) glucose sample on the left and the corresponding 
Cy5 labelled image of (+) glucose sample on the right. The Graph View on the top 
right section shows the volume comparison of the selected spot (ID: 3454), which is 
consistently higher in (+) glucose sample than in (-) glucose sample (as measured by 
standardised log abundance) across all gel images matched. The bottom left section 
shows the 3D view of the abundance of the matched protein in the two 
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corresponding gel images selected on the upper left section. The Protein Table on the 
bottom right section shows spot specific information including the master number of 
the spot, the T-test value and the average ratio of spot volume.  
In the 27 gel spots, 58 release 4 genes and 1 alternative gene model were identified 
by MS analysis. In many cases, more than one protein has been identified in a single 
gel spot, an observation seen before in other 2-DE experiments carried out in chapter 
2. The influence of this observation to the data interpretation is discussed in section 
6.4.1 and the list of proteins identified from each gel spot is provided in Appendix 
VIII. Of the 59 genes identified, 36 genes were down-regulated and 21 genes were 
up-regulated in the (-) glucose sample. Interestingly, there were two genes 
(25.m00211, cytochrome c oxidase, putative and 583.m00712, adenylyl cyclase 
associated protein) that have been identified from different gel spots that indicated 
contradictory changes. The possible reasons of this observation are discussed in 
section 6.4.1. 
6.3.3  Functional categorization and metabolic pathway coverage 
Functional categorization of the proteins identified was carried out using the same 
process described in chapter 3 and the result is shown in Figure 6.3. The proteins that 
have been regulated between +/-glucose were predicted to be involved in a variety of 
functional categories. Categories that are highly represented in the results are protein 
fate (folding, modification, destination), such as proteasome and ubiquitin proteins; 
as well as cell rescue, defence and virulence, including a few heat shock proteins. 
Notably, both a microneme protein (MIC1) and a dense granule protein (GRA5) 
were down-regulated over two fold in the (-) glucose sample, which may lead to a 
decreased invasion rate and disturbed intracellular survival and therefore contribute 
to the slower growth kinetics of T. gondii observed in the glucose depleted medium. 
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Figure 6.3 Functional categorization of the differentially expressed proteins. 
Functional assignments of identified official ToxoDB release 4 genes. The prediction 
was first determined by gene description and GO annotation provided on ToxoDB 
and then assigned to appropriate MIPS FunCat categories. Putative functional 
assignment was made to the remainder of identified proteins with information 
acquired from BlastP, Pfam domain alignments, InterPro and literature searches. 
Metabolic pathway coverage of the proteins was determined using the information 
provided on ToxoDB. Only three proteins that are directly involved in glycolysis and 
gluconeogenesis were modulated. Figure 6.4 shows the position of these enzymes in 
relation to other components of the pathway. Enzyme EC 4.2.1.11 (59.m03410, 
enolase, putative) was down-regulated, and enzyme EC 2.7.1.40 (55.m00007, 
pyruvate kinase, putative) was up-regulated in the (-) glucose sample. In pyruvate 
metabolism, enzyme EC 4.1.1.49 (80.m00002, phosphoenolpyruvate carboxykinase 
(PEP carboxykinase), putative) was up-regulated in the (-) glucose sample. 
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Figure 6.4 Metabolic pathway coverage of the differentially expressed 
proteins: Glycolysis and gluconeogenesis. Conversion of T. gondii genes to key 
pathway components was determined using the information provided on ToxoDB. 
The three enzymes identified in this study were mapped onto glycolysis and 
gluconeogenesis pathways using “Color Objects in KEGG Pathways” tool provided 
by KEGG (http://www.genome.jp/kegg/tool/color_pathway.html). The enzyme 
coloured in red is the pathway component that was down-regulated in (-) glucose 
sample and enzymes coloured in green are pathway components that were up-
regulated in (-) glucose sample. 
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Enolase (EC 4.2.1.11) catalyzes a reversible reaction of the dehydration of glycerate-
2-phosphate (glycerate-2P) to form phosphoenolpyruvate (PEP). It has also been 
found to be involved in invasion [364] as well as play some part in the control of 
gene regulation during parasite proliferation and differentiation [365, 366]. The 
precise role of 59.m03410 in the glycolysis and gluconeogenesis requires further 
investigation. It is possible that the down-regulation of enolase may be caused by the 
lack of glucose intake and influenced the invasion rate of the parasites. 
In gluconeogenesis, pyruvate kinase (EC 2.7.1.40) catalyzes the formation of 
pyruvate from PEP, and two molecules of ATP are formed for each molecule of 
glucose. Pyruvate kinase is inactivated by phosphorylation and as it is a control 
enzyme of flux through glycolysis, phosphorylation will down-regulate glycolysis 
[367]. In T. gondii, the unusual allosteric activation by glucose 6-phosphate (G6P) 
reported has suggested the involvement of pyruvate kinase to the parasitism [368, 
369]. 
PEP carboxykinase (EC 4. 1.1.49) is involved in the first stages of gluconeogenesis, 
the synthesis of PEP. After pyruvate converts to oxaloacetate (OAA), PEP 
carboxykinase then catalyzes it into PEP. This reaction is driven by the hydrolysis of 
GTP [367]. During starvation, PEP carboxykinase is up-regulated in response to 
increasing glycogen levels. [367]. In Toxoplasma, EC 4.1.1.49 (80.m00002) is the 
only gene to be predicted in this reaction (there is no evidence for the other enzymes 
in Toxoplasma on ToxoDB). It is possible that the up-regulations of pyruvate kinase 
and PEP carboxykinase have increased the efficiency of gluconeogenesis by up-
regulating the conversion of pyruvate to PEP. 
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In the biosynthesis pathway of serine, enzyme EC 2.6.1.52 (38.m00011, 
phosphoserine aminotransferase) was indicated to be down-regulated, which may be 
an indication that amino acids were used as carbon sources for T. gondii in the 
glucose depleted medium.  
6.3.4  Comparison with microarray data 
Microarray analysis has also been carried out on the +/- glucose samples. In the 7764 
release 4 genes assayed, the expression changes of 4444 release 4 genes between +/-
glucose samples were detected by microarray when the confidence value was set at 
≥0.9 (90% of them are expected to be correct, according to ToxoDB). In total, 208 
genes were up-regulated (> 1.3 fold) and 2405 genes were down-regulated (> 1.3 
fold) in the (-) glucose sample. The microarray expression value was downloaded 
from ToxoDB and compared with the DIGE results. Table 6.4 shows the comparison 
of DIGE results with the differential expression value indicated by microarray data. 
For 59 genes identified by the DIGE experiment, only 28 genes were also detected 
by microarray ≥0.9 confidence data. Eighteen of them showed less than 1.3 fold 
changes between (+) glucose and (-) glucose samples and are termed “modulated” in 
the table, while ten of them showed significant changes (greater than 1.3 fold) 
between the two samples. However, DIGE and microarray have indicated 
contradictory expression changes for 4 of those 10 genes. 
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Table 6.4 The comparison of DIGE and microarray results of +/-glucose sample. 
ID Description 
Average 
Ratio (DIGE) 
Average 
Ratio 
(Microarray) 
Correlates 
38.m00011 phosphoserine aminotransferase, putative -2.43 No data   
46.m00027 DEAD/DEAH box helicase, putative -2.43 No data   
50.m00006 heat shock protein 60 -2.43 No data   
50.m03132 hypothetical protein -2.43 No data   
50.m03261 hypothetical protein -2.43 No data   
57.m01695 hypothetical protein -2.43 -1.44 Yes 
80.m00012 microneme protein 1 (MIC1) -2.43 Modulated No 
44.m02755 
small heat shock protein, putative / bradyzoite-specific protein, 
putative 
-2.29 
Modulated No 
55.m11049 NAC domain containing protein -2.29 Modulated No 
44.m04681 hypothetical protein -2.09 No data   
59.m00008 surface antigen P22 -2.09 No data   
76.m00004 dense granule protein 5 precursor, putative -2.09 No data   
44.m00031 membrane skeletal protein IMC1, putative -1.74 7.29 No 
59.m03518 asparaginyl-tRNA synthetase, putative -1.74 Modulated No 
49.m00008 ribosomal protein L23a, putative -1.61 Modulated No 
583.m00626 hypothetical protein -1.61 Modulated No 
145.m00347 26S protease regulatory subunit 6a, putative -1.53 No data   
25.m00007 actin -1.53 No data   
38.m01067 alanyl-tRNA synthetase, putative -1.53 No data   
50.m03396 eukaryotic translation initiation factor 3 subunit 3, putative -1.43 No data   
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59.m03410 enolase, putative -1.43 Modulated No 
645.m00319 RNA recognition motif domain-containing protein -1.43 No data   
69.m00140 proliferation-associated protein 2G4, putative -1.43 Modulated No 
76.m00016 elongation factor 1-alpha, putative -1.43 Modulated No 
541.m01224 hypothetical protein -1.42 -1.38 Yes 
80.m02245 eukaryotic translation initiation factor 3 delta subunit, putative -1.42 No data   
44.m00051 prohibitin-related -1.41 No data   
50.m00042 GTP-binding nuclear protein RAN/TC4, putative -1.41 Modulated No 
583.m00630 purine nucleoside phosphorylase, putative -1.41 -1.43 Yes 
TgTwinScan_5606 No Significant Blast Hit -1.41 No data   
27.m00003 protein disulfide isomerase, putative -1.39 No data   
583.m00619 60s ribosomal protein L4, putative -1.39 No data   
583.m05569 hypothetical protein -1.36 -1.54 Yes 
42.m05838 hypothetical protein -1.35 No data   
25.m00211 cytochrome c oxidase, putative -1.33 No data   
55.m08199 hypothetical protein -1.33 Modulated No 
583.m00712 adenylyl cyclase associated protein -1.33 No data   
76.m01670 peroxiredoxin family protein/glutaredoxin, putative -1.33 -1.57 Yes 
20.m03912 elongation factor 2, putative 1.31 Modulated No 
38.m01113 heat shock protein, putative 1.31 No data   
55.m04729 heat shock protein, putative 1.31 No data   
55.m05071 26S proteasome non-ATPase regulatory subunit-related 1.31 -1.64 No 
50.m00016 bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) 1.38 1.99 Yes 
65.m00001 nucleoside-triphosphatase I 1.38 No data   
20.m03930 20k cyclophilin 1.39 No data   
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42.m00091 hypothetical protein 1.39 Modulated No 
80.m00002 phosphoenolpyruvate carboxykinase, putative 1.39 No data   
25.m00211 cytochrome c oxidase, putative 1.4 No data   
49.m03152 proteasome subunit alpha type 4, subunit 1.4 No data   
44.m00052 58 kDa phosphoprotein, putative 1.46 Modulated No 
27.m00081 hypothetical protein 1.58 No data   
44.m02723 
gi|22035894|emb|CAD43149.1|; putative PDI-like protein 
[Toxoplasma gondii]; 5e-125 
1.58 No data 
  
46.m00017 ubiquitin-conjugating enzyme, putative 1.58 Modulated No 
583.m00712 adenylyl cyclase associated protein 1.58 No data   
59.m03611 heat shock protein HSLV, putative 1.58 -1.89 No 
113.m00780 conserved hypothetical protein 1.75 Modulated No 
31.m00869 hypothetical protein 1.75 No data   
42.m00027 26S proteasome non-ATPase regulatory subunit 4, putative 1.75 Modulated No 
55.m00007 pyruvate kinase, putative 1.75 Modulated No 
55.m00139 46 kDa FK506-binding nuclear protein, putative 1.75 No data   
76.m01657 hypothetical protein 1.75 -2.30 No 
The first column shows the 59 genes identified by DIGE experiment and the gene descriptions are shown in the second column. The third 
column shows the average ratio of expression changes between +/-glucose samples indicated by DIGE. The fourth column shows the average 
ratio of changes indicated by microarray data where changes less than 1.3 fold are termed modulated. The fifth column shows the correlation 
between the two experiments. Genes coloured in red were down-regulated in (-) glucose sample and genes coloured in green were up-regulated. 
Genes coloured in blue showed contradicted results from different gel spots on DIGE.  
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6.4  Discussion 
In this chapter, DIGE analysis has been used to characterize the changes in T. gondii 
protein expression profiles in glucose depleted medium. The DIA module has shown 
that over 3000 protein spots can be detected on each of the four DIGE gels, which 
highlighted the good resolution of the technique. In the BVA module, the gel 
matching and statistical analysis helped to overcome the limitations introduced by 
both biological variations and handling variations. In total, 27 gel spots showed a 
greater than 1.3 fold change (p<0.05) between (+) glucose and (-) glucose samples 
and 58 release 4 genes and one alternative gene model have been identified. Both the 
functional categorization and metabolic pathway coverage analysis have highlighted 
some interesting groups of proteins that deserve further investigations. As the main 
focus of this chapter was to provide a preliminary test of the application of DIGE in 
quantitative proteomic studies, considerations are required to the following 
limitations observed in this chapter. 
6.4.1  Multiple proteins identified in a single gel spot 
As mentioned before, the directions of protein regulation were not definite due to the 
multiple proteins identified in a single gel spot and caution is required in the data 
interpretation. For example, among all the enzymes described in section 6.3.3, only 
one protein 80.m00002 (PEP carboxykinase) was identified by a single specific gel 
spot. 
In a gel spot from which several proteins can be identified, it is hard to determine 
which protein has dominated the changes detected at the gel spot level. On the other 
hand, a genuine protein expression change of a low abundance protein could be 
masked by a high abundance protein co-migrating that did not have any significant 
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changes. Multiple proteins identified in a single gel spot have also led to the 
observation of proteins that have been identified from different gel spots which 
indicated contradictory expression changes. 
The expression changes of a single protein candidate can be confirmed by using a 
quantitative MS platform that can specifically target signature peptides such as the 
multiple reaction monitoring (MRM) assay [370]. In this way, DIGE can serve as a 
preliminary step that provides a screening of protein expression changes in a high 
throughput fashion, while further MS analysis can be used to unambiguously 
confirm the expression changes of a specific protein. 
6.4.2  Repeatedly identified differentially expressed proteins 
A recent study has investigated the occurrence of individual differentially expressed 
proteins in 2-DE experiments reported in169 articles studying human and mouse or 
rat samples published in the Proteomics journal between 2004 and 2006 [371]. This 
meta-analysis study has revealed that among the most frequently identified 
differentially expressed proteins were enolase, heat shock proteins, proteasome 
subunits and pyruvate kinase [371] which have also been identified in this chapter.  
Since all the commonly identified proteins are highly abundant soluble proteins, it 
raised the concern whether their frequent identification represents a technical artefact, 
limitation of the method or universal cellular sensors that respond to multiple 
different stimuli [371]. Although the full list of 169 articles analysed in this study 
has not been released, it is likely that many of them were carried out using the 
conventional one-sample-one-gel setup. In fact, a quick search has revealed that only 
56 articles published in the Proteomics journal between 2004 and 2006 have used a 
DIGE platform (http://www.gopubmed.org/web/gopubmed/). It is possible that these 
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commonly identified proteins were easy to identify by 2-DE techniques and the 
changes in gel spot volume caused by gel to gel variations were falsely reported as 
biological expression differences.  
However, a higher confidence can be expected during the interpretation of DIGE 
results. One of the technical advantages provided by DIGE is the ability to minimize 
the technical limitations experienced in the conventional 2-DE gel. Firstly, by 
labelling with three fluorescent CyDyes, different samples can be separated on the 
same gel under the same running conditions. Secondly, the variations between 
different biological replicates as well as those introduced during sample handling 
and first dimension IEF are minimized using pooled internal standard and advanced 
statistical analysis. As shown in this chapter, around 70 to 170 gels spots on each 
DIGE gel have shown greater than a two-fold change between (+) glucose and (-) 
glucose samples in the DIA module. However, after matching the four DIGE gels 
together, only 27 gels spots have shown greater than a 1.3 fold change reported by 
the statistical analysis. 
Admittedly, the advantages of the DIGE technique over the conventional one-
sample-one-gel setup cannot bypass the limitations inherited from 2-DE, such as 
resolving very large or small proteins, low abundance proteins, hydrophobic proteins 
and proteins with extreme pIs as discussed in chapter 2. This would inevitably lead 
to an artificial enrichment of the identifications of high abundance, soluble proteins 
as observed in the meta-analysis study [371]. However, with the increased 
confidence provided by DIGE, it is more likely that the identifications of these 
repeatedly identified differentially expressed proteins in this chapter represent true 
universal cellular sensors responding to multiple different stimuli. 
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6.4.3  The comparison of DIGE results with the microarray data 
The comparison of DIGE results with the microarray data has shown a surprisingly 
low number of genes that have been detected by both DIGE and microarray. This 
may reflect the resolution limitations of the DIGE technique compared to microarray. 
However, more interestingly are those genes that showed different expression 
changes indicated by DIGE and microarray.  
There were 18 genes identified that have shown significant changes at protein 
expression level while the mRNA expression level has only been slightly modulated. 
Since the samples were collected after 48 hours of inoculation, it is possible that the 
significant changes of mRNA level in the initial response have returned to the basic 
level while protein expression level remains significantly altered. The similar delay 
of protein expression has been observed in chapter 5 when proteomic data were 
compared with SAGE data.  
There were also four genes that showed contradictory expression changes between 
mRNA and protein levels. The biggest discrepancy has been observed for 
44.m00031, a membrane skeletal protein (IMC1). The DIGE result indicated the 
expression of this protein in the (-) glucose sample was down-regulated 1.74 fold, 
while the mRNA expression was up-regulated 7.29 fold. Membrane skeletons play 
an important role in the maintenance of cell shape and integrity while IMC also plays 
a critical role as an anchor for the glideosome [65, 372]. It has been found that 
IMC1appears to be stable during the early stage of invasion but is degraded rapidly 
during the late stages of the endodyogeny, while the membrane skeleton of the 
daughter parasites is assembled at an earlier stage of cell division which does not 
involve recycling of components of the mother cell network [373]. This may partly 
contribute to the discrepancies observed between mRNA and protein levels where 
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the increase of the mRNA expression is required by the daughter parasites and the 
detected protein expression is affected by the degradation. However, the precise 
effect of the glucose depleted medium to the expression of IMC1 still requires 
further investigation. 
6.4.4   Conclusion and future directions 
In this chapter, the application of the quantitative proteomic approach DIGE in 
understanding protein expression changes of T. gondii tachyzoites in +/- glucose 
medium were investigated and discussed. Several interesting candidates have been 
identified such as enzymes that are involved in the glycolysis and gluconeogenesis 
pathways, as well as proteins involved in host cell invasion and intracellular survival. 
The quantitation accuracy of DIGE has been proved to be comparable to the MS-
based chemical and metabolic isotope labelling quantitation methods such as ICPL 
(Isotope Coded Protein Label), iTRAQ (isobaric tags for relative and absolute 
quantification), and cICAT (cleavable isotope-coded affinity tags) [374-376]. 
Compared to other MS-based quantitation methods that measure the protein 
abundances at the peptide level, DIGE measures the protein abundances at the 
protein level, where information on isoforms-specific expression can be preserved. 
As discussed before, DIGE is able to provide a high throughput large scale 
quantitative screening of protein expression changes. However, considerations are 
also required to the separation limitations inherited from 2-DE, as well as the 
frequently observed phenomena of multiple proteins co-migrating to the same gel 
spot. It should also be noted that, if a spot has been down-regulated to the point of 
disappearing from the gel, it would not be reported but which nevertheless, could 
represent a significant event. Data interpretation of DIGE results should be carried 
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out cautiously and in some cases, further investigations are required to confirm the 
expression changes observed. One possibility of the discrepancies observed between 
the DIGE results and microarray data is the temporal differences between mRNA 
and protein expression. The inclusion of more time-points in the investigation as 
well as the addition of metabolomic data will provide valuable insights into the 
dynamic changes of T. gondii under different conditions. 
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In the one hundred years since the discovery of Toxoplasma gondii, the 
understanding of the biology of the parasite has rapidly progressed along with the 
technical developments. Since the development of expression sequence tags (ESTs) 
[246], the rate of gene discovery has accelerated. With the first output of the T. 
gondii genome sequencing project completed in 2003, followed by the great and 
continuing efforts towards genome annotation consecutively published on ToxoDB 
[108], numerous applications have been made feasible. The focus of T. gondii 
research has gradually moved to the understanding of gene expression and gene 
functions on the genome scale. Equipped with the combination of protein separation 
techniques, the latest technical advances of mass spectrometry and bioinformatics, 
proteomics has rapidly established an important role in post-genomics era 
applications by providing first-hand data on the functional products of gene 
expression. In this study, the applications of proteomic technique in the 
understanding of the proteome of T. gondii have been investigated and discussed.  
In chapter 2, the use of three complementary proteomic separation platforms 
followed by powerful MS/MS analyses have harnessed the advantages provided by 
each technique and ensured the best coverage of the expressed proteome whilst 
utilising limited amounts of sample and labour. The raw MS data have been searched 
against a well designed, up-to-date database that provided comprehensive coverage 
of the predicted T. gondii proteome. After the careful verification of the MS data 
searching results, more than two thousand (2252) unique release 4 genes and 394 
non-redundant alternative gene models and ORFs have been identified from the 
tachyzoite proteome, which represents almost one third (29%) of the entire predicted 
proteome. Since the proteomic data were only collected from the tachyzoite stage, 
the actual proteomic coverage of tachyzoite proteome would be expected to be much 
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higher. Notably, 813 of the 2252 (36%) proteins identified are annotated as 
hypothetical or conserved hypothetical proteins. With the expression evidence 
acquired in this study, the status of these proteins can now be changed to “confirmed” 
proteins. This work has provided the first large scale proteomic profiling of T. gondii 
and greatly increased the knowledge of the T. gondii proteome, increasing the 
percentage of known expressed genes from ~4% in 2002 to 29% of the total genome. 
The acquisition of protein expression evidence for almost one third of the predicted 
T. gondii proteome has set the foundation for a diverse range of applications in the 
post-genomic era.  
In chapter 3, data interpretation has been carried out using multiple bioinformatics 
tools, which provided valuable insights into the potential biological roles of the 
expressed proteins. The SignalP and TMHMM predictions have predicted the 
composition of signal peptide and transmembrane domains in the expressed 
proteome and suggested a good sampling standard has been achieved. Both of the 
subcellular localization predictions and functional categorization have highlighted 
protein candidates with important biological functions, such as proteins involved in 
the host cell invasion process and apicoplast proteins. The confirmation of the 
expression of these proteins will enlighten further detailed studies on chosen proteins 
of interest. The analysis of metabolic pathway coverage has again demonstrated the 
sensitivity of this proteomic study and suggested a potential application of proteomic 
techniques in understanding key metabolism changes, which was further pursued in 
chapter 7. In addition to the bioinformatics interpretation of the standalone proteomic 
data, further efforts have been made to integrate proteomic data with other genomic 
resources in the context of ToxoDB. 
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In chapter 4, T. gondii proteomic data have been stored in the online data repository, 
Tranche, in the form of raw MS data; it has also been mapped on to ToxoDB in the 
form of peptide identifications for the first time. Both databases offer publically 
accessible interfaces for data downloading and examination, which will benefit the 
global research community. The integration of peptide identifications onto the 
ToxoDB genome scaffold has highlighted the incompleteness of the release 4 
genome annotations. While the majority of the peptide evidence supported the 
correct ORFs and the positioning of start and stop codons, peptide identifications 
have confirmed 421 splice sites that are only predicted by alternative gene models. 
Examined with peptide evidence, three types of annotation errors have been 
highlighted using GBrowse, such as missing exons, alternative frame shift or strand 
orientation and the incorrect positioning of the exon-intron boundaries. These 
important observations have led to the discussion of the limitation of the current 
peptide mapping algorithms. More importantly was the limitation experienced with 
the fundamental work flow of conventional bottom-up proteomics which exclusively 
relied upon the correct prediction of gene coding sequences and suffered labour 
intensive processing caused by the successive upgrades of genome annotations. 
Stimulated by the discrepancies observed between the predicted genome annotation 
and actual, expressed peptide identifications, the importance and potential of a new 
genome annotation pipeline was discussed. Despite some technical hurdles discussed 
that require further investigation, this future proteogenomic approach will harness 
the essence of the raw MS data and combined with the information contained within 
the transcriptome, should lead to a near “perfect” genome annotation in the future. 
In chapter 5, another important application of proteomic data was investigated that 
has been made available by the integration of the data with other genomic resources, 
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the comparison of the proteome and transcriptome of Toxoplasma and other 
Apicomplexa parasites. In T. gondii, a weak correlation between mRNA abundance 
and protein abundance has been observed, where more proteins have been detected 
by proteomics for genes with higher mRNA expression levels determined by 
microarray. More interesting were the discrepancies that were revealed by the 
comparison of the proteomic data with various transcriptomic data. The 60 
tachyzoite genes that were exclusively identified by proteomic data with no 
corresponding transcript expression evidence illustrated the sensitivity of proteomic 
approaches. This also provided interesting candidates for understanding the 
relationship between mRNA and protein abundance levels in Toxoplasma. Another 
interesting observation was that the proteomic data correlated better with a SAGE 
library from an earlier time point of sampling, which is likely to reflect the rapid 
changes in gene expression profiles and the temporal differences between mRNA 
and protein levels. The comparisons across four species of Apicomplexa have seen 
similar discrepancies between the proteome and transcriptome. The attempt to find 
common features amongst genes that show discrepancies between transcriptome and 
proteome at the level of orthology has highlighted several interesting observations 
and candidates that require further study. Although the analysis has not reached an 
overall conclusion, the process has highlighted the importance of temporal and 
quantitative data in a better understanding of the correlation between mRNA and 
protein expression. 
In chapter 6, a preliminary case study was carried out to test the applications of the 
quantitative proteomic approach DIGE in understanding protein expression changes 
of T. gondii tachyzoites grown in the presence or absence of glucose. DIGE has 
several technical advantages over the conventional gel based one-sample-one-gel 
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quantitative approaches. The bioinformatics interpretation of the DIGE result has 
highlighted several interesting candidates such as enzymes that are involved in the 
glycolysis and gluconeogenesis pathways, as well as proteins involved in host cell 
invasion and intracellular survival. The comparison with microarray data has shown 
a surprisingly small number of genes that have been detected by both DIGE and 
microarray, which may reflect the resolution limitations of the DIGE technique. 
More interestingly, discrepancies have been observed for 18 genes which have 
shown significant changes at the protein expression level while the mRNA 
expression level has only been slightly modulated. In addition to that, four genes 
have shown contradictory expression changes between mRNA and protein levels. 
These observations have again highlighted the importance of proteomic data in the 
understanding of the correlation between mRNA and protein expressions. In order to 
better understand the DIGE results, considerations are required to the separation 
limitations inherited from 2-DE and more importantly, the frequently observed 
phenomena of multiple proteins co-migrating to the sample gel spot. Nonetheless, 
DIGE is able to provide a preliminary, high throughput, large scale quantitative 
screening of protein expression changes, while the data verification is readily 
available using the methods discussed in the chapter such as MRM assay. 
In this study, various proteomic techniques have been used to characterize the 
proteome of the T. gondii tachyzoite. The results have expanded the knowledge of 
diverse disciplines of T. gondii biology, such as the composition of the expressed 
proteome and differential expressed proteins in glucose depleted medium. The 
proteomic data have shown important applications in the validation of the existing 
gene models and more importantly, the integration into proteogenomic pipelines to 
improve future genome annotations. The discrepancies observed between proteomic 
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and transcriptomic data have highlighted the importance of gene expression 
regulation following the central dogma of Gene-Transcription-Translation and 
enlightened further investigations.  
Proteomic analysis of T. gondii can be expanded in several directions in the future. 
Firstly, with the current knowledge, little is known about the stage conversion of T. 
gondii from different life cycle forms, the proteomic profiling of more life stages of 
T. gondii would provide valuable insights into the complex life-cycle of the parasite 
and the stage differentiation.  
Secondly, more organelle specific or condition specific sub-proteomic studies would 
benefit the understanding of T. gondii virulence and disease pathogenesis in more 
detail. For example, the proteomic characterization of proteins involved in host cell 
invasion, subcellular localizations, proteins targeting to apicoplast, as well as the 
alteration of the protein expression profile in responds to various environmental 
changes.  
Thirdly, the recent attention of post-translational modifications has already identified 
some important candidates, such as the glycosylated proteins that are involved in 
host-cell interactions [259], SUMOylated proteins that play a putative role in host 
cell invasion and cyst genesis [258]. Further investigations can be carried out in the 
characterization of important post-translational modifications using techniques such 
as 2-DE or affinity chromatography.  
In addition to that, comparative proteomic studies can be designed in Apicomplexa to 
investigate subjects such as host specificities and the regulation of gene expressions 
in different life cycle stages. Together, this will lead to a better understanding of 
Apicomplexa biology. 
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Last but not least, the application of proteogenomics investigated in this study has 
already shown promising prospects in refining genome annotation, the further 
developments in this field could result in a closer involvement of proteomic data in 
genome annotation and fundamentally change the position of proteomic data in the 
future genome annotation pipelines. 
To harness the technical advantages provided by the latest development of 
proteomics, it is important to examine temporal changes using the quantitative 
proteomic approaches. This will in turn benefit the integration of proteomic data 
with other large scale expression data such as transcriptomics and metabolomics. As 
discussed in chapters 5 and 6, the expression profiles provided by transcriptomics 
and proteomics have dramatically increased the knowledge of global gene expression 
and gene function, the ease and pace of discovery and enabled more complex global 
analysis. Together, they have formed a milestone for a comprehensive understanding 
of biological processes. 
In the past, guided by the hypothesis-driven experimentation, every major technique 
and conceptual invention has promoted the understanding of biology to a new level  
[377], such as the invention of the microscope, modern genetics discovered by 
Mendel and the discovery of the genetic code which is still rapidly powering the 
developments of modern biology. Various omics techniques such as transcriptomics, 
proteomics, interactomics and metabolomics have already made a giant step towards 
the understanding of all the basic biological process. In order to make full use of 
these expression data, the ultimate aim would be to use an integrative approach that 
can utilize multiple data sources such as literature, public databases, and high 
throughput experimental data. These data, incorporated with mathematical modelling 
and computer simulation tools, will provide a dynamic view of systems biology 
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within temporal, spatial and physiological contexts, which will in turn extend the 
future experimentation by generating novel hypotheses for further experiments. 
The detailed data standards and modelling algorithms in systems biology are beyond 
the scope of the current study. However, a well designed algorithm will undoubtedly 
accelerate the knowledge accumulation process towards the understanding of the 
entire system. To take an example from ancient Chinese philosophy, a book called “I 
Ching”, written in the 9th century BC, has described a system in which everything 
can be divided into two complementary parts (yin-yang). Yin and yang are further 
divided into 64 different hexagrams; each represents a description of a state or 
process. The hexagrams are connected by an algorithm where they either rule or are 
ruled (at various levels) by each other. The modern equivalent term to the hexagram 
would be “variable”; following the algorithm developed in “I Ching”, the correct 
input of a collection of known variables will lead to a prediction of the changes to 
the unknown variables. The philosophy developed in “I Ching” has influenced the 
development of various aspects of ancient Chinese science, such as traditional 
medicine. 
The process of knowledge accumulation towards an integrative understanding of 
every subject system can be summarized in a three-step cycle: macrocosmic-
microcosmic-macrocosmic. In the first macrocosmic step, there are too many 
variables that are unknown, everything is observed in a crude way. That is when “I 
Ching” was created to organize all the seemingly unrelated observations and guide 
the exploration. In the second step, when enough evidence and theories have been 
discovered, they are further divided into diverse disciplines, where everything can be 
studied into more detail microcosmically. In the third step, when sufficient 
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knowledge has been acquired, the subject system can be studied at a macrocosmic 
view again, only to a much higher integrative level. 
Through each cycle of the three steps, the knowledge accumulated will drive the 
development of the new cycle. In the post genomic era, it can be foreseen that the 
various omics techniques will rapidly fulfil the data requirements for the second 
microcosmic step in the current cycle. Followed by the macrocosmic step of 
integrative systems biology, this will soon uncover the mysteries of the majority of 
biological processes, which will bring the understanding of biology to a new level.  
Sharing the excitements of the post genomic era in biology with the latest 
development of physics, some potential limitations can be predicted for the 
integrative systems biology, through which perspectives can be speculated that will 
drive the development of the biology in the new cycle. In his book of “A Brief 
History of Time”, Stephen Hawking has reasoned that: “Even if we do find a 
complete set of basic laws, there will still be in the years ahead the intellectually 
challenging task of developing better approximation methods, so that we can make 
useful predictions of the probable outcomes in complicated and realistic situations” 
[378]. In physics, the limitations come from the uncertainty principle of quantum 
mechanics and the difficulty of modelling all theories to equations; whilst in biology, 
the organic world is much more difficult and complex to predict, with 
indeterminacies such as genetic mutations and stochastic behaviour.  
The proteomic study of T. gondii has emerged to be an important component of the 
rapidly developing integrative systems biology, fascinated by the power and 
applications of proteomics and other omics techniques in the pursuit of the 
comprehensive understanding of all basic biological process, I would like to end my 
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thesis quoting Stephen Hawking‟s prospect in “A Brief History of Time”: “A 
complete, consistent, unified theory is only the first step: our goal is a complete 
understanding of the events around us, and of our own existence” [378].  
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